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A B S T R A C T
Background
Pressure ulcers (i.e. bedsores, pressure sores, decubitus ulcers) are areas of localised damage to the skin and underlying tissue. They are
common in the elderly and immobile, and costly in financial and human terms. Pressure-relieving support surfaces (i.e. beds, mattresses,
seat cushions etc) are used to help prevent ulcer development.
Objectives
This systematic review seeks to establish:
(1) the extent to which pressure-relieving support surfaces reduce the incidence of pressure ulcers compared with standard support
surfaces, and,
(2) their comparative effectiveness in ulcer prevention.
Search methods
For this third update we searched: the Cochrane Wounds Group Specialised Register (searched 8 December 2010), The Cochrane
Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2010, Issue 4); Ovid MEDLINE (1950 to November Week
3 2010); Ovid MEDLINE (In-Process & Other Non-Indexed Citations December 07, 2010); Ovid EMBASE (1980 to 2010 Week
48); EBSCO CINAHL (1982 to 3 December 2010), and the reference sections of included studies.
Selection criteria
Randomised controlled trials (RCTs) and quasi-randomised studies, published or unpublished, that assessed the effects of any support
surface for prevention of pressure ulcers, in any patient group or setting which measured pressure ulcer incidence.Studies reporting
only proxy outcomes (e.g. interface pressure) were excluded. Two review authors independently selected studies.
Data collection and analysis
Data were extracted by one author and checked by another. Where appropriate, estimates from similar studies were pooled for meta-
analysis.
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Main results
One new trial was included, bringing the total of included studies to 53.
Foam alternatives to standard hospital foam mattresses reduce the incidence of pressure ulcers in people at risk (RR 0.40 95% CI
0.21 to 0.74). The relative merits of alternating- and constant low-pressure devices are unclear. One high-quality trial suggested that
alternating-pressure mattresses may be more cost effective than alternating-pressure overlays in a UK context.
Pressure-relieving overlays on the operating table reduce postoperative pressure ulcer incidence, although two studies indicated that
foam overlays caused adverse skin changes. Meta-analysis of three trials indicated that Australian standard medical sheepskins prevent
pressure ulcers (RR 0.56 95% CI 0.32 to 0.97).
Authors’ conclusions
People at high risk of developing pressure ulcers should use higher-specification foam mattresses rather than standard hospital foam
mattresses. The relative merits of higher-specification constant low-pressure and alternating-pressure support surfaces for preventing
pressure ulcers are unclear, but alternating-pressure mattresses may be more cost effective than alternating-pressure overlays in a UK
context. Medical grade sheepskins are associated with a decrease in pressure ulcer development. Organisations might consider the use
of some forms of pressure relief for high risk patients in the operating theatre.
P L A I N L A N G U A G E S U M M A R Y
Can pressure ulcers be prevented by using different support surfaces?
Pressure ulcers (also called bed sores and pressure sores) are ulcers on the skin caused by pressure or rubbing at the weight-bearing, bony
points of immobilised people (such as hips, heels and elbows). Different support surfaces (e.g. beds, mattresses, mattress overlays and
cushions) aim to relieve pressure, and are used to cushion vulnerable parts of the body and distribute the surface pressure more evenly.
The review found that people lying on ordinary foam mattresses are more likely to get pressure ulcers than those lying on a higher-
specification foam mattress. In addition the review also found that people who used sheepskin overlays on their mattress developed
fewer pressure ulcers. While alternating-pressure mattresses may be more cost effective than alternating-pressure overlays, the evidence
base regarding the merits of higher-specification constant low-pressure and alternating-pressure support surfaces for preventing pressure
ulcers is unclear. Rigorous research comparing different support surfaces is needed.
B A C K G R O U N D
Description of the condition
Pressure ulcers (also known as pressure sores, decubitus ulcers and
bed sores) are areas of localised damage to the skin and under-
lying tissue, believed to be caused by pressure, shear or friction
(EPUAP-NPUAP 2009). Pressure ulcers are more likely to oc-
cur in those who are seriously ill; neurologically compromised
(e.g. individuals with spinal cord injuries (Elliot 1999)); have im-
paired mobility (Allman 1997; Berlowitz 1990; Berlowitz 1997;
Bianchetti 1993); or who are immobile (including those wearing
a prosthesis, body brace or plaster cast). Other risk factors include
impaired nutrition (Banks 1998; Casey 1997; Casey 1998; Ek
1990); obesity (Gallagher 1997); poor posture, which puts extra
pressure on bony prominences; or using equipment that does not
provide appropriate pressure relief, such as seating or beds. Pres-
sure ulcers particularly affect older people (Hefley 1990; Krainski
1992; Orlando 1998; Pase 1998; Ronda 2002; Spoelhof 2000;
Thomas 2001; Waltman 1991); but have also been reported in
pregnant women (Prior 2002). Pressure ulcers have also been as-
sociated with an increased incidence of infection, including os-
teomyelitis (Darouiche 1994).
The development of pressure ulcers is relatively common. A re-
view of epidemiological studies in Europe, Canada and the USA
described the reported prevalence of pressure ulcers in European
hospitals as ranging from 8.3% to 23% (Vanderwee 2007). In the
UK, the overall prevalence of pressure ulcers within care settings
was 10.2%, with 59% of these being hospital-acquired (Phillips
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2009). In the USA and Canada, prevalence ranged from 12.3% in
US health care facilities (VanGilder 2009), to 33% in patients in
the community with spinal cord injury, and the overall estimate
of pressure ulcer incidence in Canadian healthcare settings has
been reported as 26% (Woodbury 2004). The presence of pres-
sure ulcers has been associated with a two- to four-fold increase
in risk of death in older people in intensive care units, however,
these findings were not adjusted for other prognostic factors (Bo
2003; Clough 1994; Thomas 1996). Based on the available Eu-
ropean data, it has been estimated that between one-in-four and
one-in-five patients within an acute hospital setting (i.e. neurol-
ogy, ICU, chronic and acute care units) will have had a pressure
ulcer (Vanderwee 2007). Estimates on pressure ulcer incidence
and prevalence from hospital-based studies vary widely according
to the definition and grade of ulcer, the patient population and
care setting. Within the community, the incidence rate within the
UK ranges from 4.4% to 6.8%, and in the USA and Canada it is
up to 16.5% (Kaltenhalter 2001).
Tthe financial cost of treating ulcers in the UK varies from GBP
1,064 for a grade 1 ulcer to GBP 10,551 for a grade 4 ulcer, with
total costs in the UK estimated as being GBP 1.4 to 2.1 billion
annually, which is equivalent to 4% of the total National Health
Service (NHS) expenditure (Bennett 2004). National prevalence
and incidence data from the US report, based on a 24 hour data
collection period at each participating institution, indicate that the
annual cost to the American health system of treating all hospital-
acquired pressure ulcers to be between USD 2.2 and 3.6 billion
(Whittington 2004).
Healthcare professionals attempt to prevent and treat pressure ul-
cers by using a variety of support surfaces with the aim of reliev-
ing pressure. These include - but are not limited to - mattresses,
beds, overlays, cushions and chairs. A summary of the available
support surfaces for pressure ulcer treatment is the subject of an-
other Cochrane review which is in preparation (Support surfaces
for treating pressure ulcers).
Description of the intervention
The aim of pressure ulcer prevention strategies is to reduce either
the magnitude, or duration, of pressure between a patient and his
(or her) support surface (i.e. the interface pressure), or both. This
may be achieved by regular manual repositioning (e.g. two-hourly
turning), or by using pressure-relieving support surfaces such as
cushions, mattress overlays, replacement mattresses or whole bed
replacements, which are widely used in both institutional and non-
institutional settings. Often a combination of repositioning and
support surface enhancement may be used. Support surfaces are
used with the aim of redistributing pressure, reducing shearing
forces and controlling the local microclimate. The cost of these
interventions varies widely; from over GBP 30,000 for some bed
replacements, to less than GBP 100 for some foam overlays. In-
formation on the relative cost-effectiveness of this equipment is
needed to inform use.
How the intervention might work
Pressure-relieving cushions, beds and mattresses either mould
around the shape of the patient to distribute the patient’s weight
over a larger contact area (constant low-pressure devices) (CLP); or
vary the pressure beneath the patient mechanically, thus reducing
the duration of the applied pressure (alternating-pressure devices)
(AP) (Bliss 1993). CLP devices (either overlays, mattresses or re-
placement beds) can be grouped according to their construction
(foam, foam and air, foam and gel, profiled foam, hammocks, air
suspension, water suspension and air-particulate suspension/air-
fluidised). These devices fit, or mould, around the body so that
the pressure is dispersed over a large area, and are mainly classified
as being of a lower technological specification (i.e. “low-tech”).
By comparison, air-fluidised beds, where warmed air circulates
through fine ceramic beads covered by a permeable sheet, and low-
air-loss beds, where patients are supported on a series of air sacs
through which warmed air passes, are high-specification CLP de-
vices.
Alternating-pressure devices generate alternating high and low in-
terface pressures between body and support, usually by alternate
inflation and deflation of air-filled cells. Such devices are available
as cushions, mattress overlays, and single-or multi-layer mattress
replacements. These devices are classified as being high specifica-
tion (i.e. “high-tech”).
Other support surfaces, such as turning beds, turning frames, net
beds, and turning/tilting beds move patients who are unable to
turn themselves manually or automatically. Pressure ulcer preven-
tion is often not the reason for using turning and tilting beds,
which may be used in Intensive and Critical Care Units for other
reasons, e.g. to promote chest drainage.
Why it is important to do this review
Research indicates that pressure ulcers represent a major burden of
sickness and reduced quality of life for patients, their carers (Franks
1999; Franks 2002; Hagelstein 1995), and their families (Benbow
1996; Elliot 1999). Often patients who develop pressure ulcers
require prolonged and frequent contactwith the healthcare system;
and suffermuch pain (Emflorgo 1999; Flock 2003; Freeman 2001;
Healy 2003; Manfredi 2002), discomfort and inconvenience (
Franks 1999).
The presence of a pressure ulcer creates a number of significant
difficulties psychologically, physically and clinically to patients,
carers and their families. Clinicians, working in a variety of clin-
ical and non-clinical settings, including primary care and acute
trusts, also face challenges when providing holistic, person-cen-
tred services for the assessment and treatment of pressure ulcers.
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These challenges include clinical decisions regarding methods of
assessment, and which treatments to use on individuals with an
existing pressure ulcer.
Healthcare professionals attempt to reduce the incidence of severe
pressure ulcers by the identification of people at high risk, and the
use of preventative strategies, such as the deployment of pressure-
relieving equipment. It is essential that initiatives are based on
the best available clinical- and cost-effectiveness evidence, and we
have, therefore, undertaken a systematic review of the evidence
for the effectiveness of pressure-relieving support surfaces such as
beds, mattresses, cushions, and repositioning interventions.
O B J E C T I V E S
This systematic review seeks to answer the following questions:
• to what extent do pressure-relieving cushions, beds,
mattress overlays and mattress replacements reduce the incidence
of pressure ulcers compared with standard support surfaces?
• how effective, compared to one another, are different
pressure-relieving surfaces in preventing pressure ulcers?
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) and quasi-randomised trials
comparing support surfaces, and which measured the incidence
of new pressure ulcers. Studies that only reported subjective mea-
sures of outcome (e.g. skin condition “better” or “worse”) were
excluded, as were studies that reported only proxy measures such
as interface pressure. Trials were eligible for inclusion if they re-
ported an objective, clinical, outcome measure such as incidence
and severity of new pressure ulcers developed.
Types of participants
People receiving health care who were deemed to be at risk of
developing pressure ulcers, in any setting. Some studies involved
people who had existing pressure ulcers, however, only the inci-
dence of new pressure ulcers was examined.
Types of interventions
Studies which evaluated the following interventions for preventing
pressure ulcers were included:
1. “Low-tech” CLP support surfaces
• Standard foam mattresses.
• Alternative foam mattresses/overlays (e.g. convoluted foam,
cubed foam): these are conformable and aim to redistribute
pressure over a larger contact area.
• Gel-filled mattresses/overlays: mode of action as above.
• Fibre-filled mattresses/overlays: mode of action as above.
• Air-filled mattresses/overlays: mode of action as above.
• Water-filled mattresses/overlays: mode of action as above.
• Bead-filled mattresses/overlays: mode of action as above.
• Sheepskins: proposed mode of action unclear.
2. “High-tech” support surfaces
• Alternating-pressure (AP) mattresses/overlays: patient lies
on air-filled sacs that inflate and deflate sequentially to relieve
pressure at different anatomical sites for short periods; these may
incorporate a pressure sensor.
• Air-fluidised beds: warmed air circulates through fine
ceramic beads covered by a permeable sheet; allowing support
over a larger contact area (CLP).
• Low-air-loss beds: patients are supported on a series of air
sacs through which warmed air passes (CLP).
3. Other support surfaces
• Turning beds/frames: these work either by aiding manual
repositioning of the patient, or by motor driven turning and
tilting.
• Operating table overlays: mode of action as above.
• Wheelchair cushions: either conforming cushions that
reduce contact pressures by increasing surface area in contact, or
mechanical cushions e.g. alternating pressure.
• Limb protectors: pads and cushions of different forms to
protect bony prominences.
Types of outcome measures
Primary outcomes
1. Incidence of new pressure ulcers
Many evaluations simply measure the pressure on different parts
of the body in contact with the support surface (i.e. the interface
pressure). This, however, is an intermediate, or surrogate, outcome
measure with serious limitations as a proxy for a clinical outcome,
since the process which leads to the development of a pressure
ulcer almost certainly involves the complex interplay of several
factors. In this review we have only considered trials that reported
the clinical outcome measure of pressure ulcer incidence.
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Some studies do not differentiate between those people who de-
velop grade 1 ulcers (in which the skin is unbroken), and those
who develop more severe ulcers. Studies that compare the inci-
dence of pressure ulcers of grade 2 or greater are more likely to
be reliable (see below for details of grading system), however, we
included all studies irrespective of whether grade 1 ulcers were de-
scribed separately.
2. Grades of new pressure ulcers
Various pressure ulcer severity classification systems are in use,
including in trials of pressure relieving interventions. An ex-
ample of a commonly-used grading system is presented below;
this has been adapted from an EPUAP classification system
(www.epuap.org.uk):
Grade 1: persistent discolouration of the skin including non-
blanchable erythema; blue/purple/black discolouration.
Grade 2: partial-thickness skin loss involving epidermis and der-
mis.
Grade 3: full-thickness skin loss involving damage or necrosis of
subcutaneous tissues, but not through the underlying fascia, and
not extending to the underlying bone, tendon or joint capsule.
Grade 4: full-thickness skin loss with extensive destruction and
tissue necrosis extending to the underlying bone, tendon or joint
capsule.
Secondary outcomes
• Costs of the devices.
• Patient comfort.
• Durability/longevity of the devices.
• Acceptability of the devices for healthcare staff.
• Quality of life.
Search methods for identification of studies
See Appendix 1 for the search methods used in the second update
of this review.
Electronic searches
For this third reviewupdate, the followingdatabaseswere searched:
• Cochrane Wounds Group Specialised Register (searched 8
December 2010);
• The Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library 2010, Issue 4);
• Ovid MEDLINE (1950 to November Week 3 2010);Ovid
MEDLINE (In-Process & Other Non-Indexed Citations
December 07, 2010);
• Ovid EMBASE (1980 to 2010 Week 48);
• EBSCO CINAHL (1982 to 3 December 2010)
The following search strategy was used for CENTRAL and mod-
ified, where appropriate, for other databases:
#1 MeSH descriptor Beds explode all trees
#2 mattress*
#3 cushion*
#4 “foam” or transfoam
#5 overlay*
#6 “pad” or “pads”
#7 “gel”
#8 pressure NEXT relie*
#9 pressure NEXT reduc*
#10 pressure NEXT alleviat*
#11 “low pressure” NEAR/2 device*
#12 “low pressure” NEAR/2 support
#13 constant NEAR/2 pressure
#14 “static air”
#15 alternat* NEXT pressure
#16 air NEXT suspension*
#17 air NEXT bag*
#18 water NEXT suspension*
#19 elevation NEAR/2 device*
#20 clinifloat or maxifloat or vaperm or therarest or sheepskin or
hammock or “foot waffle” or silicore or pegasus or cairwave
#21 (turn* or tilt*) NEXT (bed* or frame*)
#22 kinetic NEXT (therapy or table*)
#23 net NEXT bed*
#24 “positioning” or “repositioning”
#25 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR
#9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16
OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR
#24)
#26 MeSH descriptor Pressure Ulcer explode all trees
#27 pressure NEXT (ulcer* or sore*)
#28 decubitus NEXT (ulcer* or sore*)
#29 (bed NEXT sore*) or bedsore*
#30 (#26 OR #27 OR #28 OR #29)
#31 (#25 AND #30)
The search strategies for Ovid MEDLINE, Ovid EMBASE and
EBSCO CINAHL can be found in Appendix 2, Appendix 3 and
Appendix 4 respectively. The MEDLINE search was combined
with theCochraneHighly Sensitive Search Strategy for identifying
randomised trials in MEDLINE: sensitivity- and precision-max-
imizing version (2008 revision)(Lefebvre 2009). The EMBASE
and CINAHL searches were combined with the trial filters devel-
oped by the Scottish Intercollegiate Guidelines Network (SIGN
2008). There was no restriction on the basis of the language in
which the study reports were written, nor publication status.
Searching other resources
Originally, experts in the field of wound care were contacted to en-
quire about potentially-relevant ongoing, and recently published,
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trials. In addition, manufacturers of support surfaces were con-
tacted for details of any trials they were conducting. This pro-
cess was not productive, and so was not repeated for this update.
However, reference lists within obtained reviews and papers were
scrutinised in an effort to identify additional studies.
Data collection and analysis
Selection of studies
For this update the titles and abstracts of the search results were
assessed for relevance independently by two review authors (EMcI,
AJ-B). Full copies of all potentially-relevant studies were obtained.
Decisions on final inclusion after retrieval of full papers was made
by one review author (EMcI), and was checked by a second (AJ-
B); disagreements were resolved by discussion with a third review
author (NC or SB-S). Rejected studies were checked by a third
review author (SB-S or NC).
Data extraction and management
Two review authors extracted details of included studies indepen-
dently using a pre-prepared data extraction sheet. We resolved any
disagreements over data by discussion, with referral to a third re-
view author for adjudication if necessary. The following data were
extracted from each study:
• Care setting.
• Clear description of main interventions.
• Key baseline variables by group, for example, age, sex,
baseline risk of pressure ulcer development, baseline area of
existing ulcers.
• Description of the interventions and numbers of patients
randomised to each intervention.
• Description of any co-interventions/standard care.
• Duration and extent of follow-up.
• Acceptability and reliability of equipment within the
clinical setting.
• Description of inclusion and exclusion criteria used to
derive the sample from the target population.
• Description of a priori sample size calculation.
• Incident ulcers described by severity grading as well as
frequency (grade 1 ulcers are not breaks in the skin and are
subject to more inter-rater variation).
Assessment of risk of bias in included studies
For the update of this review, two review authors assessed each
included study independently using the Cochrane Collaboration
tool for assessing risk of bias (Higgins 2008). This tool addresses
six specific domains, namely sequence generation; allocation con-
cealment; blinding of either participants, or personnel or asses-
sors, or any combination of the three; incomplete outcome data;
selective outcome reporting and other issues (e.g. extreme base-
line imbalance) (see Appendix 5 for details of criteria on which
the judgements are based). Blinding and completeness of outcome
data were assessed separately for each outcome. We completed a
risk of bias table for each eligible study.We discussed any disagree-
ment amongst all review authors to achieve a consensus. We pre-
sented an assessment of risk of bias using a risk of bias summary
figure, which presents all of the judgments in a cross-tabulation of
study by entry. Evaluating the validity of each study may assist the
reader in interpreting and making conclusions about the study.
Dealing with missing data
When a paper provided insufficient information for full data ex-
traction, or if conflicting data were found, we approached study
authors for additional information. Where there are losses to fol-
low and a treatment effect exists we plan to test the robustness
of the result to different assumptions in dealing with the missing
data, for example assuming all losses did not develop pressure ul-
cers. We included studies published in duplicate only once; we
nominated a primary data source, althoughwe reviewed secondary
publications for additional data.
Data synthesis
For each trial, we calculated relative risk (RR) for categorical out-
comes such as number of patients developing ulcers, with 95%
confidence intervals (95% CI). The results were plotted on to
graphs and discussed by narrative review. Individual study de-
tails are presented in the Characteristics of included studies table.
Where there was more than one trial comparing similar devices
using the same outcome (though possibly differing lengths of fol-
low-up), statistical heterogeneity was assessed by means of the I2
statistic (Higgins 2003). An I2 value greater than 50% indicates
substantial heterogeneity, and will be considered statistically sig-
nificant where the P value is less than 0.10 (Higgins 2003). In the
absence of significant statistical heterogeneity, studies with simi-
lar comparisons were pooled using a fixed-effect model. If hetero-
geneity was observed, a random-effects model was used.
For the purpose of meta-analysis we assumed that the risk ratio
remained constant for different lengths of follow-up, hence studies
were pooled if participants were followed-up for different lengths
of time. All statistical analysis were performed on RevMan 5.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of studies awaiting classification.
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Results of the search
The search for the third update of this review resulted in the
inclusion of one new trial (Mistiaen 2009). Seven studies that
had been awaiting assessment were excluded (Büchner 1995;
Defloor 1997; Geelkerken 1994; Haalboom 1994; Holzgreve
1993; Neander 1996; Zernike 1994) and their details added to
the Characteristics of excluded studies table. A further 11 stud-
ies which were retrieved in full did not meet the inclusion crite-
ria and were excluded (Della Valle 2001; Gil Agudo 2009; Gray
2008; Grisell 2008; Heyneman 2009; Huang 2009; McMichael
2008; Timmons 2008; Turnage-Carrier 2008; Vanderwee 2007;
Vanderwee 2008) (see Characteristics of excluded studies table for
reasons). One study remained classified as awaiting assessment,
as further information has been sought from the study author
(Berthe 2007); one study Allegretti 2008 was classified as awaiting
assessment pending full publication of the study and five studies
are awaiting full text retrieval (Demarré 2010; Mastrangelo 2010;
Mayer 2008; Taccone 2009; van Leen 2011).
Included studies
The one new included study brought the total number of included
trials to 53 (Mistiaen 2009) (see Characteristics of included studies
and Table 1). Twenty-seven trials involved participants without
pre-existing pressure ulcers (intact skin); eight trials included pa-
tients with ulcers greater than or equal to grade 1 at baseline; four
trials did not specify the grading of the pre-existing ulcers, and
one trial only included people with grade 4 pressure ulcers. In 12
trials the baseline skin status of the participants was unclear.
Study settings
Five studies evaluated different operating table surfaces (
Aronovitch 1999; Feuchtinger 2006; Nixon 1998; Russell 2000;
Schultz 1999); nine evaluated different surfaces in intensive care
units (ICU) (Cadue 2008; Gebhardt 1996; Gentilello 1988;
Inman 1993; Laurent 1998; Sideranko 1992; Summer 1989;
Takala 1996; Theaker 2005); eight studies confined their evalu-
ation to orthopaedic patients (Cooper 1998; Exton-Smith 1982;
Goldstone 1982; Hofman 1994; McGowan 2000; Price 1999;
Santy 1994; Stapleton 1986); and one involved both an Accident
& Emergency and ward setting (Gunningberg 2000). Five studies
were set in extended care facilities (Conine 1990; Conine 1993;
Conine 1994; Daechsel 1985; Lim 1988); three studies were set in
nursing homes (Geyer 2001; Lazzara 1991; Mistiaen 2009); seven
studies involved two or more different hospital wards (Bennett
1998; Cavicchioli 2007; Cobb 1997; Gray 1994; Kemp 1993;
Russell 2003; Vanderwee 2005). Fifteen studies did not spec-
ify the study setting (Andersen 1982; Collier 1996; Economides
1995; Ewing 1964; Gilcreast 2005; Gray 1998; Hampton 1997;
Jolley 2004; Keogh 2001;Nixon 2006; Sanada 2003; Taylor 1999;
Tymec 1997; Vyhlidal 1997; Whitney 1984).
Interventions
Eleven trials evaluated cushions; four evaluated the use of sheep-
skins; four looked at turning beds/tables; sixteen examined over-
lays; 27 looked at mattresses; three evaluated foam surfaces, and
two examined waffle surfaces. A number of studies evaluated mul-
tiple interventions.
Small sample size
Small sample size was a major limitation of many of the studies;
the median sample size was 100 (range 12 to 1972), and only 20
studies reported an a priori sample size estimate.
Excluded studies
In total 59 studies were excluded from the review. Two were litera-
ture reviews (Heyneman 2009; Vanderwee 2008); eight studies re-
ported insufficient information or data to allow a complete assess-
ment and no further information was available through contact
with the study authors (Barhyte 1995; Braniff-Matthews 1997;
Bliss 1995; Geelkerken 1994 Holzgreve 1993; Neander 1996;
Scott 1995; Zernike 1994); 20 studies did not report clinical ul-
cer-related outcomes (Allen 1993; Ballard 1997; Brienza 2001;
Colin 1996; deBoisblanc 1993; Della Valle 2001; Flam 1995; Gil
Agudo 2009; Grindley 1996; Grisell 2008; Koo 1995;McMichael
2008; Rosenthal 1996; Scott 1999; Suarez 1995; Takala 1994;
Turnage-Carrier 2008;Wells 1984;Wild 1991; Zernike 1997); 11
studies did not use an eligible study design (Bliss 1967; Büchner
1995; Chaloner 2000; Gray 2008; Gunningberg 1998;Marchand
1993; Ooka 1995; Phillips 1999; Regan 1995; Reynolds 1994;
Stoneberg 1986); nine studies did not consider the interven-
tion of interest, i.e. a support surface, (Defloor 1997; Defloor
2000; Defloor 2004; Huang 2009; Inman 1999; Jacksich 1997;
Jesurum 1996; Torra i Bou 2002; Vanderwee 2007) and nine
studies did not meet the inclusion criteria for the review in other
ways (Andrews 1989; Conine 1991; Fleischer 1997; Haalboom
1994;Hampton 1998;Hawkins 1997; Scott 2000; Thomas 1994;
Timmons 2008).
Of the 20 studies which did not report clinical ulcer-related out-
comes, 14 recorded only interface pressure (Allen 1993; Brienza
2001; Della Valle 2001; Gil Agudo 2009; Grisell 2008; Koo 1995;
McMichael 2008; Rosenthal 1996; Scott 1999; Suarez 1995;
Takala 1994; Turnage-Carrier 2008; Wells 1984; Wild 1991; two
reported comfort data (Ballard 1997; Grindley 1996); Colin 1996
measured transcutaneous oxygen tension; deBoisblanc 1993 re-
ported pneumonia as the outcome, Flam 1995 skin temperature
and moisture level and Zernike 1997 did not report the incidence
of pressure ulcers
Risk of bias in included studies
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Details of the risk of bias of each individual study are included
in Characteristics of included studies and shown in Figure 1 and
Figure 2.
Figure 1. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
8Support surfaces for pressure ulcer prevention (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
The method of randomisation was unclear in 27 of the 53 (51%)
included studies. Although the majority of trials reported patient
eligibility criteria, fewer than half of the reports gave information
that indicated patients were allocated with concealed allocation
(16 of the 53 trials or 30%).
Blinding
Blinded outcome assessment is rarely used in wound care studies,
and this was the case in these evaluations of support surfaces. It
can be difficult or impossible to disguise the surface that a patient
is on for assessment of outcome, and patients are often too ill to
be removed from their beds for assessment of their pressure areas.
Nevertheless, some studies minimise bias in outcome assessment
by having a second assessor and presenting inter-rater reliability
data, or by presentingphotographic evidence of pressure area status
which can then be assessed by an independent assessor blinded to
treatment. Of the 53 RCTs in this review, we could be confident
that blinded outcome assessment had been used in only eight trials
(15%).
Incomplete outcome data
Assessment of whether incomplete outcome data had been ade-
quately addressed in each study involved examining whether rea-
sons for attrition or exclusion were reported; whether there was
re-inclusion of participants; and whether the completeness of data
for each main outcome was described. Twenty-five of the 53 stud-
ies reviewed (i.e. 47%) adequately addressed incomplete outcome
data. Six of the remaining studies did not address incomplete out-
come data adequately, and, for the final 22 studies it was unclear
or unstated. High attrition rates and lack of an intention-to-treat
analysis were also common.
Selective reporting
For a study tohave demonstrated itwas free of selective outcome re-
porting, a study protocol stating all pre-specified outcomes needed
to have been reported, or, if the study protocol was not available,
clear inclusion of all expected outcomes (including pre-specified
outcomes). We were satisfied that forty-two out of 53 (79%) of
the studies were free of selective outcome reporting. Three studies
were not free of selective outcome reporting due to: pre-specified
outcomes not being completely reported, incomplete reporting of
outcomes, or reporting of outcomes that were not pre-specified
(Bennett 1998; Exton-Smith 1982; Taylor 1999). For eight stud-
ies, there was insufficient information to classify whether there was
or was not selective outcome reporting (Cadue 2008; Gebhardt
1996; Gentilello 1988; Gilcreast 2005; Hampton 1997; Mistiaen
2009; Stapleton 1986; Vanderwee 2005). We cannot exclude the
possibility that we have introduced some level of bias by excluding
studies which did not report ’pressure ulcer outcomes’, this issue
will be explored in more detail in the next update.
Other potential sources of bias
Other potential sources of bias included assessing whether the tim-
ing of outcomes under investigation were similar in both groups,
and whether the groups under investigation were similar at base-
line regarding the most important prognostic indicators. Tim-
ing of outcomes under investigation were similar in both groups
under investigation in 33 (62%) of the 53 studies. In studies of
pressure ulcer prevention, it is extremely important for trialists to
report the baseline comparability of the intervention groups for
important variables such as baseline risk. Amongst the included
studies, risk of pressure ulcer development was measured by a
variety of tools including the Norton (Norton 1979), Waterlow
(Waterlow 1985), Gosnell (Gosnell 1973) and Braden (Bergstrom
1998) scales. Some of the studies reviewed here did not present
such baseline data, nor explain what the various cut-offs for inclu-
sion in the studies meant in terms of whether study participants
were at low, medium or high risk for the development of pressure
ulcers. Baseline characteristics were similar between the groups
under investigation in 37 (70%) of the 53 studies. Another short-
coming was that trial reports were unclear about whether grade 1
pressure ulcers were included in the study sample or the analysis,
or both.
Risk of bias was not used to weight the studies in the analysis us-
ing any statistical technique, however, methodological quality is
discussed in relation to the interpretation of the results. Method-
ological flaws for each study are presented in Characteristics of
included studies.
Effects of interventions
How the results are presented and what the terms
mean
Results of dichotomous variables are presented as risk ratio (RR)
with 95%confidence intervals (CI). Risk ratio has been used rather
than odds ratios as it is easier to interpret than odds ratios (Deeks
1998). Risk ratio is the pressure ulcer incidence rate in the exper-
imental group divided by the incidence rate in the control group
and indicates the likelihood of pressure ulcer development on an
experimental device compared with a comparison device. As, by
definition, the risk of an ulcer developing in the control group
is one, then the relative risk reduction associated with using the
experimental bed is one-minus-RR. The risk ratio indicates the
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relative benefit of a therapy, but not the actual benefit, i.e. it does
not take into account the number of people who would have de-
veloped an ulcer anyway. The absolute risk reduction (ARR) can
be calculated by subtracting the incidence rate in the experimen-
tal group from the incidence rate in the control group. The ARR
tells us how much the reduction is due to the support surface it-
self, and its inverse is the number needed to treat, or NNT. Thus
an incidence rate of 30% on a control mattress reduced to 15%
with an experimental mattress translates into an ARR of 30-15 =
15% or 0.15, and an NNT of seven, in other words seven patients
would need to receive the experimental mattress to prevent the
development of one additional pressure ulcer.
Methods for measuring secondary outcomes such as comfort,
durability, reliability and acceptability were not well developed.
Where data were presented they appear in the Characteristics of
included studies, but were not incorporated in the analysis.
1. “Low-tech” constant low-pressure (CLP) supports
This section considers comparisons of standard foamhospital mat-
tresses with other low specification (low-tech), constant low-pres-
sure (CLP) supports. We regarded the following as low-tech CLP:
sheepskin, static air-filled supports; water-filled supports; con-
toured or textured foam supports; gel-filled supports; bead-filled
supports; fibre-filled supports, and alternative foam mattresses or
overlays. It should be emphasised, however, that there is no inter-
national definition of what constitutes a standard foam hospital
mattress, and, indeed, this changes over time within countries, and
even within hospitals. Where a description of the standard was
provided it is included in the Characteristics of included studies
table. We have assumed that standard mattresses are likely to vary
less within countries than between countries, and undertook sub-
group analysis by country, although this was not pre-specified.
1.1 Standard foam hospital mattress compared with other
“low-tech” CLP
Eight RCTs compared ’standard’ mattresses or surfaces with “low-
tech” supports for the prevention of pressure ulcers (Andersen
1982; Collier 1996; Goldstone 1982; Gray 1994; Gunningberg
2000; Hofman 1994; Russell 2003; Santy 1994).
When compared with standard hospital mattresses, the incidence
and severity of pressure ulcers in patients deemed to be high risk
were significantly reduced when patients were placed on either the
cubed foam mattress (Comfortex DeCube) (RR 0.34; 95% CI
0.14 to 0.85) (Hofman 1994); the bead-filled mattress (Beaufort
bead bed) (RR 0.32; 95%CI 0.14 to 0.76) (Goldstone 1982); the
Softfoam mattress (RR 0.2; 95% CI 0.09 to 0.45) (Gray 1994);
or the water-filled mattress (RR 0.35; 95% CI 0.15 to 0.79) (
Andersen 1982) (Analysis 1.1).
In an unpublished British study of older people with hip frac-
tures admitted to orthopaedic trauma wards, patients allocated to
receive the then NHS standard foam mattress (manufactured by
Relyon) experienced over three times the rate of pressure ulcers
experienced by those using one of a number of foam alternatives
(Clinifloat, Therarest, Transfoam and Vaperm) (RR 0.36; 95%
CI 0.22 to 0.59) (Santy 1994). Another study found a significant
decrease in the incidence of grade 1 pressure ulcers from 26.3%
to 19.9% (P value 0.0004), and a non-significant decrease in the
incidence of pressure ulcers grade 2 to 4 from 10.9% to 8.5% in
patients allocated to the high-specification foam mattress/cush-
ion (CONFOR-med) (RR 0.78; 95% CI 0.55 to 1.11) (Russell
2003). No patient developed a pressure ulcer in the Collier 1996
trial which involved a comparison of eight different foam mat-
tresses (Reylon, Clinifloat, Omnifoam, Softform, STM5, Ther-
arest, Transfoam and Vapourlux). The comparisons were consid-
ered too heterogeneous, and so we did not pool these seven studies
(Analysis 1.1).
Gunningberg 2000 examined the effects of a viscoelastic foam
trolley mattress and subsequent overlay on 101 patients with a
suspected hip fracture in the Accident & Emergency (A&E) and
ward setting. There was no significant difference in pressure ul-
cer incidence between those assigned a visco-elastic foam trolley
mattress on arrival in A&E followed by a viscoelastic foam overlay
on the standard ward mattress (4/48, 8%) and those assigned a
standard trolley mattress and then a standard hospital mattress on
the ward (8/53, 15%).
The five trials comparing foam alternatives with the standard hos-
pital foam mattress were pooled using a random-effects model (I2
= 77%) (Collier 1996; Gray 1994; Hofman 1994; Russell 2003;
Santy 1994). These trials were of mixed quality; they all provided
evidence of allocation concealment, but none used blinded out-
come assessment. To avoid double counting the control patients in
the trials with more than two comparisons, and in the absence of
major differences between the effects of different foams, the foam
alternatives were pooled. This approach maintains the randomi-
sation, but resulted in comparison groups of unequal size. This
analysis yielded a pooled risk ratio of 0.40 (95% CI 0.21 to 0.74),
or a relative reduction in pressure ulcer incidence of 60% (95%CI
26% to 79%) (Analysis 2.1). Concern regarding the heterogeneity
in standard hospital mattress between these trials led us to under-
take a separate meta analysis of UK-based studies (where variation
in the standard hospital mattress is likely to be lower). Pooling
the four studies which compared alternative foam supports with
standard foam mattresses in the UK resulted in the significant
benefit of alternative foam over standard foam being maintained
(RR 0.41; 95% CI 0.19 to 0.87) (Analysis 2.2) (Collier 1996;
Gray 1994; Russell 2003; Santy 1994). However, the heterogene-
ity remained high (I2= 84%; P value 0.002), and Russell 2003
was removed as it was the only study that clearly included grade
1 ulcers as incident ulcers, thereby potentially inflating its results
compared with the other trials. This resulted in I2 being reduced
to 39% (P value 0.20), and the results still favoured the alternative
foam support over standard support (RR 0.29 95% CI 0.16 to
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0.52). Therefore, foam alternatives to the standard hospital mat-
tress significantly reduce the incidence of pressure ulcers in at-risk
patients, including patients with fractured neck of femur, when
compared with the standard hospital foam.
1.2 Comparisons between alternative foam mattresses
This section covers results of head-to-head comparisons between
high-specification foam products (i.e. contoured foam, support
surfaces comprising foam of different densities). Five RCTs com-
pared different foam mattresses (Analysis 3.1) (Collier 1996; Gray
1998; Kemp 1993; Santy 1994; Vyhlidal 1997).
No patients developed a pressure ulcer in theCollier 1996 trial, re-
ported in the section above, which compared eight different foam
mattresses. Santy 1994 and colleagues compared five alternative
foam mattresses (Clinifloat, Vaperm, Therarest, Transfoam, NHS
standard foam), and found significant reductions in pressure ul-
cer incidence associated with Clinifloat, Therarest, Vaperm and
Transfoam compared with standard foam; and Vaperm compared
with Clinifloat (RR 0.36; 95% CI 0.22 to 0.59). Vyhlidal 1997
compared a 4-inch thick foam overlay (Iris 3000) with a foam and
fibre mattress replacement (Maxifloat), and reported a significant
reduction in pressure ulcer incidence with the mattress replace-
ment (RR 0.42; 95% CI 0.18 to 0.96), however, this trial did not
state the methods used for allocation concealment nor blinded
outcome assessment clearly.
Kemp1993 compared a convoluted foamoverlaywith a solid foam
overlay in only 84 patients, and found no significant difference
in pressure ulcer incidence rates, however, this may be a Type 2
error, as the small sample size may have precluded detection of a
clinically important difference as statistically significant (RR 0.66;
95% CI 0.37 to 1.16). Gray 1998 compared the Transfoam and
Transfoamwave foammattresses, however, only one patient in each
group (50 in each arm) developed an ulcer. Analysis 3.1.
In summary, existing evidence is inadequate to guide choice be-
tween alternative foam mattresses.
1.3 Comparisons between “low-tech” constant low-pressure
supports
This section covers head-to-head comparisons of the following
types of support: foams; static air-filled supports (including dry
flotation); water-filled supports; gel-filled supports; silicore-filled
supports; heel elevators and sheepskins (Analysis 4.1). These de-
vices and support surfaces feature particular or specialised tech-
nologies and therefore are considered in a separate category. [NB:
’Silicore’ fibres are said to resist matting down and to provide in-
sulation against heat or cold]
Eleven RCTs compared different “low-tech” CLP devices (Cadue
2008; Cooper 1998; Ewing 1964; Gilcreast 2005; Jolley 2004;
Lazzara 1991; McGowan 2000; Sideranko 1992; Stapleton 1986;
Takala 1996; Tymec 1997). Most of these trials were underpow-
ered with, or without other methodological flaws.
• Static air-filled supports (including dry flotation);
water-filled supports; gel-filled supports; silicore-filled
supports
A trial from Finland (Takala 1996), compared a constant low-
pressure mattress (Optima, Carital) - that consists of 21 double
air bags on a base - with the standard hospital mattress and found
that significantly more patients (37%) developed ulcers on the
standard mattress than on the CLP mattress (on which nobody
developed an ulcer) (RR 0.06; 95% CI 0 to 0.99). The report
of this study did not describe either allocation concealment or
blinded outcome assessment.
The remaining trials were all unique comparisons with low power
(Cooper 1998; Lazzara 1991; Sideranko 1992; Stapleton 1986),
and none found statistically significant differences between the
surfaces tested (Analysis 4.1).
• Heel devices
One trial (52 patients) compared a proprietary heel elevation de-
vice (Foot Waffle) comprising a vinyl boot with built-in foot cra-
dle, against elevation of the heels using a hospital pillow (Tymec
1997). The study reported that more heel ulcers developed in the
group using the Foot Waffle (n = 6) compared with the group
using a hospital pillow) (n = 2) although this difference was not
statistically significant, the number of people in each group was
not clearly reported, and, therefore, data were not plotted.
Gilcreast 2005 assessed three heel pressure relief devices: a fleece
cushion heel protector (the BunnyBoot); the egg-crate heel lift po-
sitioner and the foot waffle air cushion. There were no statistically
significant differences between the devices in terms of incidence
of pressure ulcers (3/77 (4%) for the Bunny boot; 4/87 (4.6%) for
the egg crate and 5/76 (6.6%) for the foot waffle). However, it was
not clear from the trial whether the number of incident ulcers or
number of participants with incident ulcers was being reported.
Furthermore, the analysis of this trial was not by intention-to-
treat, and 30% of data were not included in the analysis due, in
part, to non-compliance. Therefore this result is at high risk of
bias.
• Sheepskins
Four trials examined the effects of sheepskins on pressure ulcer in-
cidence. The first, which compared the standard hospital mattress
with, and without, sheepskin overlays (Ewing 1964), was consid-
ered too small and suffering from risk of bias to the extent that its
results could not be regarded as valid. The second involved 297
orthopaedic patients (McGowan 2000), and found that pressure
ulcer incidence was significantly reduced in those assigned an Aus-
tralian medical sheepskin (RR for sheepskins relative to standard
treatment was 0.30; 95% CI 0.17 to 0.52). The third, by Jolley
2004, was a study on amixed inpatient population of a metropoli-
tan hospital comparing a sheepskin mattress overlay with ‘usual
care’ that included repositioning and any other pressure-relieving
devices with, or without, “low-tech” constant pressure relieving
devices. It seems that analysis by intention-to-treat was not used,
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as 539 participants were randomised, but only 441 analysed. The
study stated that any patient whose risk increased to high, as mea-
sured by a Braden score of less than 12 for 48 hours, was no longer
followed-up. The rationale for this was not clear. The results, in
terms of incidence of new pressure ulcers of grade 2 or above, were
12/218 (5.5%) for the sheepskin group and 20/223 (9%) for the
‘usual care’ group (reported denominators). A study by Mistiaen
2009 investigated the use of an Australian medical sheepskin for
use 48 hours after admission, compared with usual care. The 543
patients, mainly from aged care rehabilitation facilities, were fol-
lowed-up for 30 days. Pooling the trials byMcGowan 2000; Jolley
2004 and Mistiaen 2009 using a random-effects model, and in-
cludingdata for patientswhodevelopedpressure ulcers of all grades
(including grade 1), showed there were statistically significantly
fewer pressure ulcers among those allocated sheepskins (RR 0.48
95% CI 0.31 to 0.74)(Analysis 4.1). These three trials were then
pooled using only data for patients with pressure ulcers grade 2
or above using a fixed-effect analysis as the heterogeneity was low
(I2 = 3%). This analysis also showed statistically significant fewer
pressure ulcers in the group using sheepskins (RR 0.56 95% CI
0.32 to 0.97) (Analysis 4.2).
• Foam body support
One trial, with 70 intensive care unit participants (Cadue 2008),
compared a foam body support plus usual care (half-seated posi-
tion, water mattress and preventative massage six times a day) with
usual care alone for the prevention of heel ulcers. In total 8.6% (3/
35) of participants in the support group developed heel ulcers (all
grades) compared with 55.4% (19/35) in the control group, this
difference was statistically significant (RR 0.16 95% CI 0.05 to
0.49) (Analysis 4.1). This study was at low or unclear risk of bias
(unclear because we could not ascertain whether outcome assess-
ment was blinded, nor whether there was risk of selective outcome
reporting).
Summary: Foam alternatives to the standard hospital foam mat-
tress reduce the incidence of pressure ulcers in people at risk, al-
though one large trial found no difference between high-specifica-
tion foam mattress and use of standard mattress (Russell 2003).
Three trials investigating the effectiveness of a specific sheepskin
product in preventing pressure ulcers showed that sheepskin over-
lays are effective in reducing the incidence of pressure ulcers.Other
evidence about competing CLP devices did not show clear differ-
ences between the effectiveness of products.
2. “High-tech” pressure supports
This section outlines three main groups of supports; alternating-
pressure (AP) supports, low-air loss beds and air-fluidisedLow
beds.
Alternating-pressure supports
A variety of alternating-pressure (AP) supports is used in hospital
and community locations. The depth of the air-cells, cell cycle
time and mechanical robustness vary between devices, and these
factors may be important in determining effectiveness. It is worth
emphasising thatmost of theRCTs ofAP supports did not describe
the equipment being evaluated adequately, including the size of
the air cells and cell cycle time.
Sixteen RCTs of AP supports for pressure ulcer prevention were
identified: these included the following comparisons:
a) alternating-pressure compared with standard hospital mattress
(three studies);
b) alternating-pressure compared with constant low-pressure (11
studies) including:
• static air;
• water;
• foam;
• continuous low-pressure;
• silicore.
c) Comparison between different AP devices (five studies).
2.1 Alternating-pressure compared with standard hospital
mattress
Andersen 1982 reported that the use of alternating-pressure sur-
faces significantly reduced the incidence of pressure ulcers com-
pared with standard hospital mattresses. The report of this large
trial, involving 482 patients who were defined by the authors as
being at high-risk of pressure ulcers, gave no indication that either
allocation concealment or blinded outcome assessment had been
used. In an underpowered and unblinded study conducted on pa-
tients requiring head elevation, Sanada 2003 compared a single
layer air cell overlay (the Air Doctor), a double-layer cell overlay
(the Tricell) (both with five-minute alternating air pressure) and a
standard hospital mattress (Paracare). In the Sanada trial, both the
experimental groups and control group had a two-hourly change
of position and skin care. In the Air Doctor group 4/29 (13.8%)
participants developed grade 2 pressure ulcers, in the Tricell group
1/26 (3.8%) participants developed grade 2 pressure ulcers; and
in the standard hospital mattress group 6/27 (22%) participants
developed grade 2 pressure ulcers. The number of grade 1 ulcers
was also reported in the study.The denominators are numbers pre-
sented by the authors after withdrawals and attrition, and the study
was not analysed by intention-to-treat (in that withdrawals were
excluded from the analysis). For the purpose of meta-analysis, this
three-armed trial was merged into two groups receiving AP over-
lay.
These two trials were pooled using a fixed-effect model (I2 = 0%).
There was a statistically significant reduction in development of
pressure ulcers with the AP surface compared with the standard
hospital mattress (RR 0.31; 95% CI 0.17 to 0.58), however, it
should be recognised that these trials were at unclear or high risk
of bias (Andersen 1982 was poorly reported for randomisation,
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allocation concealment and blinding and Sanada 2003 was at high
risk of attrition bias) (Analysis 5.1).
Summary:Results of two studies comparing AP devices with stan-
dardmattresses showed some evidence in favour of the AP support
surfaces, however these studies were at high risk of bias.
2.2 Alternating-pressure compared with constant low-
pressure
Ten trials compared AP devices with various constant low-pressure
(CLP) devices, however, there was conflicting evidence regarding
their relative effectiveness. A two-armed trial compared a range of
AP supports with a range of CLP supports in a range of specialties
in acute care settings (Gebhardt 1996), and reported significantly
more pressure ulcers in patients in the CLP group (34% compared
with 13% in the AP group) (RR 0.38; 95% CI 0.22 to 0.66)
(Analysis 6.1). This trial was difficult to interpret because of the
wide variety of surfaces it used; there is currently insufficient evi-
dence to support a ’class effect’ for all alternating-pressure devices
and all constant low-pressure devices.
In contrast, nine RCTs comparing different types of AP supports
and a variety of CLP devices, such as the Silicore overlay (Conine
1990;Daechsel 1985; Stapleton1986); awatermattress (Andersen
1982; Sideranko 1992); a foam pad (Stapleton 1986; Whitney
1984); and static air mattresses (Price 1999; Sideranko 1992);
a visco-elastic foam mattress (including four-hourly turning and
a sitting protocol with a cushion) (Vanderwee 2005); and CLP
mode of the Hill-Rom Duo mattress (Cavicchioli 2007); individ-
ually reported no difference in effectiveness, although some were
too small to be able to detect clinically important differences as
statistically significant. In the Vanderwee study, a sub-group anal-
ysis on the location of pressure ulcers reported that there were
significantly more heel pressure ulcers in the control group using
the viscoelastic mattress (P value 0.006 Fischer’s exact test). The
study authors also noted that patients nursed on the experimental
equipment (Huntleigh APAM, Alpha X-cell) seemed to develop
more severe ulcers (Analysis 6.1).
Four studies that compared AP with Silicore or foam overlays were
pooled (Conine 1990; Daechsel 1985; Stapleton 1986; Whitney
1984). To avoid double counting of the patients in the AP arm of
the Stapleton three-arm trial, and in the absence of obvious het-
erogeneity in the outcomes for Silicore and foam, the Silicore and
foam arms were pooled against the AP arm (maintaining the ran-
domisation, avoiding double counting, but resulting in unequal
comparison groups). Overall the pooled relative risk of pressure
ulcer development for AP compared with Silicore or foam over-
lays (using a fixed-effect model; I2 = 0%) was 0.91 (95% CI 0.72
to 1.16), indicating no statistically significant difference between
Silicore or foam overlays and AP (Analysis 6.1).
The studies that compared AP with static water, or static air mat-
tresses, were also considered together (Andersen 1982; Price 1999;
Sideranko 1992). The Sideranko trial also had three comparison
groups, and, for the purposes of the meta-analysis, the water and
static air arms of this study were considered sufficiently similar to
pool together against AP to avoid double counting of the AP pa-
tients. Pooling these three trials to answer the question of whether
AP is associated with fewer incident ulcers than air- or water-filled
mattresses using a random-effects model (I2 = 25%) yielded a
pooled RR of 1.31 (95% CI 0.51 to 3.35), indicating no statisti-
cally significant difference (Analysis 6.3). It is worth emphasising,
however, that some of these studies were small, and, even when
pooled, were too underpowered to detect clinically important dif-
ferences in effectiveness as statistically significant.
All nine RCTs comparing the various CLP devices and AP devices
were pooled to try to determine whether AP is more effective than
CLP in pressure ulcer prevention. Double counting was avoided
for the Sideranko and Stapleton trials as before. In view of the
different devices evaluated in the studies, the I2 of 34%and theChi
2 statistic of 13.69 (df = 9), a random-effects model was applied.
This yielded an overall relative risk of 0.85 (95%CI 0.64 to 1.13),
which suggested no statistically significant difference between the
rates of pressure ulcer incidence with AP compared with CLP
(Analysis 6.1). Further trials are needed to determine whether
the CLP and AP devices are associated with a clinically important
difference in risk of pressure ulceration.
One trial used a complex factorial design to compare various
combinations of standard, constant low-pressure (Tempur) and
alternating-pressure (Nimbus) support in surgical intensive care
patients intra- and post-ICU. This trial (which involved only 75 to
80 patients in each group) did not identify any significant benefit
associated with using alternating-pressure in the ICU (Laurent
1998) (Analysis 7.1).
Summary: The relative merits of alternating- (AP) and constant
low-pressure (CLP) devices, and of the different AP devices for
pressure ulcer prevention are unclear with most trials comparing
AP with CLP devices and showing no significant difference be-
tween treatment groups. One large, high quality study found no
significant differences between an AP overlay with an APmattress.
However, the AP mattresses were associated with an 80% proba-
bility of reducing costs, due to a delay in pressure ulceration and
reduced length of stay in hospital when they were used.
2.3 Comparisons between different alternating-pressure
devices
AP devices differ somewhat in structure, for example, the size of
the inflatable air cells. One early study of pressure ulcer preven-
tion compared two large-celled alternating-pressure devices (Pe-
gasus Airwave and the Large Cell Ripple - similar except that the
Airwave has two layers of cells) (Exton-Smith 1982). The authors
reported that the Airwave system was significantly more effective
than the Large Cell Ripple in preventing and reducing severity
of pressure ulcers in a high risk group of elderly patients. How-
ever, the allocation was not truly random, and an analysis which
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regarded losses to follow-up as having not developed pressure ul-
cers did not show a statistically significant difference in the rate of
pressure ulcers (16% versus 34%; P value > 0.05; Analysis 8.1).
Hampton 1997 compared the Pegasus Airwave mattress with a
new Cairwave Therapy system by the same manufacturer, in 75
patients. No patients developed an ulcer within the 20-day follow-
up in either arm of this study.
Taylor 1999 compared the Pegasus Trinova three-cell alternating-
pressure air mattress plus a pressure redistributing cushion (inter-
vention) with a two-cell alternating-pressure air mattress plus a
pressure redistributing cushion (control). This study was under-
powered and so could not detect important differences (22 pa-
tients in each group), and, whilst two patients developed a superfi-
cial ulcer in the control group and none in the intervention group,
this difference was not statistically significant (RR 0.20; 95% CI
0.01 to 3.94) (Analysis 8.1).
In another underpowered trial, Theaker 2005 examined two AP
devices in an ICU setting. The KCITherapulse, a stand-alone unit
that incorporates a mattress into a bed frame and uses optional
pulsation technology and low-air-loss to reduce tissue interface
pressure, and the Hill-Rom Duo mattress (control), which is de-
signed to lie directly on most standard hospital frames and uses
either continuous or alternating low-pressure modes. Details of
the alternating cycle were not provided. Pressure ulcer incidence
(restricted to grade 2 ulcers or greater) was 3/30 (10%) in the ex-
perimental group and 6/32 (19%) in the control group (no statis-
tically significant difference).
In a large trial, at low risk of bias, Nixon 2006 compared an AP
overlay with an AP mattress, the primary outcome was incidence
of pressure ulcers (grade 2 or above). An intention-to-treat anal-
ysis was conducted on data from 1971 participants (989 in the
overlay group and 982 in the mattress group). One-hundred and
six (10.7%) people in the overlay group and 101 (10.3%) in the
mattress group developed one or more new grade 2 pressure ul-
cers. The majority of incidence ulcers were grade 2. There was no
significant difference between the two groups in terms of devel-
opment of a new pressure ulcer of grade 2 or greater (RR 1.04;
95% CI 0.81 to 1.35). More participants on the overlay requested
a change to another device due to their dissatisfaction (23.3%),
compared with patients allocated to the APmattress (18.9%), this
difference was statistically significant.
Nixon 2006 also conducted a full cost-effectiveness analysis from
the perspective of the UK NHS and Personal Social Service. Cal-
culation of cost information was based on length of hospital stay
and pressure-relieving surface used. Benefits were measured as the
number of pressure-ulcer-free days. In the base case analysis the
mean cost per patient of the AP mattress was GBP 6509.73, and
the mean cost per patient of the AP overlays was GBP 6793.33.
The mattress cost on average GBP 283.6 less per patient, (95%
CI, GBP 377.59 to GBP 976.79), and also conferred greater ben-
efits (a delay in mean time to ulceration of 10.64 days (95% CI
24.40 to 3.09). Whilst neither the difference in costs nor bene-
fits reached statistical significance, the assessment of uncertainty
around the cost-effectiveness decision indicated that, on average,
AP mattresses were associated with an 80% probability of being
a cost saving. This was because the mattress was associated with
a delay in ulceration (measured by Kaplan Meier estimates), and
reduced costs as a consequence of shorter length of hospital stay.
The conclusions of the base case analysis was not altered when
challenged in sensitivity analyses.
Low-air-loss (LAL) beds
Three studies evaluated the use of low-air-loss beds. Such devices
provide a flow of air that assists in controlling the microclimate of
the patient’s skin (NPUAP 2007).
2.4 Comparisons between LAL and other support surfaces
Inman 1993 reported that low-air-loss beds were more effective at
decreasing the incidence of pressure ulcers in critically-ill patients
than a standard (but poorly described) ICU bed (RR 0.24; 95%
CI 0.11 to 0.53) (Analysis 9.1).
A second trial of 98 participants, compared low-air-loss hydrother-
apy (LAL-hydro) with standard care (some patients received alter-
nating-pressure in this group); more patients developed ulcers of
grade 2 ulcer or greater in the LAL-hydro group (19%) than the
standard care group (7%) though this difference was not statisti-
cally significant (Analysis 9.1) (Bennett 1998).
A third trial with 123 participants recruited from hospital wards
and intensive care units compared a low-air-loss bed (KinAir) with
a static air overlay in the prevention of pressure ulcers (Cobb
1997). Three people developed grade 1 ulcers on the low-air-loss
bed (3/62) compared with one on the static air overlay (1/61).
However, three people developed grade 2 ulcers on the low-air-
loss bed (3/62) compared with 11 on the static air overlay (11/
61). Comparing the incidence of all ulcers showed no statistically
significant difference between the two groups (Analysis 9.1).
Cobb and Inman were pooled as they investigated LAL beds with
alternatives in the ICU setting. This showed a statistically signif-
icant difference in favour of the low-air-loss bed (RR 0.33; 95%
CI 0.16 to 0.67) (random-effects, I2 = 26%) (Analysis 9.2) (Cobb
1997; Inman 1993). Inman 1993 also reported that low-air-loss
beds reduced the incidence of patients developing multiple pres-
sure ulcers compared with the standard ICU mattress (RR 0.08
95% CI 0.01 to 0.62) (Analysis 9.3).
Air-fluidised beds
2.5 Comparison between air-fluidised bed and dry flotation
mattress
One small trial that investigated 12 patients after plastic surgical
repair of pressure ulcers showed no difference between an air-
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fluidised bed and the Roho dry flotation mattress in postoperative
tissue breakdown rates (Economides 1995) (Analysis 10.1).
3. Other pressure supports
Other pressure supports included Kinetic turning tables, profil-
ing beds, operating table overlays and seat cushions. Turning beds
contain motors which constantly turn and tilt the patient. This
includes kinetic beds and profiling beds. They are used in critical
care settings, primarily to prevent pneumonia and atelectasis (col-
lapsed lung). Operating table overlays are used as pressure relief
during surgery.
Kinetic turning tables
3.1 Comparison between kinetic beds and conventional beds
Four RCTs were identified in a meta-analysis of kinetic therapy
(Choi 1992), however, full copies of only two of the individual
trials could be obtained for this systematic review (Gentilello 1988;
Summer 1989). These two trials evaluated kinetic bed against
conventional beds. Sample sizes in all the trials were small, and no
beneficial effect of kinetic therapy on incidence of pressure ulcers
was detected (Analysis 11.1).
Profiling beds
3.2 Comparison between profiling bed and flat-based bed
Keogh 2001 recruited 70 participants, and found that no pressure
ulcers developed in either the group assigned to the profiling bed
with a pressure-reducing foammattress or cushion combination or
the group assigned to a flat-based bed with a pressure-relieving/re-
distributing foam mattress or cushion combination. Patients were
followed-up for five to 10 days, however, the extent of the follow-
up was difficult to ascertain
Operating table overlay
3.3 Comparison with viscoelastic polymer pad with standard
table
Five RCTs evaluated different methods of pressure relief on the
operating table. The first compared a viscoelastic polymer padwith
a standard table (Nixon 1998), and found a relative reduction in
the incidence of postoperative pressure ulcers of 47% associated
with using the polymer pad for patients undergoing elective,major
general, gynaecological or vascular surgery (supine or lithotomy)
(RR 0.53; 95% CI 0.33 to 0.85) (Analysis 12.1). It is important
to note that the majority of incident pressure ulcers were grade
1 (i.e. early ulcers with no break in the skin), and the length of
follow-up was eight days.
Two further RCTs compared the Micropulse alternating system
(applied both during surgery and postoperatively) with a gel pad
during surgery and a standardmattress postoperatively. We pooled
these two trials (I2 = 0%), and derived a pooled risk ratio (fixed-
effect) of 0.21 (95% CI 0.06 to 0.7) in favour of the Micropulse
system (Aronovitch 1999; Russell 2000). It is not clear from these
two trials whether the effect was due to the intra-operative or the
postoperative pressure relief, or both (Analysis 13.1).
Schultz 1999 compared an operating theatre mattress overlay with
usual care (which included padding as required, e.g. gel pads,
foam mattresses). People in the overlay group were more likely
to experience postoperative skin changes, and six patients in the
overlay group developed ulcers of grade 2, or worse, compared
with three people in the control group. No attempt was made to
gather information on the patients’ postoperative skin care.Details
regarding stage of ulcer by group and of the unnamed product were
sought unsuccessfully from the study authors. In the absence of
this information, the clinical importance of the findings is difficult
to assess.
Gunningberg 2000 examined the effects of a viscoelastic foam
trolley mattress and subsequent overlay on 101 patients with a
suspected hip fracture in the A&E and ward setting, this trial is
dealt with in the review in the section: 1.1 Standard foam hospital
mattress compared with other low-tech CLP.
Summary: Pressure-relieving overlays on the operating table and
in the postoperative period reduce the incidence of postoperative
pressure ulcers, although there is some evidence that certain oper-
ating room overlays may result in postoperative skin changes.
3.4 Comparison of water-filled warming mattress and
thermoactive viscoelastic foam overlay with an operating
theatre table with water-filled warming mattress
Another trial compared an operating theatre table that included a
water-filled warming mattress and a 4-cm thermoactive viscoelas-
tic foam overlay, with an operating theatre table with water-filled
warming mattress only (Feuchtinger 2006). The trial was termi-
nated before the full sample was recruited because more patients
in the experimental group with the 4-cm thermoactive viscoelastic
foam overlay developed pressure ulcers (all were grades 1 to 2),
with 15/85 (18%) in the experimental group and 10/90 (11%) in
the control group. For grade 2 pressure ulcers only, there were two
in the experimental group and one in the control group. There
was no statistically significant difference between the two groups
at the point at which the trial was terminated (Analysis 12.1).
Seat cushions
3.5 Comparisons between different cushions
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Four RCTs compared different types of seating cushion for pre-
venting pressure ulcers; one study compared slab foam with be-
spoke contoured foamand foundno difference between the groups
(RR 1.06; 95% CI 0.75 to 1.49) (Lim 1988). The second study
compared contoured foam over a gel pad (Jay gel) plus a foam
wheelchair cushion with a foam cushion alone in 141 people
(Conine 1994), and found fewer ulcers in the gel pad plus cushion
group, though this was not statistically significant (RR 0.61; 95%
CI 0.37 to 1.00). The third study found no difference in pres-
sure ulcer incidence between those assigned a slab foam cushion
bevelled at the base and those assigned a contoured foam cush-
ion with an area cut out to accommodate the patient’s bottom
(Conine 1993) (RR 1.00; 95% CI 0.81 to 1.18) ( Analysis 14.1).
The fourth study was a small pilot trial of 32 wheelchair-users
that compared a standard foam (eggcrate) cushion with a pres-
sure-reducing wheelchair cushion (Geyer 2001). The trial did not
differentiate between patients with grade 1 ulcers or higher grades
of ulcer. In total, 40% of participants on the pressure-reducing
cushion developed an ulcer (6/15) compared with 58.5% (10/17)
on the foam cushion (RR 0.68; 95% 0.33 to 1.42); this difference
was not statistically significant (Analysis 14.1).
Summary: There is insufficient evidence to determine the value
of seat cushions, various CLP devices and A&E trolley overlays as
pressure ulcer prevention strategies.
Summary of results
• Foam alternatives to the standard hospital foam mattress
reduce the incidence of pressure ulcers in people at risk, although
one large trial found no difference between high-specification
foam mattress and use of standard mattress (Russell 2003).
• The relative merits of alternating- (AP) and constant low-
pressure (CLP) devices, and of the different AP devices for
pressure ulcer prevention are unclear with most trials comparing
AP with CLP devices and showing no significant difference
between treatment groups. One large, high quality study found
no significant differences between an AP overlay with an AP
mattress. However, the AP mattresses were associated with an
80% probability of reducing costs, due to a delay in pressure
ulceration and reduced length of stay in hospital when they were
used.
• Results of two studies comparing AP devices with standard
mattresses showed some evidence in favour of the AP support
surfaces, however these studies were at high risk of bias.
• Three trials investigating the effectiveness of a specific
sheepskin product in preventing pressure ulcers showed that
sheepskin overlays are effective in reducing the incidence of
pressure ulcers. Other evidence about competing CLP devices
did not show clear differences between the effectiveness of
products.
• Pressure-relieving overlays on the operating table and in the
postoperative period reduce the incidence of postoperative
pressure ulcers, although there is some evidence that certain
operating room overlays may result in postoperative skin changes.
• There is insufficient evidence to determine the value of seat
cushions, various CLP devices and A&E trolley overlays as
pressure ulcer prevention strategies.
D I S C U S S I O N
The confidence with which we can draw firm conclusions from
the studies detailed in this review is greatly tempered by (a) the
poor quality of many of the trials; (b) the lack of replication of
most comparisons; and (c) that the “standard”mattress is often not
clearly defined. The clearest conclusion that can be drawn is that
standard hospital mattresses have been consistently outperformed
by a range of foam-based, low-pressuremattresses andoverlays, and
also by higher-specification pressure-relieving beds and mattresses
in the prevention of pressure ulcers.
The application of this conclusion to current clinical practice is,
however, hampered by the fact that the “standard” was poorly de-
scribed in many of these studies, and what is standard varies by
hospital, country and with time. This factor leads to major diffi-
culties in interpretation of trial results and the importance of pro-
viding clear descriptions of all interventions in future studies can-
not be overemphasised. In view of this, and because we thought
there would be less variation within a country, a subgroup anal-
ysis of UK-based studies was undertaken, which showed that the
advantage of alternative foam was maintained.
Many of the trials reviewed did not provide convincing reassurance
that manual repositioning was provided equally to each group of
participants. This is a possible confounder, as care providers were
not blinded to treatment allocation in any of the trials, and may
havemovedpatients in one groupmore frequently if they perceived
a particular mattress to be less effective. As experimental evidence
of the effectiveness of manual repositioning is lacking, it is difficult
to say what impact this has. In addition, in many studies the
definitions of pressure ulcer free, low-risk,moderate-risk and high-
risk varied widely. Also, it is often difficult to ascertain whether
study participants with grade 1 ulcers have been accepted into
the sample and included in the analyses, or not, and this needs
to be taken into account when interpreting findings. Some of the
included studies did recruit participants with pressure ulcers worse
than grade 1 therefore only the incidence of new pressure ulcers
was reported.
The results of three of the five trials evaluating the use of pres-
sure-relieving overlays on the operating table suggest that these
are beneficial in reducing subsequent pressure ulcer incidence in
high-risk surgical patients. These three trials were of reasonable or
good quality; in particular the Nixon 1998 trial was adequately
powered, with allocation concealment and blinded outcome as-
sessment lending further weight to the result. At present, the most
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effective means of pressure relief on the operating table is unclear;
Nixon and colleagues found a gel-filled overlay to be significantly
better than a standard operating table, whilst a gel-filled overlay on
the operating table was less effective than an alternating-pressure
overlay intra- and postoperatively (the Micropulse system) in the
other two trials (Aronovitch 1999; Russell 2000).TheMicropulse
trials were confounded by their provision of a standard mattress
postoperatively in the gel overlay arm, and an alternating-pres-
sure overlay postoperatively in the Micropulse arm. Thus whilst
there is clearly a reduction in pressure ulcer incidence associated
with the alternating-pressure system, it is not clear whether this is
merely a result of better postoperative pressure relief. Two other
trials showed that postoperative skin changes occurred as a result
of different operating theatre overlays (Feuchtinger 2006; Schultz
1999), but the clinical importance of these results is difficult to
determine in the absence of further details about pressure ulcer
grading and products used.
Previously the evidence for different alternating-pressure devices
was unclear due to the poor quality and small size of existing
studies. This review includes a large, robust trial which suggests
that AP mattresses are clinically as effective as overlays, but likely
to be more cost effective, and more acceptable to patients (Nixon
2006).
Trials published in the early 1980s found that water-filled and
bead-filled mattresses were both associated with reductions in the
incidence of pressure ulcers when comparedwith standard hospital
mattresses, however, the products evaluated are no longer available.
There are tentative indications that four interventions may be
harmful. Firstly, Tymec 1997 found that Foot Waffle heel eleva-
tors were associated with a trebling in the incidence of pressure ul-
cers, though this was not statistically significant and the study was
small (52 patients) (Tymec 1997). Secondly, Bennett 1998 eval-
uated low-air-loss hydrotherapy (LAL-hydro) in a trial in which
19% LAL-hydro patients developed ulcers compared with 7% of
standard care patients, though again this was not a statistically sig-
nificant difference and the study was underpowered (98 partici-
pants). Thirdly, Schultz 1999 investigated the effectiveness of an
alternative foam overlay used in the operating theatre; the results
suggested that patients placed on the intervention devices were
significantly more likely to experience postoperative skin changes
(i.e. mainly grade 1 pressure ulcers). It is difficult, however, to
separate out the role of postoperative care and padding, which
was used as a concomitant intervention, either of which may have
caused the skin changes (mainly found on buttock and coccyx).
Lastly Feuchtinger 2006 terminated the trial comparing an operat-
ing theatre table that included a water-filled warming mattress and
a 4-cm thermoactive viscoelastic foam overlay with an operating
theatre table with a water-filled warming mattress only. The trial
was terminated before the full sample was recruited because more
patients ii the group receiving the 4-cm thermoactive viscoelastic
foam overlay developed pressure ulcers (all were grades 1 to 2). It
is important to note, however, that two of the above studies did
not provide clear information to indicate that the groups under
investigation were similar at baseline for themost important prog-
nostic factors (Bennett 1998; Tymec 1997).
Few comparisons have been replicated, and, as most of the com-
pleted trials were under-powered there is little information from
which to draw firm conclusions. For example, air-fluidised ther-
apy has only been compared with dry flotation as a prevention
strategy, and low-air-loss only with standard care. There remain
gaps in the knowledge base to which a rational research agenda
could be addressed. It is always important to consider publica-
tion bias and its potential influence on the population of studies
on a topic. Whilst equipment manufacturers appear to have con-
tributed funding to many of the trials identified, it is difficult to
see what the impact of this has been. For example, whilst bias in
favour of positive results cannot be discounted, most of the studies
published did not find a statistically significant difference. It is
also important for the reader to be aware of the development of
materials used in the production of support surfaces over the past
30 years, and how this may impact on the effectiveness of such de-
vices. A systematic review of RCTs and quasi-randomised studies
investigating the prevention of heel pressure ulcers conducted by
Junkin 2009 reported similar conclusions regarding the current
state of the evidence, and the need for further rigorous research in
this area.
Common methodological flaws which increase the risk of bias in
trials investigating support surfaces include lack of allocation con-
cealment, lack of baseline comparability, high attrition rates, lack
of intention-to-treat analysis, lack of blind - or independently ver-
ified - outcome assessment. Specific to pressure ulcer intervention
research, other flaws include failing to report on whether or not
participants were free from pressure ulcers on study entry, and
providing an adequate definition for pressure ulcer status. These
deficiencies further reduce the confidence with which we can re-
gard many of the individual study findings. It is, however, hearten-
ing that the recently included studies have improved reporting of
some study details to enable quality assessment. It is important to
acknowledge that the different follow-up times amongst the trials
contribute to both clinical and statistical heterogeneity, and this
needs to be taken into account when reading this review.
Future trials should continue to address these deficiencies and col-
lect data on aspects of equipment performance such as reliability.
It is hoped that future studies will be reported in line with current
international standards for trial reporting (Moher 2001).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
For people at high risk of developing pressure ulcers, higher-spec-
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ification foam mattresses rather than standard hospital foam mat-
tresses should be used, where possible. Organisations should con-
sider the use of selected pressure relief devices for high risk patients
in the operating theatre, as this is associated with a reduction in
postoperative incidence of pressure ulcers. Medical grade sheep-
skins are associated with a decrease in pressure ulcer development.
The relative merits of higher-tech constant low-pressure and alter-
nating-pressure for prevention are unclear, however, alternating-
pressure mattresses may be more cost effective than alternating-
pressure overlays in the UK context. Seat cushions have not been
adequately evaluated.
Implications for research
Independent, well-designed, multi-centre RCTs are needed to
compare the clinical and cost-effectiveness of different types of
pressure-relieving devices for patients at different levels of risk in
a variety of settings. Particular gaps, include comparisons of:
(a) alternating-pressure devices with other “high-tech” equipment
(such as low-air-loss and air-fluidised beds) for prevention in very
high risk groups;
(b) alternating-pressure devices with “lower-tech” alternatives
(such as different types of high-specification foam mattresses and
other constant low-pressure devices).
The evaluation of alternating-pressure devices is given emphasis
as they are viewed as standard preventive interventions in some
areas, but not others, and may vary widely in cost (from less than
GBP 1000 to more than GBP 4,000).
Research is needed into valid and reliable methods of detecting
early skin damage that is prognostic of pressure ulcer development,
and of the impact of pressure ulcers on quality of life. Future
research must address the methodological deficiencies associated
with much of the research described in this review.
Patients should be truly randomised (with concealed allocation),
trials should be of sufficient size to detect clinically-important dif-
ferences, and have clear criteria for measuring outcomes which,
ideally, should be assessed without knowledge of the intervention
received (blinded). Interventions under evaluation should be thor-
oughly and clearly described. Researchers should be encouraged to
developmeasures to assess patient experiences of pressure-relieving
equipment e.g. comfort. The studies should also have adequate fol-
low-up and appropriate statistical analysis. The CONSORT state-
ment should be used as a guideline for reporting (Moher 2001).
Given the high costs associated with the prevention of pressure
ulcers in general, and of pressure-relieving surfaces specifically,
emphasis should be given to robust economic evaluations to be
conducted concurrently with trials.
A C K N OW L E D G E M E N T S
The original review was commissioned by the UK NIHR HTA
Programme (Cullum 2001). The authors are indebted to Julie
Glanville, Centre for Reviews andDissemination Information Ser-
vice, for early assistance with the search, location and collection of
the literature; to Trevor Sheldon, Alison Fletcher, Fujian Song and
Jon Deeks who participated in early versions of this review. Early
versions of this review have appeared as an Effective Healthcare
Bulletin (Cullum 1995).
The authors would like to thank Janet Cuddigan, Margaret Har-
rison, David Margolis, Susan O’Meara, Gerben ter Riet and Gill
Worthy who have peer reviewed at least one of the updates of this
review and whose feedback contributed enormously to its final
quality. The authors would like to acknowledge the contribution
of Rosa Legood who made inclusion decisions, extracted data, as-
sessed study quality and contributed to the text for the first update
and of Ruth Foxlee who undertook all database searches for the
second and third updates. The authors would also like to thank
Elizabeth Royle who copy edited the review update.
R E F E R E N C E S
References to studies included in this review
Andersen 1982 {published data only}
Andersen KE, Jensen O, Kvorning SA, Bach E. Decubitus
prophylaxis: a prospective trial on the efficiency of
alternating pressure air mattresses and water mattresses. Acta
Dermato-Venereologica (Stockholm) 1982;63(3):227–30.
Aronovitch 1999 {published data only}
Aronovitch SA, Wilber M, Slezak S, Martin T, Utter D.
A comparative study of an alternating air mattress for the
prevention of pressure ulcers in surgical patients. Ostomy/
Wound Management 99;45(3):34-40, 42-4.
Bennett 1998 {published data only}
Bennett RG, Baran PJ, DeVone LV, Bacetti H, Kristo B,
Tayback M, et al.Low airloss hydrotherapy versus standard
care for incontinent hospitalized patients [see comments].
Journal of the American Geriatrics Society 1998;46(5):
569–76.
Cadue 2008 {published data only}
Cadue J-F, Karolewicz S, Tardy C, Barrault C, Robert
R, Pourrat O. Prevention of heel pressure sores with a
foam body-support device. A randomized controlled trial
in a medical intensive care unit [Efficacite de supports
anatomiques en mousse pour la prevention des escarres de
19Support surfaces for pressure ulcer prevention (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
talons]. Presse Medicale 2008;37(1 SUPPL. PART 1):30–6.
Cavicchioli 2007 {published data only}
Cavicchioli A, Carella G. Clinical effectiveness of a low-tech
versus high-tech pressure redistributing mattress. Journal of
Wound Care 2007;16(7):285–9.
Cobb 1997 {published data only}
Cobb GA, Yoder LH, Warren JB. Pressure ulcers: patient
outcomes on a KinAir bed or EHOB waffle mattress.
TriService Nursing Research Program (TSNRP). Bethesda,
Maryland, USA, 1997.
Collier 1996 {published data only}
Collier ME. Pressure-reducing mattresses. Journal of Wound
Care 1996;5(5):207–11.
Conine 1990 {published data only}
Conine TA, Daechsel D, Choi AK, Lau MS. Costs and
acceptability of two special overlays for the prevention of
pressure sores. Rehabilitation Nursing 1990;15(3):133–7.
∗ Conine TA, Daechsel D, Lau MS. The role of alternating
air and silicore overlays in preventing decubitus ulcers.
International Journal of Rehabilitation Research 1990;13(1):
57–65.
Conine 1993 {published data only}
Conine TA, Daeschel D, Hershler C. Pressure sore
prophylaxis in elderly patients using slab foam or customised
contoured foam wheelchair cushions. Occupational Therapy
Journal of Research 1993;13(2):101–16.
Conine 1994 {published data only}
Conine TA, Hershler C, Daechsel D, Peel C, Pearson
A. Pressure sore prophylaxis in elderly patients using
polyurethane foam or Jay wheelchair cushions. International
Journal of Rehabilitation Research 1994;17(2):123–37.
Cooper 1998 {published and unpublished data}
Cooper PJ, Gray DG, Mollison J. A randomised controlled
trial of two pressure reducing surfaces. Journal of Wound
Care 1998;7(8):374–6.
Daechsel 1985 {published data only}
Daechsel D, Conine TA. Special mattresses: effectiveness in
preventing decubitus ulcers in chronic neurologic patients.
Archives of Physical Medicine and Rehabilitation 1985;66(4):
246–8.
Economides 1995 {published data only}
Economides NG, Skoutakis VA, Carter CA, Smith VH.
Evaluation of the effectiveness of two support surfaces
following myocutaneous flap surgery. Advances in Wound
Care 1995;8(1):49–53.
Ewing 1964 {published data only}
Ewing MR, Garrow C, Presley TA, Ashley C, Kinsella NM.
Further experiences in the use of sheep skins as an aid in
nursing. The Australian Nurses’ Journal 1964;Sept:215–9.
Exton-Smith 1982 {published data only}
Exton-Smith AN, Overstall PW, Wedgewood J, Wallace G.
Use of the ’air wave system’ to prevent pressure sores in
hospital. The Lancet 1982;1(8284):1288–90.
Feuchtinger 2006 {published data only}
Feuchtinger J. Preventing decubitus ulcer in heart surgery
interventions: visco-elastic foam layer on the operating
room table - a study [Viskoelastische schaumstoffauflage auf
dem operationstisch - eine studie]. Pflege Zeitschrift 2006;
59(8):498–501.
∗ Feuchtinger J, de Bie R, Dassen T, Halfens R. A 4-cm
thermoactive viscoelastic foam pad on the operating room
table to prevent pressure ulcer during cardiac surgery.
Journal of Clinical Nursing 2006;15(2):162–7.
Gebhardt 1996 {published data only}
∗ Gebhardt K. A randomized trial of alternating pressure
(AP) and constant low pressure (CLP) supports for the
prevention of pressure sores. Journal of Tissue Viability
1994;4(3):93.
Gebhardt KS, Bliss MR, Winwright PL. A randomised
controlled trial to compare the efficacy of alternating and
constant low pressure supports for preventing pressure sores
in an intensive care unit. Personal Communication 1994.
Gebhardt KS, Bliss MR, Winwright PL, Thomas J. Pressure
relieving supports in an ICU. Journal of Wound Care 1996;5
(3):116–21.
Gentilello 1988 {published data only}
Gentilello L, Thompson DA, Tonnesen AS, Hernandez
D, Kapadia AS, Allen SJ, et al.Effect of a rotating bed on
the incidence of pulmonary complications in critically ill
patients. Critical Care Medicine 1988;16(8):783–6.
Geyer 2001 {published data only}
Geyer MJ, Brienza DM, Karg P, Trefler E, Kelsey S. A
randomized control trial to evaluate pressure-reducing seat
cushions for elderly wheelchair users. Advances in Skin and
Wound Care 2001;14(3):120–9.
Gilcreast 2005 {published data only}
Gilcreast DM, Warren JB, Yoder LH, Clark JJ, Wilson JA,
Mays MZ. Research comparing three heel ulcer-prevention
devices. Journal of Wound, Ostomy and Continence Nursing
2005 ;32(2):112–20.
Goldstone 1982 {published data only}
Goldstone L, Norris M, O’Reilly M, White J. A clinical trial
of a bead bed system for the prevention of pressure sores in
elderly orthopaedic patients. Journal of Advanced Nursing
1982;7(6):545–8.
Gray 1994 {published data only}
Gray D. A randomised clinical trial of two foam mattresses.
Aberdeen Royal Hospitals NHS Trust.
Gray D. A randomised controlled trial of two foam
mattresses. Journal of Tissue Viability 1994;4(3):92.
∗ Gray DG, Campbell M. A randomized clinical trial of two
types of foam mattresses. Journal of Tissue Viability 1994;4
(4):128–32.
Gray DG, Cooper PJ, Campbell M. A study of the
performance of a pressure reducing foam mattress after three
years of use. Journal of Tissue Viability 1998;8(3):9–13.
Gray 1998 {published data only}
Gray D, Smith M. A randomized controlled trial of two
pressure-reducing foam mattresses. European Wound
20Support surfaces for pressure ulcer prevention (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Management Association Conference; 1998 November;
Harrogate, UK. 1998:4.
Gunningberg 2000 {published data only}
Gunningberg L, Lindholm C, Carlsson M, Sjoden P-O.
Effect of visco-elastic foam mattresses on the development
of pressure ulcers in patients with hip fractures. Journal of
Wound Care 2000;9(10):455–60.
Hampton 1997 {published and unpublished data}
Hampton S. Evaluation of the new Cairwave Therapy
System in one hospital trust. British Journal of Nursing
1997;6(3):167–70.
Hofman 1994 {published data only}
Hofman A, Geelkerken RH,Wille J, Hamming JJ, Hermans
J, Breslau PJ. Pressure sores and pressure-decreasing
mattresses: controlled clinical trial. Lancet 1994;343
(8897):568–71.
Inman 1993 {published data only}
Inman KJ, Sibbald WJ, Rutledge FS, Clark BJ. Clinical
utility and cost-effectiveness of an air suspension bed in the
prevention of pressure ulcers. JAMA 1993;269(9):1139–43.
Jolley 2004 {published data only}
Jolley DJ, Wright R, McGowan S, Hickey MB, Campbell
DA, Sinclair RD, et al.Preventing pressure ulcers with the
Australian Medical Sheepskin: an open-label randomised
controlled trial. Medical Journal of Australia 2004;180(7):
324–7.
Kemp 1993 {published data only}
Kemp MG, Kopanke D, Tordecilla L, Fogg L, Shott S,
Matthiesen V, et al.The role of support surfaces and patient
attributes in preventing pressure ulcers in elderly patients.
Research in Nursing and Health 1993;16(2):89–96.
Keogh 2001 {published data only}
Dealey C, Keogh A. A randomised controlled trial
comparing the effect of using an electric profiling bed with
standard hospital bed for patients at high risk of pressure
sore development. 10th Conference of the European
Wound Management Association; 2000 18-20 May;
Stockholm, Sweden. 2000:30.
∗ Keogh A, Dealey C. Profiling beds versus standard hospital
beds: effects on pressure ulcer incidence outcomes. Journal
of Wound Care 2001;10(2):15–9.
Laurent 1998 {unpublished data only}
Laurent S. Effectiveness of pressure decreasing mattresses in
cardiovascular surgery patients: a controlled clinical trial.
3rd European Conference for Nurse Managers, 1997 Oct;
Brussels, Belgium. Brussels, 1998.
Lazzara 1991 {published data only}
Lazzara DJ, Buschmann MBT. Prevention of pressure ulcers
in elderly nursing home residents: are special support
surfaces the answer?. Decubitus 1991;4(4):42–6.
Lim 1988 {published data only}
Lim R, Sirett R, Conine TA, Daechsel D. Clinical trial
of foam cushions in the prevention of decubitis ulcers in
elderly patients. Journal of Rehabilitation Research 1988;25
(2):19–26.
McGowan 2000 {published data only}
McGowan S, Montgomery K, Jolley D, Wright R. [The
role of sheepskins in preventing pressure ulcers in elderly
orthopaedic patients]. First World Wound Healing
Congress; 2000, 10-13 September; Melbourne, Australia.
2000:108.
∗ McGowan S, Montgomery K, Jolley D, Wright R. The
role of sheepskins in preventing pressure ulcers in elderly
orthopaedic patients. Primary Intention 2000;8(4):1–8.
Mistiaen 2009 {published data only}
Mistiaen P, Francke A, Achterberg W, Ament A, Halfens R,
Huizinga J. Australian Medical Sheepskin is effective for
the prevention of pressure ulcers [Australische Medische
Schapenvacht effectief bij de preventie van stuitdecubitus].
Tijdschrift voor Ouderengeneeskunde 2009;5:186–90.
Nixon 1998 {published data only}
Bridel-Nixon J, McElveney D, Brown J, Mason S. [Findings
from a double–triangular sequential–design randomized
clinical trial of a dry polymer pad]. European Wound
Management Association Conference; 1997, 27-29 April;
Milan, Italy. London: Macmillan Magazines, 1997:20–1.
Bridel-Nixon J, McElveney D, Brown J, Mason S. A
randomized controlled trial using a double-triangular
sequential design: methodology and management issues.
European Wound Management Association Conference;
1997, 27-29 April; Milan, Italy. London: Macmillan
Magazines, 1997:65–6.
∗ Nixon J, McElvenny D, Mason S, Brown J, Bond
S. A sequential randomised controlled trial comparing
a dry visco-elastic polymer pad and standard operating
table mattress in the prevention of postoperative pressure
sores. International Journal of Nursing Studies 1998;35(4):
193–203.
Nixon 2006 {published data only}
Iglesias C, Nixon J, Cranny G, Nelson EA, Hawkins
K, Phillips A, et al.Pressure relieving support surfaces
(PRESSURE) trial: cost effectiveness analysis. BMJ 2006;
332(7555):1416.
Nixon J, Cranny G, Iglesias C, Nelson EA, Hawkins K,
Phillips A, et al.Randomised, controlled trial of alternating
pressure mattresses compared with alternating pressure
overlays for the prevention of pressure ulcers: PRESSURE
(pressure relieving support surfaces) trial. BMJ 2006;332
(7555):1413–5.
∗ Nixon J, Nelson EA, Cranny G, Iglesias CP, Hawkins
K, Cullum NA, et al.Pressure relieving support surfaces:
A randomised evaluation. Health Technology Assessment
(Winchester, England) 2006;10(22):iii–101.
Price 1999 {published data only}
Price P, Bale S, Newcombe R, Harding K. Challenging the
pressure sore paradigm. Journal of Wound Care 1999;8(4):
187–90.
Russell 2000 {published and unpublished data}
Dunlop V. Preliminary results of a randomised controlled
study of a pressure ulcer prevention system. Advances in
Wound Care 1998;11(3 suppl 1):14.
Lichtenstein S. A 7 day comparative randomized parallel
21Support surfaces for pressure ulcer prevention (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
single centre study to determine the safety and efficacy of
the Micropulse system for the prevention of pressure ulcers.
Micropulse 1997.
∗ Russell JA, Lichtenstein SL. Randomised controlled trial
to determine the safety and efficacy of a multi-cell pulsating
dynamic mattress system in the prevention of pressure ulcers
in patients undergoing cardiovascular surgery. Ostomy/
Wound Management 2000;46(2):46-51, 54-5.
Russell 2003 {published data only}
Russell LJ, Reynolds TM, Park C, Rithalia S, Gonsalkorale
M, Birch J, et al.Randomised clinical trial comparing
CONFOR-Med and standard hospital mattresses: results of
the prevention of pressure ulcers study (PPUS-1). Advances
in Skin and Wound Care 2003;16(6):317–27.
Sanada 2003 {published data only}
Matsui Y, Miyake S, KawasakiT, Konya C, Sugama J,
Sanada H. Randomized controlled trial of a two layer
type air cell mattress in the prevention of pressure ulcers.
Japanese Journal of Pressure Ulcers 2001;3(3):331–7.
∗ Sanada H, Sugama J, Matsui Y, Konya C, Kitagawa A,
Okuwa M, et al.Randomised controlled trial to evaluate
a new double-layer air-cell overlay for elderly patients
requiring head elevation. Journal of Tissue Viability. 3
2003;13(3):112-4, 116, 118 passim.
Santy 1994 {published data only}
Santy JE, Butler MK, Whyman JD. A comparison study
of 6 types of hospital mattress to determine which most
effectively reduces the incidence of pressure sores in elderly
patients with hip fractures in a District General Hospital.
Report to Northern & Yorkshire Regional Health Authority.
1994.
Schultz 1999 {published data only}
Schultz A, Bien M, Dumond K, Brown K, Myers A.
Etiology and incidence of pressure ulcers in surgical patients.
AORN Journal 1999;70(3):434, 437-40, 443-9.
∗ Schultz AA. Study results: prediction and prevention of
pressure ulcers in surgical patients. Advances in Wound Care
1998;11(3 Suppl):11.
Sideranko 1992 {published data only}
Sideranko S, Quinn A. Burns K, Froman RD. Effects of
position and mattress overlay on sacral and heel pressures in
a clinical population. Research in Nursing and Health 1992;
15(4):245–51.
Stapleton 1986 {published data only}
Stapleton M. Preventing pressure sores -- an evaluation
of three products... foam, ripple pads, and Spenco pads.
Geriatric Nursing (London, England) 1986;6(2):23–5.
Summer 1989 {published data only}
Summer WR, Curry P, Haponikm EF, Nelson S, Elston
R. Continuous mechanical turning of intensive care unit
patients shortens length of stay in some diagnostic-related
groups. Journal of Critical Care 1989;4:45–53.
Takala 1996 {published data only}
Takala J, Varmavuo S, Soppi E. Prevention of pressure sores
in acute respiratory failure: a randomised controlled trial.
Clinical Intensive Care 1996;7(5):228–35.
Taylor 1999 {published data only}
Taylor L. Evaluating the Pegasus Trinova: a data hierarchy
approach. British Journal of Nursing 1999;8(12):771–8.
Theaker 2005 {published data only}
Theaker C, Kuper M, Soni N. Pressure ulcer prevention in
intensive care - a randomised control trial of two pressure-
relieving devices. Anaesthesia 2005;60(4):395–9.
Tymec 1997 {published data only}
Tymec AC, Pieper B, Vollman K. A comparison of two
pressure relieving devices on the prevention of heel pressure
ulcers. Advances in Wound Care 1997;10(1):39–44.
Vanderwee 2005 {published data only}
Vanderwee K, Grypdonck MH, Defloor T. Effectiveness of
an alternating pressure air mattress for the prevention of
pressure ulcers. Age and Ageing 2005;34(3):261–7.
Vyhlidal 1997 {published data only}
Vyhlidal SK, Moxness D, Bosak KS, Van Meter FG,
Bergstrom N. Mattress replacement or foam overlay? A
prospective study on the incidence of pressure ulcers.
Applied Nursing Research 1997;10(3):111–20.
Whitney 1984 {published data only}
Whitney JD, Fellows BJ, Larson E. Do mattresses make a
difference?. Journal of Gerontological Nursing 1984;10(9):
20–5.
References to studies excluded from this review
Allen 1993 {published data only}
Allen V, Ryan DW, Murray A. Potential for bed sores due to
high pressures: influence of body sites, body position, and
mattress design. British Journal of Clinical Practice 1993;47
(4):195–7.
Andrews 1989 {published data only}
Andrews J, Balai R. The prevention and treatment of
pressure sores by use of pressure distributing mattresses.
Care Science and Practice 89;7(3):72–6.
Ballard 1997 {published data only}
Ballard K. Pressure-relief mattresses and patient comfort.
Professional Nurse 1997;13(1):27–32.
Barhyte 1995 {published data only}
Barhyte DY, McCance L, Valenta A, Van Tatenhove J,
Walker MS, Bethea S. Selection of a standard hospital
mattress: data-based decision making. Journal of Wound,
Ostomy and Continence Nursing 1995;22(6):267–70.
Bliss 1967 {published data only}
∗ Bliss MR, McLaren R, Exton Smith AN. Preventing
pressure sores in hospital: controlled trial of a large-celled
ripple mattress. British Medical Journal 1967;1(537):394–7.
Bliss MR, McLaren R, Exton-Smith AN. Mattresses for
preventing pressure sores in geriatric patients. Medical
Bulletin of the Ministry of Health 1966; Vol. 25:238–68.
22Support surfaces for pressure ulcer prevention (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Bliss 1995 {published data only}
∗ Bliss MR. Preventing pressure sores in elderly patients -
a comparison of seven mattress overlays. Age and Ageing
1995;24:297–302.
Bliss MR. Randomised controlled trial of seven pressure
relieving mattress overlays for preventing pressure sores in
elderly patients. Conference of the Tissue Viability Society;
1994; Harrogate, UK. 1994:5.
Braniff-Matthews 1997 {published data only}
Braniff-Matthews C, Rhodes J. Prevention versus treatment:
long term management of care. New Approaches to the
Management of Chronic Wounds. 1997:27–9.
Brienza 2001 {published data only}
∗ Brienza DM, Karg PE, Geyer MJ, Kelsey S, Trefler E. The
relationship between pressure ulcer incidence and buttock-
seat cushion interface pressure in at-risk elderly wheelchair
users. Archives of Physical Medicine and Rehabilitation 2001;
82(4):529–33.
Geyer MJ, Brienza D, Karg P, Kelsey S, Trefler E. Are
commercial seat cushions efficacious in preventing pressure
ulcers in the at-risk, elderly nursing home population?. The
13th Annual Symposium on Advanced Wound Care and
10th Annual Medical Research Forum on Wound Repair.
USA: HMP Communications, LLC, 2000.
Büchner 1995 {published data only}
Büchner T. Comparison of 3 decubitus prevention measures
stemming from the same principle - with reference to cost-
benefit analysis. Krankenpflege 1995;33(6):248–52.
Chaloner 2000 {published data only}
Chaloner D. A prospective, controlled comparison between
two dynamic alternating mattress replacement systems
within a community setting. 9th European Conference on
Advances in Wound Management; 1999, 9-11 November;
Harrogate UK. 2000:9–11.
Colin 1996 {published data only}
Colin D, Loyant R, Abraham P, Saumet JL. Changes in
sacral transcutaneous oxygen tension in the evaluation of
different mattresses in the prevention of pressure ulcers.
Advances in Wound Care 1996;9(1):25–8.
Conine 1991 {published data only}
Conine TA, Hershler C. Effectiveness: a neglected
dimension in the assessment of rehabilitation devices and
equipment. International Journal of Rehabilitation Research
1991;14(2):117–22.
deBoisblanc 1993 {published data only}
deBoisblanc BP, Castro M, Everret B, Grender J, Walker
CD, Summer WR. Effect of air-supported, continuous,
postural oscillation on the risk of early ICU pneumonia in
non-traumatic clinical illness. Chest 1993;103(5):1543–7.
Defloor 1997 {published data only}
Defloor T. The effect of position and mattress on the
development of pressure sores. Verpleegkunde 1997;12(3):
140–9.
Defloor 2000 {published data only}
Defloor T. The effect of position and mattress on interface
pressure. Applied Nursing Research 2000;13(1):2–11.
Defloor 2004 {published data only}
Defloor T. Less frequent turning intervals and yet less
pressure ulcers [Wisselhounding minder frequent en toch
minder decubitus]. Tijdschrift voor Gerontologie en Geriatrie
2001;32:174–7.
∗ Defloor T, De Bacquer D, Grypdonck MHF. The effect
of various combinations of turning and pressure reducing
devices on the incidence of pressure ulcers. International
Journal of Nursing Studies 2005;42:37–46.
Della Valle 2001 {published data only}
Della Valla AG, Salonia-Ruzo P, Peterson MGE, Salvati EA,
Sharrock NE. Inflatable pillows as axillary support devices
during surgery performed in the lateral decubitus position
under epidural anesthesia. Anesthesia and Analgesia 2001;93
(5):1338–43.
Flam 1995 {published data only}
Flam E, Isayeva E, Kipervas Y, Shklyarevsky V, Raab L. Skin
temperature and moisture management with a low air loss
surface. Ostomy Wound Management 1995;41(9):50–6.
Fleischer 1997 {published data only}
Fleischer I, Bryant D. Evaluating replacement mattresses.
Nurse Management 1997;28(8):38–42.
Geelkerken 1994 {published data only}
Geelkerken RH, Breslau PJ, Hermans J, Wille J, Hofman
A, Hamming JJ. Anti-decubitus mattress (letter; comment).
Nederlands Tijdschrift voor Geneeskunde 1994;138(36):
1834.
Gil Agudo 2009 {published data only}
Gil-Agudo A, De la Peña-González A, Del Ama-Espinosa
A, Pérez-Rizo E, Díaz-Domínguez E, Sánchez-Ramos A.
Comparative study of pressure distribution at the user-
cushion interface with different cushions in a population
with spinal cord injury. Clinical Biomechanics 2009;24(7):
558–63.
Gray 2008 {published data only}
Gray D, Cooper P, Bertram M, Duguid K, Pirie G. A
clinical audit of the Softform Premier Active[trademark]
mattress in two acute care of the elderly wards. Wounds UK
2008;4(4):124–8.
Grindley 1996 {published data only}
Grindley A, Acres J. Alternating pressure mattresses:
comfort and quality of sleep. British Journal of Nursing
1996;5(21):1303–10.
Grisell 2008 {published data only}
Grisell M, Place HM. Face tissue pressure in prone
positioning: a comparison of three face pillows while in
the prone position for spinal surgery. Spine 2008;33(26):
2938–41.
Gunningberg 1998 {published data only}
Gunningberg L, Lindholm C, Carlsson M, Sjoden PO.
Patients with hip fracture: risk for pressure ulcers. A
prospective, controlled study of 124 patients in Uppsala,
Sweden. European Wound Management Association
and Journal of Wound Care Autumn Conference; 1998
November; Harrogate, UK. 1998:10.
23Support surfaces for pressure ulcer prevention (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Haalboom 1994 {published data only}
Haalboom J R. Anti-decubitus mattresses. Nederlands
Tijdschrift voor Geneeskunde 94;138(26):1309–10.
Hampton 1998 {published data only}
Hampton S. Can electric beds aid pressure sore prevention
in hospitals?. British Journal of Nursing 1998;7(17):1010–7.
Hawkins 1997 {published data only}
Hawkins JE. The effectiveness of pressure-reducing table
pads as an intervention to reduce the risk of intraoperatively
acquired pressure sores. Military Medicine 1997;162:
759–61.
Heyneman 2009 {published data only}
Heyneman A, Vanderwee K, Grypdonck M, Defloor T.
Effectiveness of two cushions in the prevention of heel
pressure ulcers. Worldviews on Evidence-Based Nursing 2009;
6(2):114–20.
Holzgreve 1993 {published data only}
Holzgreve A, Waldner M, Waldner PW, Hohlbach G. Bed
sore prophylaxis in patients with chronic arterial occlusive
disease with a new thermoactive pressure alternating
mattress. Langenbecks Archiv fur Chirurgie 1993;Suppl
Kongessbericht:1117.
Huang 2009 {published data only}
Huang TT, Tseng CE, Lee TM, Yeh JY, Lai YY. Preventing
pressure sores of the nasal ala after nasotracheal tube
intubation: from animal model to clinical application.
Journal of Oral and Maxillofacial Surgery 2009;67(3):
543–51.
Inman 1999 {published data only}
Inman KJ, Dymock K, Fysh N, Robbins B, Rutledge
FS, Sibbald WJ. Pressure ulcer prevention: a randomized
controlled trial of 2 risk-directed strategies for patient
surface assignment. Advances in Wound Care 1999;12(2):
72–80.
Jacksich 1997 {published data only}
Jacksich BB. Pressure ulcer prevalence and prevention
of nosocomial development: one hospital’s experience.
Ostomy/Wound Management 1997;43(3):32-4, 36, 38-40.
Jesurum 1996 {published data only}
Jesurum J, Joseph K, Davis JM. Balloons, beds and
breakdown. Effects of low air loss therapy on the
development of pressure ulcers in cardiovascular surgical
patients with intra-aortic balloon pump support. Critical
Care Nursing Clinics of North America 1996;8(4):423–40.
Koo 1995 {published data only}
Koo TK, Mak AF, Lee YL. Evaluation of an active seating
system for pressure relief. Assistive Technology 1995;7(2):
119–28.
Marchand 1993 {published data only}
Marchand AC, Lidowski H. Reassessment of the use
of genuine sheepskin for pressure ulcer prevention and
treatment. Decubitus 1993;6(1):44–7.
McMichael 2008 {published data only}
McMichael JC, Place HM. Face tissue pressures in prone
positioning: a comparison of 3 pillows. Journal of Spinal
Disorders and Techniques 2008;21(7):508–13.
Neander 1996 {published data only}
Neander KD, Michels S, Bering F, Rich A, Merseburg M.
Effects of soft bedding on body perception and posture.
Pflege 1996;9(4):293–9.
Ooka 1995 {published data only}
Ooka M, Kemp MG, McMyn R, Shott S. Evaluation of
three types of support surfaces for preventing pressure ulcers
in patients in a surgical intensive care unit. Journal of Wound
Ostomy Continence Nursing 1995;22(6):271–9.
Phillips 1999 {published data only}
Phillips L. Providing correct pressure-relieving devices for
optimum outcome. British Journal of Nursing 1999;8(21):
1447–52.
Regan 1995 {published data only}
Regan MB, Byers BH, Mayrovitz HN. Efficacy of a
comprehensive pressure ulcer prevention programme in an
extended care facility. Advances in Wound Care 1995;8(3):
51–5.
Reynolds 1994 {published data only}
Reynolds A, Suarez C. Pressure-reducing capability of
Conforma II mattress overlay. Advances in Wound Care
1994;7:36–40.
Rosenthal 1996 {published data only}
Rosenthal MJ, Felton RM, Hileman DL, Lee M, Friedman
M. A wheelchair cushion designed to redistribute sites
of sitting pressure. Archives of Physical Medicine and
Rehabilitation 1996;77:278–82.
Scott 1995 {published data only}
Scott F. Easing the pressure for hip fracture patients. Nursing
Times 95;91(29):30–1.
Scott 1999 {published data only}
Scott EM, Baker EA, Kelly PJ, Stoddard EJ, Leaper DJ.
Measurement of interface pressures in the evaluation of
operating theatre mattresses. Journal of Wound Care 1999;8:
437–41.
Scott 2000 {published data only}
Scott EM. The prevention of pressure ulcers in the operating
department. Journal of Wound Care 2000;9(1):18–21.
Stoneberg 1986 {published data only}
Stoneberg C, Pitcock N, Myton C. Pressure sores in the
homebound: one solution. American Journal of Nursing
1986;April:426–8.
Suarez 1995 {published data only}
Suarez CH, Reynolds A. Pressure reduction with a
hospitalized population using a mattress overlay. Ostomy
Wound Management 1995;41:58-60, 62-3.
Takala 1994 {published data only}
Takala J, Soini HO, Soppi E, Kataja M, Olkkonen K. Is it
possible to reduce the risk factors of pressure sores by means
of special mattresses?. Duodecim 1994;110(4):407–14.
Thomas 1994 {published data only}
Thomas J. Support surface evaluation methodological and
statistical considerations. Journal of Tissue Viability 1994;4
(3):93.
24Support surfaces for pressure ulcer prevention (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Timmons 2008 {published data only}
Timmons J, Bertram M. The use of micro-stimulation in
pressure ulcer prevention. Wounds UK 2008;4(4):120–3.
Torra i Bou 2002 {published data only}
Torra i Bou JE, Rueda López J, Camañes G, Herrero
Narváez E, Blanco Blanco J, Martínez-Esparza EH, et
al.Heel pressure ulcers. Comparative study between heel
protective bandage and hydrocellular dressing with special
form for the heel. Revista de Enfermeria 2002;25(5):50–6.
Turnage-Carrier 2008 {published data only}
Turnage-Carrier C, McLane KM, Gregurich MA. Interface
pressure comparison of healthy premature infants with
various neonatal surfaces. Advances in Neonatal Care 2008;
8(3):176–84.
Vanderwee 2007 {published data only}
Vanderwee K, Grypdonck MH, De Bacquer D, Defloor
T. Effectiveness of turning with unequal time intervals on
the incidence of pressure ulcer lesions. Journal of Advanced
Nursing 2007;57(1):59–68.
Vanderwee 2008 {published data only}
Vanderwee K, Grypdonck M, Defloor T. Alternating
pressure air mattresses as prevention for pressure ulcers: a
literature review. International Journal of Nursing Studies
2008;45(5):784–801.
Wells 1984 {published data only}
Wells P, Geden E. Paraplegic body-support pressure on
convoluted foam, waterbed, and standard mattresses.
Research in Nursing and Health 1984;7(2):127–33.
Wild 1991 {published data only}
Wild D. Body pressures and bed surfaces. Nursing Standard
1991;5(27):23, 25-7.
Zernike 1997 {published data only}
Zernike W. Heel pressure relieving devices how effective are
they?. Australian Journal of Advanced Nursing 1997;14(4):
12–9.
Zernike 1994 {published data only}
Zernike W. Preventing heel pressure sores: a comparison of
heel pressure relieving devices. Journal of Clinical Nursing
1994;3(6):375–80.
References to studies awaiting assessment
Allegretti 2008 {unpublished data only}
Allegretti A. Factors associated with clinical decisions and
pressure ulcer development in long term care residents.
University of Pittsburgh.
Berthe 2007 {published data only}
Berthe JV, Bustillo A, Melot C, de Fontaine S. Does a
foamy-block mattress system prevent pressure sores? A
prospective randomised clinical trial in 1729 patients. Acta
Chirurgica Belgica 2007;107(2):155–61.
Demarré 2010 {published data only}
Demarré L, Vanderwee K, Beeckman D, Defloor T.
Pressure ulcer prevention: randomized controlled trail
comparing the effect of a standard alternating pressure air
mattress and a alternating low pressure air mattress with
gradual inflation and deflation. EWMA Journal 2010;10
(2):44, Abstract 48.
Mastrangelo 2010 {published data only}
Mastrangelo D, Farina E, Gallicchio V, De Anna D,
Bresadola F, FArina MA. Initial analyses of the prospective
study randomized on the anti-decubitis lesion mattress
cover. SAWC Spring: The Symposium on Advanced
Wounds Care and the Wound Healing Society; 2010, April
17-20; Orlando, Florida. 2010:S32, Abstract CR-053.
Mayer 2008 {published data only}
Mayer H, Schröder G, Osterbrink J. Clinical evaluation of
the efficiency of the micro-stimulation-system thevo-activ:
Final report [Klinische Evaluation der Wirksamkeit des
MiS Micro–Stimulations–Systems Thevo–Activ]. Florida
International University 2008.
Taccone 2009 {published data only}
Taccone P, Polli F, Mietto C, Gattinoni L. Effects of a
new rotational device on complication rate during prone
ventilation in patients with acute respiratory distress
syndrome: A retrospective analysis. Intensive Care Medicine
2009;36(4):585–99.
van Leen 2011 {published data only}
van Leen M, Hoviuy S, Neyens J, Halfens R, Schols J.
Pressure relief, cold foam or static air? A single center,
prospective, controlled randomized clinical trial in a Dutch
nursing home. Journal of Tissue Viability 2011;20:30–4.
Additional references
Allman 1997
Allman RM. Pressure ulcer prevalence, incidence, risk
factors, and impact. Clinical Geriatric Medicine 1997;13(3):
421–36.
Banks 1998
Banks V. Nutrition and pressure area management. Journal
of Wound Care 1998;7(6):318–9.
Benbow 1996
Benbow M. Pressure sore guidelines: patient/carer
involvement and education. British Journal of Nursing 1996;
5(3):182,184–7.
Bennett 2004
Bennett G, Dealey C, Posnett J. The cost of pressure ulcers
in the UK. Age and Ageing 2004;33(3):230–5.
Bergstrom 1998
Bergstrom, N, Braden, B, Champagne, M, Kemp, M, &
Ruby, E. Predicting pressure ulcer risk: a multisite study of
the predictive validity of the Braden Scale. Nursing Research
1998;47(5):261–269.
Berlowitz 1990
Berlowitz DR, Wilikin SVB. Risk factors for pressure sores:
a comparison of cross-sectional and cohort derived data.
Journal of the American Geriatrics Society 1990;37(11):
1043–50.
Berlowitz 1997
Berlowitz DR, Brandeis GH, Anderson J, Brand HK.
Predictors of pressure ulcer healing among long-term care
25Support surfaces for pressure ulcer prevention (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
residents. Journal of the American Geriatrics Society 1997;45
(1):30–4.
Bianchetti 1993
Bianchetti A, Zanetti O, Rozzini R, Trabucchi M. Risk
factors for the development of pressure sores in hospitalized
elderly patients: results of a prospective study. Archives of
Gerontology and Geriatrics 1993;16(3):225–32.
Bliss 1993
Bliss MR, Thomas JM. Clinical trials with budgetary
implications: establishing randomised trials of pressure-
relieving aids. Professional Nurse 1993;8(5):292–6.
Bo 2003
Bo M, Massaia M, Raspo S, Bosco F, Cena P, Molaschi
M, et al.Predictive factors of in-hospital mortality in older
patients admitted to a medical intensive care unit. Journal
of American Geriatrics Society 2003;51(4):529–33.
Casey 1997
Casey G. Nutrition helps wound healing. Nursing New
Zealand 1997;3(11):19.
Casey 1998
Casey G. The importance of nutrition in wound healing.
Nursing Standard 1998;13(3):51–2.
Choi 1992
Choi SC, Nelson LD. Kinetic therapy in critically ill
patients: combined results based on meta-analysis. Journal
of Critical Care 1992;7:57–62.
Clough 1994
Clough NP. The cost of pressure area management in an
intensive care unit. Journal of Wound Care 1994;3:33–5.
Darouiche 1994
Darouiche RO, Landon GC, Klima M, Musher DM,
Markowski J. Osteomyelitis associated with pressure sores.
Archives of Internal Medicine 1994;154(7):753–8.
Deeks 1998
Deeks J. Odds ratios should be used only in case control
studies and logistic regression analyses. BMJ 1998;317:
1155–6.
Ek 1990
Ek AC, Larsson J, Von Schenck H, Thorslund S, Unosson
M, Bjurulf P. The correlation between energy, malnutrition
and clinical outcome in an elderly hospital population.
Clinical Nutrition 1990;9(4):185–9.
Elliot 1999
Elliott TR, Shewchuk RM, Scott Richards J. Caregiver social
problem-solving abilities and family member adjustment to
recent-onset physical disabilities. Rehabilitation Psychology
1999;44(1):104–23.
Emflorgo 1999
Emflorgo CA. The assessment and treatment of wound
pain. Journal of Wound Care 1999;8(8):384–5.
EPUAP-NPUAP 2009
European Pressure Ulcer Advisory Panel and National
Pressure Ulcer Advisory Panel. Prevention and treatment
of pressure ulcers: quick reference guide. Washington DC:
National Pressure Ulcer Advisory Panel 2009.
Flock 2003
Flock P. Pilot study to determine the effectiveness of
diamorphine gel to control pressure ulcer pain. Journal of
Pain and Symptom Management 2003;25(6):547–54.
Franks 1999
Franks PJ, Morfatt CJ. Focus on wound management:
Quality of life issue in chronic wound management. British
Journal of Community Nursing 1999;4(6):283–4.
Franks 2002
Franks PJ, Winterburg JH, Moffatt CJ. Health-related
quality of life and pressure ulceration assessment in patients
treated in the community. Wound Repair and Regeneration
2002;10(3):133–40.
Freeman 2001
Freeman K, Smyth C, Dallam L, Jackson B. Pain
measurement scales: a comparison of the visual analogue
and faces rating scales in measuring pressure ulcer pain
(comment). Journal of Wound, Ostomy and Continence
Nursing 2001;28(6):290–6.
Gallagher 1997
Gallagher SM. Morbid obesity: a chronic disease with an
impact on wound and related problems. Ostomy/Wound
Management 1997;43(5):18–24,26-7.
Gosnell 1973
Gosnell DJ. An assessment tool to identify pressure sores.
Nursing Research 1973;22:55–59.
Hagelstein 1995
Hagelstein SM, Banks V. Maintaining quality of life for
elderly patients in residential care. Journal of Wound Care
1995;8(4):347–8.
Healy 2003
Healy M. Wound care and pain. World of Irish Nursing
2003;11(5):39–40.
Hefley 1990
Hefley ML, Radcliffe J. The 1988-1989 decubitus study.
Can a standardization of treatment be set for the elderly
patient with decubiti ulcers stage III?. Hawaii Medical
Journal 1999;49(9):346, 349-50.
Higgins 2003
Higgins JPT, Thompson SG, Deeks JJ, Altman DG.
Measuring inconsistency in meta-analyses. BMJ 2003;327:
557–60.
Junkin 2009
Junkin J, Gray M. Are pressure redistribution surfaces or
heel protection devices effective for preventing heel pressure
ulcers?. Journal of Wound Ostomy Continence Nursing 2009;
36(6):602–8.
Kaltenhalter 2001
Kaltenhaler E, Whitfield, Walters SJ, Akehurst RL, Paisley
S. UK, USA and Canada: how do their pressure ulcer
prevalence and incidence data compare?. Journal of Wound
Care 2001;10(1):530–5.
26Support surfaces for pressure ulcer prevention (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Krainski 1992
Krainski MM. Pressure ulcers and the elderly. Ostomy
Wound Management 1992;38(5):22.
Lefebvre 2009
Lefebvre C, Manheimer E, Glanville J, on behalf of the
Cochrane Information Retrieval Methods Group. Chapter
6: Searching for studies. In: Higgins JPT, Green S (editors).
Cochrane Handbook for Systematic Reviews of Interventions
Version 5.0.2 [updated September 2009]. The Cochrane
Collaboration, 2008. Available from www.cochrane-
handbook.org.
Manfredi 2002
Manfredi PL, Breuer B, Meier DE, Libow L. Pain assessment
in the elderly with severe dementia. Journal of Pain and
Symptom Management 2002;25(1):48–52.
Moher 2001
Moher D, Schulz KF, Altman D. The CONSORT
statement: revised recommendations for improving the
quality of reports of parallel-group randomized trials.
CONSORT group. JAMA 2001;285(15):1987–91.
Norton 1979
Norton D, McLaren R, Exton-Smith A.N. An Investigation
of Geriatric Problems in Hospital. 3rd Edition. London:
Churchill Livingstone, 1979.
NPUAP 2007
National Pressure Ulcer Advisory Panel (NPUAP). Support
Surface Standards Initiative. Terms and Definitions Related
to Support Surfaces. www.npuap.org/NPUAP˙S3I˙TD.pdf
2007.
Orlando 1998
Orlando PL. Pressure ulcer management in the geriatric
patient. Annals of Pharmacotherapy 1998;32(11):1221–7.
Pase 1998
Pase MN, Hoffman RG. Selection and use of risk assessment
tools and treatment protocol in extended care facilities in
the southwest. Journal of Wound Ostomy and Continence
Nursing 1998;25(1):44–50.
Phillips 2009
Phillips L, Buttery J. Exploring pressure ulcer prevalence
and preventative care. Nursing Times 2009;105(16):34–6.
Prior 2002
Prior J. The pressure is on: midwives and decubitus ulcers.
RCM Midwives Journal 2002;5(5):196–200.
Ronda 2002
Ronda L, Falce RL. Skin care in older people. Primary
Health Care 2002;12(7):51–7.
SIGN 2008
Scottish Intercollegiate Guidelines Network (SIGN). Search
filters. http://www.sign.ac.uk/methodology/filters.html#
random (accessed 28 February 2008).
Spoelhof 2000
Spoelhof GD. Management of pressure ulcers in the nursing
home. Annals of Long Term Care 2000;8(8):69–77.
Thomas 1996
Thomas DR, Goode PS, Tarquine PH, Allman RM.
Hospital acquired pressure ulcers and risk of death. Journal
of American Geriatrics Society 1996;44:1435–40.
Thomas 2001
Thomas DR. Improving outcomes of pressure ulcers
with nutritional interventions: a review of the evidence.
Nutrition 2001;17:121–5.
Vanderwee 2007
Vanderwee K, Clark M, Dealey C, Gunningberg L, Defloor
T. Pressure ulcer prevalence in Europe: a pilot study. Journal
of Evaluation in Clinical Practice 2007;13(2):227–35.
VanGilder 2009
VanGilder C, Amlung S, Harrison P, Meyer S. Results of the
2008-2009 International Pressure Ulcer Prevalence Survey
and a 3-year, acute care, unit-specific analysis. Ostomy/
Wound Management 2009;55(11):39–45.
Waltman 1991
Waltman NL, Bergstrom N, Armstrong N, Norvell K,
Braden B. Nutritional status, pressure sores, and mortality
in elderly patients with cancer. Oncology Nursing Forum
1991;18(5):867–73.
Waterlow 1985
Waterlow J. A risk assessment card. Nursing Times 1985;81
(49):51–5.
Whittington 2004
Whittington K, Briones R. National prevalence and
incidence study: 6-year sequential acute care data. Advances
in Skin and Wound Care 2004;17(9):490–5.
Woodbury 2004
Woodbury M, Houghton P. Prevalence of pressure ulcers in
Canadian healthcare settings. Ostomy/Wound Management
2004;50(10):22–4,26,28,30,32,34,36-8.
References to other published versions of this review
Cullum 1995
Cullum NA, Deeks JJ, Fletcher AW, Sheldon TA, Song F.
Preventing and treating pressure sores. Quality in Health
Care 1995;4:289–97.
Cullum 2001
Cullum N, Nelson EA, Flemming K, Sheldon T. Systematic
reviews of wound care management: (5) Beds: (6)
Compression: (7) Laser therapy, therapeutic ultrasound,
electrotherapy and electromagnetic therapy. Health
Technology Assessment 2001;5(9):1–221.
Cullum 2003
Cullum N, Nelson EA, Nixon JE. Pressure Sores. Clinical
Evidence. Vol. 9, London: BMJ Publishing Group, June
2003:408–9.
∗ Indicates the major publication for the study
27Support surfaces for pressure ulcer prevention (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Andersen 1982
Methods RCT with 10 day follow-up. Method of allocation unclear.
Participants Patients in acute setting at high risk of pressure ulcer development (Andersen scale), and
without existing pressure ulcers
Interventions 1. Standard hospital mattress (n = 161).
2. Alternating air mattress (AP) (n = 166).
3. Water-filled mattress (air mattress for camping filled with water) (n = 155)
Outcomes Incidence of pressure ulcers (skin examined on alternate days):
1. Standard mattress: 13.0% (21/161).
2. Alternating mattress: 4.2% (7/166).
3. Water mattress: 4.5% (7/155).
Notes 118 out of 600 selected patients dropped out during first 24 h. A priori sample size
calculation.
AP easily punctures and in this studywas not always set at optimumpressure.Water bed is
heavy and time-consuming to fill. Patients more satisfied with ordinary bed: complained
of the noise and pressure changes of AP
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Patients “were allotted to one of the three
group”. Method of randomisation not re-
ported
Allocation concealment? Unclear Not reported.
Blinding?
Pressure ulcer incidence
Unclear Not reported.
Incomplete outcome data addressed?
All outcomes
Unclear Only participant drop-out pre-randomisa-
tion reported.
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes “The distribution showed no significant
difference between the three groups accord-
ing to age, sex, body weight, or risk score”
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Andersen 1982 (Continued)
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes Observation took place on alternate days
for 10 days.
Aronovitch 1999
Methods Quasi-randomised trial with 7 day follow-up.
Participants > 18 y; free of pressure ulcers; undergoing elective surgery under GA, of > 3 h operative
time.No significant differences between groups for age, sex, race, weight, height, smoking
status at baseline, but patients in conventional management group were at greater risk
of pressure ulcer development as defined by Knoll score
Interventions 1. AP system intra and postoperatively (Micropulse) (n = 112). Micropulse is thin pad
with over 2,500 small air cells in rows; 50% cells inflated at any time.
2. Conventional management (n = 105): consisted of use of a gel pad in the operating
room and a replacement mattress postoperatively
Outcomes Occurance of pressure ulcer within 7 days of surgery: number/size/grade of ulcers on
each postoperative day:
1.MicroPulse system1% (1/90), however, ulcer was due to a foreign body and considered
“not related to the bed”.
2. Conventional management 9% (7/80) (7 patients developed 11 pressure ulcers; the
stage of 6 of these could not be determined because of eschar). Grade 1: 1; Grade 2: 4
Notes 1. MicroPulse system: device was inadvertently turned off during treatments of 4 pa-
tients. 4 patients asked to withdraw for various unreported reasons. 3 patients withdrew
due to back pain. 12 patients assigned to this group were placed on another surface
postoperatively for reasons unrelated to the surface.
2. Conventional management: 6 patients were placed on theMicroPulse postoperatively.
Analysis was on an ITT basis
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Quasi-randomised: “randomisation was
performed by week rather than by patient
to decrease protocol error”
Allocation concealment? Unclear Not reported.
Blinding?
Pressure ulcer incidence
Unclear Not reported.
Incomplete outcome data addressed?
All outcomes
Yes All reasons/numbers for attrition/exclu-
sions reported.
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Aronovitch 1999 (Continued)
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes It was stated, however, that all data were
not available for all patients
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes Outcomes assessed on days 1, 4 and 7.
Bennett 1998
Methods RCT with 60-day follow-up.
Median length of follow-up (days):
Group 1: 4 (1-60).
Group 2: 6 (1-62) P value <0.017.
Participants Acute and long-term care patients incontinent of urine and/or faeces, in bed >16 h/
day, with pressure ulcers grade 2 or below (or none). If urinary catheter present, this
was removed in the LAL group (not control group). Most common diagnoses: sepsis;
malignancy; fractured neck of femur; hypovolaemia; dementia
Interventions Group 1. Low-air-loss Hydrotherapy (LAL) (n = 42) Clensicair (SSI/Hill Rom). Perme-
able fast drying filter sheet over low-air-loss cushions (circulating air). Urine collection
device integral to bed.
Group 2. Standard care (n = 56) comprised standard bed or foam, air, alternating-pressure
mattresses. Skin care not standardised
Outcomes Number of patients who developed any kind of skin lesion more than 1 day after enrol-
ment:
Group 1: 64% (27/42);
Group 2: 18% (10/56).
Number of patients who developed pressure ulcers Grade 2-4:
Group 1: 19% (8/42);
Group 2: 7% (4/56) P value 0.11; NS.
Number of patients with non-blanchable erythema (Grade 1):
Group 1: 14% (6/42);
Group 2: 0/56 P value 0.008.
Only 26 ulcers present on enrolment, and only 3 were Grades 3 or 4, so no healing data
presented
Notes The first 68 patients were discounted, and a further 26 out of 116 withdrew. No ITT
analysis. Nurses received special extra training for the LAL bed. LAL patients were inter-
viewed about satisfaction, control patients were not. There were many nurse complaints
about the LAL; firmly held belief that it was associated with more ulceration. Two sub-
jects in the LAL group developed hypothermia. Findings may not relate to subsequent
products developed since
Risk of bias
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Bennett 1998 (Continued)
Item Authors’ judgement Description
Adequate sequence generation? Yes “Randomization of subject to low-air-loss
hydrotherapy or standard care was done by
unblocked allocation using a table of ran-
dom numbers stratified by pressure sore
and by setting”
Allocation concealment? Unclear Method of concealment not described.
Blinding?
Pressure ulcer incidence
Unclear Not reported.
Incomplete outcome data addressed?
All outcomes
Yes Shown in Table 2 and reported in text.
Free of selective reporting? No “Because too few patients with pressure
sores at enrolment were enrolled long
enough to have changes in pressure sore
size, grade, or status, no data on change in
pressure sores present at enrolment are pre-
sented herein”
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes “There were no statistically significant dif-
ferences in enrolment characteristics be-
tween the two groups”
Free of other bias - was the timing of the
outcome assessment similar in all groups?
No “For all subjects, the study treatment period
commenced on the day of enrolment and
continued until withdrawal of consent, dis-
charge from the hospital, transfer to a crit-
ical care unit from a medical-surgical ward
or to the acute hospital from the chronic
hospital ward, death, cessation of inconti-
nence, bed use less than 16 hours per day,
enrolment for more than 60 days, or end
of the overall study”
Cadue 2008
Methods RCT with maximum follow-up 30 days.
Participants Patients in an intensive care setting with a Waterlow Score >10, no existing heel pressure
ulcers, ≥18 y or over. Participants seemed generally matched at baseline
Interventions 1. Foam body support and standard pressure prevention protocol (half-seated position,
water mattress preventative massage 6 times/day) (n = 35).
2. Standard pressure ulcer protocol (as above) (n = 35).
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Cadue 2008 (Continued)
Outcomes Number of participants developing non-blanching pressure ulcer or worse on the heel:
1. Foam body support 8.6% (3/35);
2. Usual care 55.4% (19/35).
Notes Full paper not available in English.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes From English summary. Quote: “a randomi-
sation table was used to allocate 70 patients
into 2 groups”. The two groups were formed
randomly by following a randomisation ta-
ble
Allocation concealment? Yes Quote: “envelope cachetee” translated as
sealed envelope.
Blinding?
Pressure ulcer incidence
Unclear “le masseur-kinesitherapeute et l’infirmiere”
translated to: the physiotherapist and nurse
assessed the stage of the lesion daily - but it
is not clear if they were blinded
Incomplete outcome data addressed?
All outcomes
Yes 70 patients were included, 35 in each group.
Table 2 presents the principle results and
notes that “n = 35” which has been inter-
preted that data were presented on 35 pa-
tients in each group. Nomention was found
of any withdrawals
Free of selective reporting? Unclear The judgement has been recorded due to
the difficulty in making this assessment in a
trial that has been published in French and
partially translated
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes “a l’inclusion il n’existait pas de difference
significative entre les 2 groupes au niveau du
risque theorique de developper des escarres
ni au niveau des principaux facteurs connus
pour favoriser la survenue d’escarres”, was
translated to: at inclusion there was no sig-
nificant difference between the 2 groups in
the theoretical risk of developing pressure ul-
cers or any of the main factors known to
contribute to the occurrence of bedsores
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Cadue 2008 (Continued)
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes The physiotherapist and nurse assessed the
stage of the lesion daily? it is assumed this
was done for both experimental and control
groups
Cavicchioli 2007
Methods RCT with follow-up of 2 weeks.
Participants Acute and long-term care participants deemed at risk of pressure ulceration (Braden score
< 17 activity or mobility sub-scales < 3 respectively). Patients had an expected admission
of at least 2 weeks. Patients could have 1 grade 1 pressure ulcer at baseline, but were
excluded if they had more; or the ulcer was grade 2 or above. Baseline balance for age,
sex and Braden score in the randomised groups
Interventions 1. High-tech (Duo 2, Hill Rom) mattress on alternating low-pressure setting (n = 86).
2. High-tech (Duo 2, Hill Rom) mattress on continuous low-pressure setting (n = 84)
Outcomes Number of participants with Incidence pressure ulcer (blinded outcome assessment at
study end):
Grade 1:
1. Alternating low-pressure 1% (1/69);
2. Continuous low-pressure 0/71.
Grade 2:
1. Alternating low-pressure 1% (1/69);
2. Continuous low-pressure 1% (1/71).
Notes This was a 3-armed study. There was a 2-armed RCT, as described, and a control group
(standard mattress), which was not formed by randomisation and not included here
Blinded outcome assessment was conducted for the randomised groups
Follow up figures were:
1. 69 (4 deaths, 8 participants discharged before final assessment, and 5 classed as not
having completed the study due to non-concordance);
2. 71 (5 deaths, 4 discharged and 4 classed as non-concordant). Not ITT
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Participants not randomly allocated to the 3 groups
from same pool of patients. Controls from another
hospital. Only patients in high tech groups appeared
to be randomised “by means of a sealed envelope”
Allocation concealment? Unclear Unclear.
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Cavicchioli 2007 (Continued)
Blinding?
Pressure ulcer incidence
Yes External observer was blinded to which treatment
mattress was in use
Incomplete outcome data addressed?
All outcomes
Yes Reasons for attrition and exclusion reported.
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
No “The two treatments groups were assessed as at
greater risk of pressure ulceration than the control
group both at baseline (p <0.001) and the study end
(p <0.005).”
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes 2-week study period with assessments taking place
at the beginning and end of the study
Cobb 1997
Methods RCT with 40-day follow-up.
Participants Recruitment in hospital wards and intensive care units. Participants > 18 y of age, ≤ 290
pounds, without pre-existing pressure ulcer, an expected length of stay of 1-2 weeks and
considered at “high risk” on the basis of the Braden Scale. Patients allocated through
the selection of a treatment card by an independent nurse. Some baseline imbalance
observed with older participants; more participants with co-morbidities in the KinAir
group
Interventions 1. Low loss air bed (KinAir Bed) (n = 62).
2. Static air mattress overlay (EHOB waffle) (n = 61).
Outcomes Number of participants with incidence pressure ulcer (ICU participants assessed daily,
ward patients assessed every 48 h):
Grade 1
1. KinAir Bed 5% (3/62);
2. EHOB waffle 2% (1/61).
Grade 2.
1. KinAir Bed 5% (3/62);
2. EHOB waffle 18% (11/61)
Eschar
1. KinAir Bed 3% (2/62);
2. EHOB waffle 0/61.
Notes No higher grades reported. No loss to follow-up reported.
Risk of bias
Item Authors’ judgement Description
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Cobb 1997 (Continued)
Adequate sequence generation? Unclear “Patients were placed into one of the study groups by
random selection of a treatment card”. Method of ran-
domisation unclear
Allocation concealment? Yes The use of an independent nurse picking a treatment
card.
Blinding?
Pressure ulcer incidence
Unclear Not reported.
Incomplete outcome data addressed?
All outcomes
Yes No numbers/reasons given for exclusions/attrition.
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
No EHOB waffle group had more participants in younger
age bracket; KinAir group had more with diabetes and
cancer
Free of other bias - was the timing of the
outcome assessment similar in all groups?
No “Patients in the ICUs had skin assessments daily and
those on the wards were assessed every 48 hours”
Collier 1996
Methods RCT comparing 8 different foam mattresses; length of follow-up not clear but patients
assessed weekly. Allocation as follows: mattresses assigned to beds and coded numerically
with only the principal investigator andward link nurse aware of identity of eachmattress.
Mattresses then allocated to patients “as available”
Participants Patients on a general medical ward; no further details given
Interventions Comparison of 8 foam mattresses:
1. New Standard Hospital Mattress (Relyon) (130 mm) (n = 9).
2. Clinifloat (n = 11).
3. Omnifoam (n = 11).
4. Softform (n = 12).
5. STM5 (n = 10).
6. Therarest (n = 13).
7. Transfoam (n = 10).
8. Vapourlux (n = 14).
Outcomes Incidence of pressure ulcers. Patients assessed at least weekly throughout hospital stay.
No patient developed a pressure ulcer of any grade during whole study
Notes 9 patients allocated the Cyclone mattress, however, this group was withdrawn from
the study at manufacturer’s request and data not presented. All mattresses assessed for
“grounding”, deterioration of cover and contamination of inner foam core, interface
pressures. No “grounding” of any mattresses during the evaluation period; softening of
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Collier 1996 (Continued)
the centre of the foam base in Standard and Omnifoam mattresses on completion of
study (detected using a “fist test” of unknown reliability). All mattress covers remained
intact and inner foam protected
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Only information provided: “Mattresses
were randomly allocated to patients on ad-
mission as available”
Allocation concealment? Unclear Not reported.
Blinding?
Pressure ulcer incidence
No “Only the principal investigator and the
ward link nurse knew the identification of
each mattress”
Incomplete outcome data addressed?
All outcomes
Unclear 9 patients missing from data in Table 2 as
their treatment, Cyclone mattress, was re-
moved during the evaluation process at the
request of the manufacturer. No other raw
data presented in the paper to evaluate if
incomplete outcome data addressed
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Unclear Not reported.
Free of other bias - was the timing of the
outcome assessment similar in all groups?
No “Frequency of assessment was determined
by each patient’s condition, but in all cases
was conducted at least weekly throughout
their period in hospital”
Conine 1990
Methods Sequential RCT with 3-month follow-up. Method of allocation unclear
Participants Patients with chronic neurological diseases aged 18-55 y with no evidence of skin break-
down for at least 2 weeks prior to the study. Patients in the 2 groups were well matched at
baseline for key variables e.g. Norton score; sex; age; underweight/overweight; diagnoses;
years as a wheelchair user; history of previous pressure ulcers; incontinence. Setting ex-
tended care facility for chronic neurological conditions
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Conine 1990 (Continued)
Interventions 1. Alternating-pressure overlay (n = 72); 10-cm air cells. Cycle time not reported, nor
the make of overlay.
2. Silicore (Spenco) overlay (n = 76); siliconised hollow fibres in waterproofed cotton
placed over standard hospital mattress (spring or foam).
All patients received usual care including 2-3 hourly turning; daily bed baths; weekly
bath/shower; use of heel, ankle and other protectors
Outcomes Incidence of pressure ulcers (including grade 1). Pressure ulcer status was checked by
another researcher blind to the study. Inter-rater reliability high.
Included grade 1 ulcers:
1. Alternating air overlay: 54% (39/72);
2. Spenco overlay: 59% (45/76).
The alternating air overlay group had a slightly lower than average ’Exton-Smith severity
score’ (1.59 vs 1.69); a shorter than average healing duration (25 days vs 29 days); NS
Notes Alternating air overlay needed frequent monitoring and expensive prolonged repairs.
Reported that patients sank into the Silicore overlay and found it difficult to move.
Patients complained of build-up of bad odour, instability (especially Silicore), and noise
of the alternating-pressure motor. High dropout rate due to discomfort
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Only information given: a modified se-
quential clinical trial as described byPocock
(1981) was used to assign subjects ran-
domly to one of the two mattress groups of
20
Allocation concealment? Unclear Not reported.
Blinding?
Pressure ulcer incidence
Yes “The Norton’s scale was administered by
a blind experienced occupation therapist
who was external to the institution” and
“The research nurse...was responsible for
the assessment of all outcome measures.
She was not associated with the institution
and was not informed about the study”
Incomplete outcome data addressed?
All outcomes
Yes As shown in Table 1.
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes No statistically significant differences be-
tween the 2 groups as shown in Table II
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Conine 1990 (Continued)
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Unclear Timing not specified.
Conine 1993
Methods Trial with 3-month follow-up.
Participants Extended care patients > 60 y; free of skin breakdown for at least 2 weeks prior to study;
considered to be at high risk of pressure ulcers; sitting in wheelchair for a minimum of
4 consecutive h; free of any progressive disease which could lead to bed confinement
Interventions 1. Slab cushion bevelled at base to prevent seat sling (n = 144).
2. Contoured foam cushion with a posterior cut out in the area of ischial tuberosities
and an anterior ischial bar (n = 144)
Outcomes 1. Slab cushion 68% (85/125);
2. Contoured foam cushion 68% (84/123).
Notes No ITT analysis.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Method of randomisation unclear, only information
given: “the patients were entered into the trial in se-
quential groups of 40, 20 on each cushion type”
Allocation concealment? Unclear Not reported.
Blinding?
Pressure ulcer incidence
Unclear “The Exton-Smith scale was used weekly by a blinded
research assistant who was a registered nurse (RN)”,
but, “A sore was declared to be healed by the patient’s
primary nurse with the joint agreement of the research
RN” - unclear if the primary nurse was blinded to
treatment groups
Incomplete outcome data addressed?
All outcomes
Yes Shown in Table 3.
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes “No significant differenceswere foundbetween the slab
and contoured groups in the reasons for drop-outs or
between the group characteristics of the 248 remaining
patients”
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Conine 1993 (Continued)
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes It is reported that the occupational therapist conducted
monthly checks for change in status. The checking of
ulcers was carried out 30minutes after returning to bed
by the patient’s primary nurse with the joint agreement
of the research RN
Conine 1994
Methods RCT of 2 wheelchair cushions with 3-month follow-up. Method of randomisation un-
clear as patients were described as ”randomly allocated by the principal investigator“
Participants Elderly patients (mean age 82 y) in an extended care hospital deemed at high risk of
pressure ulcers (NortonScore≤ 14); sitting in awheelchair forminimumof 4 consecutive
h/day; free of progressive disease likely to confine to bed. Excluded if diabetic, had
peripheral vascular disease; confined to bed for more than 120 consecutive h (except if
to heal a pressure ulcer).
There were no statistically significant differences between groups at baseline for Norton
scores; age; hours in bed/day; sex; diagnosis; sensory loss; history of previous ulcers;
weight; nutritional status; oedema; incontinence; hours in wheelchair/day
Interventions 1. Jay cushion (n = 68); the Jay cushion is a contoured urethane foam base over gel pad.
2. Foam cushion (n = 73); 30 kg/m3 density foam bevelled at the bottom to prevent
sling effect.
Both cushions fitted with identical Jay air-exchange covers of knitted polyester. Patients
assigned to their specific wheelchairs by a seating specialist according to a local policy
unaffected by the trial
Outcomes 1. Jay Cushion 25% (17/68);
2. Foam Cushion 41% (30/73).
Pressure ulcer incidence data presented as number of ulcers and number of affected
patients for all grades of ulcer, but only as number of ulcers by grade (and there were cases
of multiple ulcers on the same patient). Therefore impossible to present the incidence
data as number of patients affected by ulcers of grade 2 or above
Notes 13% attrition; not analysed by ITT.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear ”Qualified patients were randomly as-
signed to either foam or Jay cushions in
groups of 40 by the principal investigator“
Method of randomisation not reported
Allocation concealment? Unclear Not reported.
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Conine 1994 (Continued)
Blinding?
Pressure ulcer incidence
Yes ”The principal investigator was blind to all
data“ and ”A research assistant, an experi-
enced registered nurse (RN), examined the
patients weekly, blind, and classified the
status of any skin lesions”
Incomplete outcome data addressed?
All outcomes
Yes Shown in Table 3.
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes “No statistically significant differenceswere
found between groups”
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes Weekly for 3 months.
Cooper 1998
Methods RCT with 7-day follow-up. Allocation by consecutively-numbered, sealed, opaque en-
velopes
Participants 100 patients > 65 y, with no pressure ulcers, from 3, 24-bedded mixed emergency
orthopaedic trauma wards. All patients at risk of pressure ulcers with Waterlow Risk
scores of ≥15. Baseline variables similar for each group (age, sex, mobility, Waterlow
scores)
Interventions 1. Dry flotation mattress (Roho) (n = 49) (data supplied for only 43).
2. Dry flotation mattress (Sofflex) (n = 51) (data supplied for only 41)
Outcomes Grade 2 ulcers and above: 1. Roho mattress: 5% (2/43); Sofflex mattress: 2% (1/51).
Grade 1 ulcers: 1. Roho mattress: 12% (5/43); 2. Sofflex mattress 5% (2/41)
Notes Roho mattress: 79% patients found it comfortable or very comfortable, 5 found it un-
comfortable. Sofflex mattress: 90% patients found it comfortable or very comfortable.
Staff had difficulty setting the level of inflation correctly; this can now be done automat-
ically. 16% attrition; no ITT analysis
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes “The subjects were then randomly allo-
cated to one of two types of mattress using
consecutively numbered sealed opaque en-
velopes”
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Cooper 1998 (Continued)
Allocation concealment? Yes See above.
Blinding?
Pressure ulcer incidence
Unclear Not reported.
Incomplete outcome data addressed?
All outcomes
Yes No missing outcome data. Reasons for
attrition reported: death, change in care
circumstances, transferred and discharged,
however, not specified for each interven-
tion group
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes As seen in Table 1.
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes 24 h post admission and at 7 days.
Daechsel 1985
Methods RCT with 3-month follow-up. Method of allocation unclear.
Participants 32 patients with chronic neurological conditions in a long term care hospital. All aged
19-60 y, free from skin breakdown on entry, considered at high risk of pressure ulcers
Interventions 1. Alternating-pressure mattress (Gaymar Inc) (n = 16).
2. Silicore overlay (JW Westman Inc) (n = 16).
Outcomes Included grade 1 ulcers:
1. Alternating overlay: 25% (4/16);
2. Spenco overlay: 25% (4/16).
No statistically significant differences were found between the 2 groups with regard to
location and severity of pressure ulcers
Notes 100% follow-up. Patients’ satisfaction was similar for both devices
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear “All qualified subjects were entered into the
trial for a period of three months and all
were randomly assigned to one of the two
types of mattress”. Method of randomisa-
tion not reported
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Daechsel 1985 (Continued)
Allocation concealment? Unclear Not reported.
Blinding?
Pressure ulcer incidence
Unclear Not reported.
Incomplete outcome data addressed?
All outcomes
Unclear No reasons/numbers for exclusions/attri-
tion given.
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes “Statistical tests of significance indicated
that the groups were comparable on the
factors that are considered to be associated
with the development of DU”
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes Daily observations and weekly skin checks
over 3 months.
Economides 1995
Methods RCT with 2-week follow-up. Allocation by sealed envelope.
Participants 12 patients with grade 4 pressure ulcers needing myocutaneous flap closure. 10/12
participants paraplegic or quadriplegic. Groups appeared broadly comparable at baseline,
except the Roho group seem to have slightly better nutritional status (not tested for
significance)
Interventions 1. Roho dry flotation mattress (n = 6) - bed overlay consisting of 720 air cells that
conform to the body to provide maximum support area and a “floating” environment.
2. Air-fluidised Clinitron bed (n = 6) - ceramic microspheres through which warm pres-
surised air is blown, covered by a polyester sheet. The bed forms a dry-fluid environment
on which the patient floats, thus distributing body weight away from bony prominences
Outcomes Wound breakdown: 33% (2/6) on Roho vs 33% (2/6) on Clinitron. No significant dif-
ference between 2 support surfaces in the prevention of flap breakdown in the immediate
postoperative period
Notes Do not appear to have had any withdrawals.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes “The patients were assigned to a support
surface by using a table of random num-
bers”
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Economides 1995 (Continued)
Allocation concealment? Yes “The names of the two support surfaces
were placed in envelopes that were sealed
and numbered sequentially”
Blinding?
Pressure ulcer incidence
Unclear Not reported.
Incomplete outcome data addressed?
All outcomes
Unclear No reasons/numbers for exclusions/attri-
tion reported.
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes Table 1.
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes Daily assessments for 2 weeks.
Ewing 1964
Methods RCTwith 6-month follow-up.Mode of allocation unclear - reported as random selection
Participants Elderly patients, average age 72.5 y, confined to bed, with reducedmobility in legs due to
neurological disorder, fixed joints, or peripheral vascular disease. No baseline data given
and baseline comparability not described. Setting was geriatric unit of a convalescent
hospital
Interventions 1. Sheepskins adjusted so that both legs were supported on the woolly fleece (n = 18).
2. Control, without sheepskins (n = 18). All were submitted to the same 4-hourly routine
skin care involving washing, drying, powdering, light massage of pressure areas, bed
cradle
Outcomes The study was too small and poorly designed to detect a difference. No reports of
withdrawals. Outcomes not clearly described or reported in terms of numerator and
denominator. Reports incidence of pressure ulcers areas of ’reddened’ skin. Grading of
outcomes not done
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear “The patients were studied for a period of
six months, and were allotted to a ’treated’
or a ’control’ group by random selection”’.
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Ewing 1964 (Continued)
Method of randomisation not reported
Allocation concealment? Unclear Not reported.
Blinding?
Pressure ulcer incidence
Unclear Not reported.
Incomplete outcome data addressed?
All outcomes
Unclear No reasons/numbers for attrition/exclu-
sions reported.
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Unclear No patient demographics given.
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes At the end of the study period - at six
months
Exton-Smith 1982
Methods Trial with 2-week follow-up. Allocation by alternation, and, where surface of choice was
not available, patients were given an available surface
Participants Newly-admitted geriatric patients, with fractured neck of femur, and long-stay patients;
without pressure ulcers of grade 2 or greater. Norton score <14. Patients were matched
in pairs for sex and Norton score. Where a match was not possible, the Airwave patient
was matched with a Large Cell Ripple patient with a higher risk score. Groups appear
well matched at baseline
Interventions 1. Pegasus Airwave system (AWS) (n = 31) 2 layers of air cells; pressure alternated by
deflating every 3rd cell in a 7.5 minute cycle. Mattress ventilated by pinholes through
which air passes to keep patient’s skin dry.
2. Large Cell Ripple (LCR) mattress (n = 31) large cell ripple not described
Outcomes Grade 2 ulcer or greater:
1. AWS: 16% (5/31);
2. LCR: 39% (12/31).
Notes During the trial period, no breakdowns with AWS, 10 breakdowns on LCR, 4 patients
withdrawn; 94% follow-up
Risk of bias
Item Authors’ judgement Description
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Exton-Smith 1982 (Continued)
Adequate sequence generation? No “Patients were alternately allocated the
AWS or the LCM unless the appropriate
mattress was not available: in that case the
patient was allocated the mattress not in
use”. Proper randomisation not completed
Allocation concealment? Unclear Not reported.
Blinding?
Pressure ulcer incidence
Unclear Not reported.
Incomplete outcome data addressed?
All outcomes
Unclear No reasons/numbers for exclusions/attri-
tion reported.
Free of selective reporting? No Not all of the study’s pre-specified primary
outcomes were reported i.e. the reliability
and acceptability of both types of appara-
tus.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes “There was no significant difference be-
tween the two groups”
Free of other bias - was the timing of the
outcome assessment similar in all groups?
No “Each patient remained on the allocated
regimen for 2 weeks unless he died or was
discharge from hospital, or the clinic score
rose to 17 or more”
Feuchtinger 2006
Methods RCT with 5-day follow-up (postoperative).
Participants Recruitment from a Department of Cardiovascular Surgery. Eligible patients > 18 y,
scheduled for cardiac surgery with extracorporal circulation. Not required to be free
of pressure ulcers; 4 patients had grade 1 pressure ulcers as they went into surgery.
Participants well matched at baseline
Interventions 1. Operating table with waterfilled warming mattress and a 4-cm thermoactive viscoelas-
tic foam overlay (Thermo) (n = 85).
2. Standard OR table configuration (OR table with waterfilled warming mattress) (n =
90)
Outcomes Number of participants with incidence pressure ulcer (assessed day 1, 3 and 5 postoper-
atively; blinded outcome assessment):
Grade 1 ulcers postoperative days 0-5:
1. Thermo 15.3% (13/85);
2. Standard 10% (9/90).
Grade 2 ulcers postoperative day 0-5:
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Feuchtinger 2006 (Continued)
1. Thermo 2.4% (2/85);
2. Standard 1% (1/90).
Notes No higher grades of ulcers reported. No participant loss reported. The study was stopped
after interim analysis due to the 11.1% total incidence in the standard group compared
with 17.6% in the treatment group
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear ”Included patients were randomised to ei-
ther the standard operating table configu-
ration or the test configuration“. Method
of randomisation unclear
Allocation concealment? Unclear Not reported.
Blinding?
Pressure ulcer incidence
Yes “The postoperative nurses who assess the
skin condition were unaware of the patient
assignment”
Incomplete outcome data addressed?
All outcomes
Unclear No numbers/reasons given for exclusions/
attrition.
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes ”Ninety paired assessments were under-
taken for the inter-rater reliability assess-
ment”. No statistically significant differ-
ences were found
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes Day 1, 3 and 5 postoperatively.
Gebhardt 1996
Methods Trial allocation by hospital number. Two systems: patients were automatically placed on
the low-cost mattress within the allocated system. Patients who deteriorated or experi-
enced persisted erythema were transferred to a medium-cost mattress. If deterioration
continued they were placed on the highest-cost mattress, or transferred to the alternate
group, if appropriate
Participants Patients in ICU with a Norton score <13, who had been in the unit for < 3 days, with
no pressure ulcers
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Gebhardt 1996 (Continued)
Interventions 1. Alternating-pressure air mattresses (shallow small cell overlays, medium depth large
cell overlays, deep mattresses and deep pulsating low-air-loss beds) (n = 23).
2. Constant low-pressure supports (fibre overlays, foam mattresses/overlays, static air
overlays, gel overlay, water overlay, bead overlay, low-air-loss mattresses, static air overlay,
low-air-loss beds and air-fluidised bead beds) (n = 20)
Outcomes 1. Support provided.
2. Pressure ulcer development: Alternating pressure group (n=0 participants), Constant
low-pressure group (n=8 participants of which grade 2 (n=4), grade 3 (n=2), both grade
2 and 3 (n=2))
3. Cost: Low cost (less than £500) n=22 (n=1shallow small cell overlay, n=5 fibre over-
lays, n=4 medium-depth large-cell overlays, n=6 foam mattresses/overlays, n=3 static air
overlays, n=1 gel overlay, n=1 water overlay, n=1 bead overlay)
Medium cost (£500- £5000) n=4 (n=2 deep mattresses, n=1 low-air-loss mattresses, n=
1 static air overlays)
High cost (Greater than £5000) n=6 (n=2 deep pulsating low-air-loss beds, n=2 low-air-
loss beds, n=2 air fluidised bead beds)
Notes No ITT analysis. Mechanical unreliability and poor management of alternating-pressure
supports was a problem
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? No Patients allocated “according to the final
digit of their hospital number (even to alter-
nating pressure, odd to constant low pres-
sure supports).”
Allocation concealment? No Patients allocated “according to the final
digit of their hospital number (even to alter-
nating pressure, odd to constant low pres-
sure supports).”
Blinding?
Pressure ulcer incidence
Unclear Not reported.
Incomplete outcome data addressed?
All outcomes
Yes Reasons for exclusion/attrition given.
Free of selective reporting? Unclear Pre-specified aims not reported. Incidence
of pressure ulcers as well as mean cost per
type of mattress provided
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes As shown in Table 2.
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Gebhardt 1996 (Continued)
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Unclear “Patients were visited four times weekly by
the research nurse”, however, “patientswere
taken out of the trial after three months,
or if their condition improved so that they
were no longer at risk of developing pres-
sure sores, if they were discharged or trans-
ferred to another ward or hospital, or if they
died”.
Gentilello 1988
Methods RCT, duration of follow up unclear. Trial primarily not a pressure ulcer trial, but of
kinetic treatment tables used to prevent chest infection in immobile patients
Participants Critically ill patients in surgical ICU immobilised because of head injury, spinal injuries
or traction.Groupswell matched at baseline for demographic and pulmonary risk factors;
patients in the conventional bed group had higher incidence of cigarette smoking
Interventions 1. Kinetic Treatment Table (KTT) (n = 27): rotates through an arc of 124o every 7
minutes. Nurses instructed to leave bed rotating except when vital signs were being
recorded and treatments being given. If a patient developed a serious complication as
result of KTT, they were moved onto a conventional bed.
2. Conventional beds (n = 38): patients turned in conventional fashion every 2 h. Patients
who developed a chest infection, where positioning was thought to be a factor, were
moved onto a KTT
Outcomes Primary outcomes were:
Incidence of pulmonary complications.
Other outcomes measured included Incidence of pressure ulcers:
KTT 30%;
Conventional beds: 26%.
Notes 1 patient withdrew and was not included in the analysis. No raw data provided for
incidence of pressure ulcers
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes “Randomization was performed by draw-
ing a randomizing card”.
Allocation concealment? Unclear Not reported.
Blinding?
Pressure ulcer incidence
Unclear Only reported that the physician in charge
of interpreting X-rays was blinded to treat-
ment allocation
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Gentilello 1988 (Continued)
Incomplete outcome data addressed?
All outcomes
Unclear No reasons/numbers for attrition/exclu-
sion reported.
Free of selective reporting? Unclear All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes “Patients in the control and experimental
groups were similar for most demographic
variables”
Free of other bias - was the timing of the
outcome assessment similar in all groups?
No “Patients were evaluated daily. The active
study period started with randomisation
and ended when the patient was allowed
out of bed, died or was discharged from the
SICU”
Geyer 2001
Methods Pilot RCT with 12-month follow-up.
Participants Recruitment in nursing homes (for the elderly). Eligible patients were wheelchair users
aged > 65 y at risk of developing pressure ulcers (Braden score ≤ 18); with a combined
Barden activity and mobility sub-scale of ≤ 5; no pressure ulcers on their sitting surface;
and tolerant of daily wheelchair sitting for ≥ 6 h in the ETAC twin wheelchair (body
weight required to be < 250 lb). Participants well matched at baseline for age, initial
Braden score, sex
Interventions 1. Pressure-reducing wheelchair cushion (n = 15). No single make of cushion specified,
rather this could be selected by the nurse from a group of cushions based on the partic-
ipants’ clinical status. Further details about cushion design were not provided.
2. Standard foam (eggcrate) cushion (Bioclinic Standard, Sunrise Medical) (n = 17)
Outcomes Number of participants with Incidence pressure ulcer (weekly assessment; blinded out-
come assessment):
Grade not reported (all grades):
1. Pressure-reducing cushion 40% (6/15);
2. Foam cushion 58.5% (10/17).
Notes Seating assessments were performed in both groups throughout the study.
1. 1 participant died, 3 lost to follow-up.
2. 1 participant died, 2 lost to follow-up.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes “Random treatment assignments with a 1-to-1
scheme were generated prior to the start of the
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Geyer 2001 (Continued)
study by a separate research team member who
was not involved in executing the trial”
Allocation concealment? Yes “Sequentially numbered sealed envelopes con-
taining the treatment assignment were pre-
pared”
Blinding?
Pressure ulcer incidence
Yes “Nursing staff members performing the out-
comes measurements were blinded to the treat-
ment group”
Incomplete outcome data addressed?
All outcomes
Yes All reasons/numbers for attrition/exclusion
provided.
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes Table 4 in the study report.
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes Weekly patient assessments.
Gilcreast 2005
Methods RCT of heel ulcers: follow-up period unclear.
Participants Recruitment frommilitary tertiary-care academic medical centres. Eligible patients were
at moderate or high risk of pressure ulcer development (Braden score ≤ 14). Patients
with hip surgery were excluded, as were patients anticipated to be admitted for < 72 h,
and those with pre-existing heel pressure ulcers. Limited baseline information presented.
There was baseline imbalance in sex
Interventions 1. Bunny Boot (fleece) high cushion heel protector.
2. Egg crate heel lift positioner (holds the foot suspended above the bed surface with
heel through a window).
3. Foot waffle air cushion (felt coated plastic inflatable plastic pillow that encircles the
foot)
Outcomes Pressure ulcer incidence (did not stratify by grade; baseline numbers not available and
unclear whether the unit was number of ulcers or number of patients):
1. Bunny Boot 4% (3/77);
2. Egg crate 5% (4/87);
3. Foot waffle 7% (5/76).
Notes 69% of participant were in ICU. Of the initial 338 patients, only 240 had follow-up
data, given as n in outcomes. Not clear how the 338 were distributed among the three
groups. 53 not included, as did not wear the devices for at least 48 h; 45 not included as
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Gilcreast 2005 (Continued)
they were non-compliant. No ITT
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Drawing of cards.
Allocation concealment? No Inadequate (non-numbered envelopes)
Blinding?
Pressure ulcer incidence
No “The 1 nurse was performing all research
tasks and was not blinded to the device to
which the participant was assigned”
Incomplete outcome data addressed?
All outcomes
Yes All reasons/numbers for attrition/exclu-
sions reported.
Free of selective reporting? Unclear All pre-specified outcomes reported, how-
ever, raw numbers of participants unclear
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Unclear Only differences in gender distribution re-
ported.
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes Daily assessments.
Goldstone 1982
Methods Patients randomised alternately on arrival in A&E to 1 of 2 alternative surfaces. Follow-
up not clear
Participants Patients (> 60 y) with femur fracture. (Mean Norton score 13). Groups comparable at
baseline for age and Norton score
Interventions 1. Beaufort bead bed system (includes bead-filled mattress on A&E trolley; bead-filled
operating table overlay; bead-filled sacral cushion for operating table; bead-filled boots
to protect heels on operating table (n = 32).
2. Standard supports in A&E, operating theatre, ward (n = 43)
Outcomes Grading of ulcers not given.
Beaufort bead bed system: 16%;
Standard surface: 49%.
Maximum width of broken skin (mean):
Beaufort bead bed system: 6.4 mm;
Standard surface: 29.5 mm.
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Notes Patients in the Beaufort bead bed group who were incontinent of urine (numbers not
given) were catheterised, however, this did not seem to be the same for the control group.
Patients who were removed from the Beaufort bed standard surfaces for any reason not
included in analysis. Number of withdrawals unclear; no ITT analysis
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? No “Patients...were assigned alternately (from
a random start) either to the Beaufort sys-
tem or to the existing ‘standard’ surfaces as
encountered on trolleys, beds, surgical ta-
bles etc”
Allocation concealment? Unclear See above - not reported.
Blinding?
Pressure ulcer incidence
Unclear Not reported.
Incomplete outcome data addressed?
All outcomes
No “Patients who were later found to have suf-
fered no fracture, or who requested to be
removed from the Beaufort system for any
reason, or who died before reaching the
post operative ward are excluded from the
analysis”
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes “The two groups were well matched on a
variety of criteria on admission”
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes No other concerns.
Gray 1994
Methods RCT with 10-day follow-up. Allocation by sealed envelope.
Participants Patients from orthopaedic trauma, vascular and medical oncology units without breaks
in the skin (Waterlow score > 15).
Groups well matched at baseline for age, sex and Waterlow score
Interventions 1. Softfoam mattress (n = 90).
2. Standard 130 mm NHS foam mattress (n = 80).
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Outcomes Incidence of pressure ulcers. Skin condition assessed at 5 and 10 days; presumably assessor
not blind to treatment group.
Grade 2 or greater ulcer:
Softform: 7%;
Standard: 34%.
Rate of transfer to dynamic support surface: 19% in standard group vs 2% in Softform
group
Notes Impossible to calculate attrition rate, as incidence reported as % only and unclear what
the denominator was. Nurses were more positive, and patients gave higher comfort scores
to Softform mattress
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear The subjectswere then “randomly allocated
to one of the two types of mattress using
unmarked envelopes”.
Allocation concealment? Unclear The subjectswere then “randomly allocated
to one of the two types of mattress using
unmarked envelopes”.
Blinding?
Pressure ulcer incidence
Unclear No mention of blinding.
Incomplete outcome data addressed?
All outcomes
Unclear Num-
bers not reported post-baseline.Might have
been issues as the discussion notes that: “A
number of patients were excluded from the
study because the Waterlow score awarded
by the ward staff differed greatly from that
of the researcher”. Not clear if this exclu-
sion was post-randomisation.
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Unclear More patients in orthopaedic and vascular
specialities in the treatment arm
Free of other bias - was the timing of the
outcome assessment similar in all groups?
No “...were assessed for deterioration in skin
condition at 5 and 10 days respectively....”
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Gray 1998
Methods Trial with follow-up of 10 days.
Participants Patients admitted to a District General Hospital for bed-rest or surgery, with intact skin,
no other skin abnormalities, no terminal illness, weight <160 kg.
Mean Waterlow score on admission: Group 1: 14 (3.6); Group 2: 13 (2.5)
Interventions 1. Transfoam mattress (n = 50).
2. Transfoamwave (n = 50) (both foam).
Outcomes 1. 1x grade 4 ulcer.
2. 1x grade 2 ulcer.
Notes 95% follow-up; ITT analysis. Length of stay, pressure ulcer incidence. Comfort not
specified (and only in treatment arm)
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear “Subjects were selected from the admissions using
serially numbered, sealed opaque envelopes and allo-
cated to either a study mattress... or a non -study mat-
tress.......This form of randomisation ensured that
staff were not able to choose which patients be allo-
cated to the study mattress”
Allocation concealment? Yes “Subjects were selected from the admissions using se-
rially numbered, sealed opaque envelopes and allo-
cated to either a study mattress... or a non -study mat-
tress.......This form of randomisation ensured that
staff were not able to choose which patients be allo-
cated to the study mattress”
Blinding?
Pressure ulcer incidence
Yes “Subjects were reviewed at 5 and 10 days post ad-
mission. Observations of the skin were made and any
pressure sores documented; these observations were
confirmed blindly by the ward link nurse”
Incomplete outcome data addressed?
All outcomes
Unclear Numbers not reported post-baseline.
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Unclear Only data for the treatment arm were provided. Peo-
ple were randomised to a non-study treatment, but
were not followed-up
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Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes Subjects were reviewed at 5 and 10 days post admis-
sion.
Gunningberg 2000
Methods RCT with follow-up until discharge, or 14 days postoperatively
Participants Patients admitted with a suspected hip fracture via an A&E department. Participants
were > 65 y and did not have pressure ulcers
Interventions 1. 10 cm visco-elastic foam mattress on arrival in A&E, and visco-elastic foam overlay
on standard ward mattress (n = 48).
2. Standard A&E trolley mattress and ward mattress (n = 53).
Outcomes Grade 2 to 4 incidence:1. 8.3% (4/48); 2. 15% (8/53).
Pressure ulcer incidence (all grades):1. 25% (12/48);2. 32% (17/53)
Mean comfort rating:1. 4.2;2. 4.0
All results NS.
Notes Only 44 participants completed the comfort questionnaire.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Only details of process provided state, “On
arrival to A and E patients with a suspected
hip fracture were randomised to an experi-
mental or control group with concealed al-
location”
Allocation concealment? Unclear “On arrival to A and E patients with a sus-
pected hip fracture were randomised to an
experimental or control group with con-
cealed allocation”
Blinding?
Pressure ulcer incidence
Unclear Main outcome not blinded, but study au-
thors undertook blinded outcome assess-
ment as a ‘process check’ on a sub-set.
“25% Pus....in 13 patients were pho-
tographed during the study. The ulcers
in these photos were graded by an expert
nurse..who was blinded to treatment...”
Incomplete outcome data addressed?
All outcomes
Unclear Difficult to tell if 18 people were excluded
before or after randomisation. Outcomes
reported for 101 patients:
“This study...included 119 patients aged
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over 65 years with a hip fracture....Eighteen
were excluded because they died, did not
have skin assessment on arrival, were ad-
mitted with PUs. Of the remaining 101 pa-
tients 48 and53were allocated to the exper-
imental and control groups respectively”
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes Similar.
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Unclear “The pressure ulcer nurse on the ward usu-
ally performed the assessments on the 4th
day postoperatively and at discharge”
Hampton 1997
Methods RCT, but method of allocation not described. Duration of follow-up to a maximum of
20 days
Participants Very little detail; average age 77 y. No data regarding baseline status of patients presented
in published paper, therefore, impossible to judge baseline comparability. Only limited
information obtained on request: number of patients at high-very high risk Airwave
group = 31; number of patients at high-very high risk Cairwave group = 27. Mean age:
Airwave group = 79 y; Cairwave group = 75 y
Interventions 1. Alternating-pressure (Cairwave System) (n = 36): 3-cell, 7.5 minute cycle. Manufac-
turers claim that zero pressure achieved for more than 20% of the cycle.
2. Alternating-pressure (Airwave System) (n = 39): cells arranged in sets of 3 and inflated
in waves. 7.5 minute cycle; zero pressure said to be applied for 15% of the time
Outcomes Incidence of pressure ulcers. No patient in this study developed a pressure ulcer
Notes Attrition unclear.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Report states, “randomised controlled
trial”, but no further details given
Allocation concealment? Unclear States, “patients were allocated to the Cair-
wave Therapy System during the ran-
domised controlled trial”, but no further
information was given
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Blinding?
Pressure ulcer incidence
Unclear No report of blinding.
Incomplete outcome data addressed?
All outcomes
Unclear No information provided.
Free of selective reporting? Unclear No access to study protocol.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Unclear No information provided.
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Unclear No information provided.
Hofman 1994
Methods RCT with 2-week follow-up. Patients randomised in blocks of 6 but method of ran-
domisation not described
Participants Patientswith a femoral-neck fracture and risk score > 8 (Dutch consensus scale). Excluded
patients with pressure ulcers of grade 2 or greater on admission.
Groups were similar at baseline for pressure ulcer risk; haemoglobin; total serum protein
and serum albumin
Interventions 1. Cubed foammattress (Comfortex DeCube mattress) (n = 21) - allows removal of small
cubes of foam from beneath bony prominences.
2. Standard hospital mattress (n = 23) - standard polypropylene SG40 hospital foam
mattress.
Both groups were treated according to the Dutch consensus protocol for the prevention
of pressure ulcers
Outcomes Incidence of ulcers of grade 2 or greater at 2 weeks. Outcome assessment not blind to
treatment group. Patients were examined 1 and 2 weeks after surgery by 2 independent
observers; disagreement resolved by a 3rd observer.
Grade 2 or greater ulcers:
Comfortex DeCube: 24% (4/17);
Standard: 68% (13/19).
Maximum pressure ulcer gradings were significantly higher for the standard mattress
than the DeCube mattress at 1 and 2 weeks
Notes 78% follow-up. No ITT analysis. DeCube mattress was not always used correctly, and
its size was not optimal for all patients. A priori sample size calculation
Risk of bias
Item Authors’ judgement Description
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Adequate sequence generation? Unclear “Each group of 6 consecutively admitted
patients was randomly divided into 3 pa-
tients nursed preoperatively and postoper-
atively on the standard Vredestein polypro-
leen SG 40 hospital mattress (Vredestein,
Netherlands) and 3 nursed on the comfo-
tex DeCube”
Allocation concealment? Unclear See above, only description of the randomi-
sation process in paper.
Blinding?
Pressure ulcer incidence
No “The study was not blinded with respect to
observer or nurse”.
Incomplete outcome data addressed?
All outcomes
Unclear Of the 46 patients randomised, 2 were ex-
cluded due to the randomisation not be-
ing performed correctly (no further details)
both in control group. By week 1, 1 patient
had left each group (1 death, 1 discharge).
By 2 weeks post randomisation, 4 patients
in each group had been discharged or died.
It is not totally clear but seems that only
those remaining (n = 17 comparedwith 19)
were included in the 2 week analysis.
Free of selective reporting? Yes Main outcome of interest was occurrence
of pressure ulcers and this was recorded
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes Age and length of hospital stay balanced.
More medial fractures in control group
and 24% male in treatment group com-
pared with 4% in control group. Not sure,
though, how these would be linked to out-
come and cause bias
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes Patients were examined 1 and 2 weeks after
surgery.
Inman 1993
Methods RCT with an average of 17 days’ follow-up. Method of allocation unclear
Participants Patients > 17 y with an Acute Physiology and Chronic Health Evaluation (APACHE II)
score > 15 who had an expected ICU stay of > 3 days
Interventions 1. Low-air-loss beds (n = 49).
2. Standard ICU bed (n = 49); patients rotated every 2 h.
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Outcomes Incidence of pressure ulcers reported in the trial both as ulcers per patient and patients
with ulcers. We have only extracted the incidence of patients developing ulcers.
Grade 2 or greater ulcers:
Low-air-loss beds: 12% (6/49);
Standard ICU bed: 51% (25/49).
Patients with multiple pressure ulcers:
Low-air-loss beds: 2% (1/49);
Standard ICU bed: 24% (12/49).
Notes A priori sample size calculation. 98/100 randomised participants completed the study,
1 lost from each group as did not stay in ICU for 3 days; neither developed an ulcer.
No ITT analysis.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear “100 consecutive patients were randomly
assigned to receive treatment with either
the air suspension bed or a standardised
ICU bed”
Allocation concealment? Unclear See above.
Blinding?
Pressure ulcer incidence
Unclear Blinding not mentioned in the description
of outcome assessment. Not explicit that
anyone was blinded
Incomplete outcome data addressed?
All outcomes
No 100 randomised, 98 analysed. One patient
from each group was excluded post-ran-
domisation
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes Groups similar at baseline in age and reason
for admission. More men in control com-
pared with standard group (59% vs 45%)
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes Timing of assessment daily in both groups.
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Jolley 2004
Methods RCT with unclear follow-up period, mean bed days observed/participant Group 1: 7
days, and Group 2: 7.9 days
Participants Participants recruited from a single hospital, and had to be at low to moderate risk of
developing a pressure ulcer and > 18 y. Patients were excluded if they had no risk or high
risk (as more complex interventions required), if they had any pre-existing ulcers, had
an expected length of stay of < 48 h or had darkly-pigmented skin (justified by authors
as making grade 1 ulcers difficult to detect)
Participants well matched at baseline for age, sex, mean pressure ulcer risk score
Interventions 1. Sheepskin mattress overlay: leather-backed with a dense, uniform 25 mm wool pile.
Used as a partial mattress overlay. Pressure points that were not covered by sheepskin
were protected by a second sheepskin, or specific sheepskin elbow and heel protectors.
Overlays were changed 3 times a week (unless required). Received usual care including
repositioning (n = 270).
2. Usual care as determined by ward staff. Included repositioning and any other PRD or
prevention strategy with/without low-tech constant pressure relieving devices (n = 269)
Outcomes Number of participants with incidence pressure ulcer (daily assessment; unblinded out-
come assessment):
All ulcers (grade 1 and 2; no grade 3 or 4 recorded)
1. Sheepskin: 10% (21/218);
2. Usual care: 17% (37/223).
Total number of ulcers:
1. Sheepskin: 27;
2. Usual care: 58.
Total number of incident grade 2 ulcers:
1. Sheepskin: 12;
2. Usual care: 20.
Notes Whilst 270were allocated to the sheepskin and 269 to control; only 218 and 223 received
their allocated treatment and are included in the analysis. Not ITT
“Any patient whose risk increased to high (Braden score <12) for 48 h was no longer
followed up for pressure-ulcer endpoints.” Authors did not say why. Of the 218 partici-
pants in the sheepskin group 2 died, 7 became high risk (treatment change), 14 requested
withdrawal, 6 had ward staff intervention and 11 changed treatment for other reasons.
Of the 223 control participants 5 died, 1 became high risk, 8 requested withdrawal, 5
had ward staff intervention and 10 changed treatments for other reasons
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Shuffling cards(?): “Patients were randomly
allocated to receive.......using numbered
cards in individually sealed opaque en-
velopes; blocks of 16 envelopes (eight of
each group) were shuffled before use”
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Allocation concealment? Yes “Patients were randomly allocated to re-
ceive.......using numbered cards in individ-
ually sealed opaque envelopes; blocks of 16
envelopes (eight of each group) were shuf-
fled before use”
Blinding?
Pressure ulcer incidence
No “As it was logistically impossible to blind
patients, ward staff and research nurses to
the treatment group this was an open-label,
unblinded trial”
Incomplete outcome data addressed?
All outcomes
No “539....were randomly allocated. Of these,
441 received the allocated intervention. All
441 were followed up to the endpoints...”.
Data for 441 not 539. Is a per protocol
analysis.
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Unclear Baseline data for 441 participants and not
the 539 randomised
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes “Research nurse assessed each participant
daily for pressure ulcer risk.....and skin in-
tegrity”
Kemp 1993
Methods RCT with 1-month follow-up. Allocation by random-number table
Participants Inclusion criteria: > 65 y, inpatients, with a Braden Score of ≤16. Age ranged from 65-
98 y, 58 women, 26 men. Recruited from general medicine, acute geriatric medicine and
long term care. All patients free from pressure ulcers on admission.
Groups similar for important variables at baseline.
Interventions 1. Convoluted foam overlay (CF), 3 or 4 inches thick (n = 45).
2. Solid foam overlay (SF) 4 inches thick, sculptured (n = 39)
Outcomes Incidence of pressure ulcers assessed by Research Nurse presumably not blinded to in-
tervention.
Included grade 1 ulcers:
CF: 47%;
SF: 31%.
Notes All patients appear to have completed the study.
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Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes “..a random number table was used to as-
sign study participants to....”
Allocation concealment? Unclear not clearly reported
Blinding?
Pressure ulcer incidence
Unclear not clearly reported
Incomplete outcome data addressed?
All outcomes
No “..45 patients were assigned to the CF
group and 39 to the SF group......”
“...33 (39%) patients developed a total of
57 pressure ulcers....”
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Unclear Similar for Braden score, age, mobility, but
these figureswere not presented for all those
randomised. Treatment group were lighter,
118.51 lb vs 129.46 lbwhen all participants
included
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes “Research nurses assessed each patient’s
skin and completed a Braden scale ev-
ery Monday, Wednesday and Friday for 1
month or until discharge...”
Keogh 2001
Methods RCT with follow-up of 5-10 days.
Participants Patients from 2 surgical and 2 medical wards: > 18 y; Waterlow score of 15-25; tissue
damage no greater than grade 1
Interventions 1. Profiling bed with a pressure reducing foam mattress/cushion (n = 50).
2. Flat-based bed with a pressure relieving/redistributing mattress/cushion (n = 50)
Outcomes Number of pressure ulcers developed:
1. 0/35;
2. 0/35.
Healing of existing grade 1 ulcers:
1. 100% (4/4);
2. 20% (2/10).
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Notes Extent of follow-up difficult to ascertain. No difference between the groups in terms of
transferring in and out of bed
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes “The block design randomisation code was com-
puter generated by an independent statistician us-
ing blocks of eight”
Allocation concealment? Yes “The allocation for each patient was placed in
sealed opaque envelopes that were numbered se-
quentially. The patient and researcher were not
aware of allocation until after recruitment”
Blinding?
Pressure ulcer incidence
Unclear Pressure ulcer incidence.
Incomplete outcome data addressed?
All outcomes
No “A total of 100 patients were recruited into the
study. Data were incomplete for 30 of these pa-
tients. All 100 patients were included in an inten-
tion-to-treat analysis in respect of pressure ulcer
incidence”
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes Imbalance in male to female ratio (M:F 20:30 in
control and 35:15 in treatment). Balanced on ini-
tial nutritional assessment score BMI, age, mobil-
ity score.
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes “Waterlow scores were assessed and pressure areas
observed daily”
Laurent 1998
Methods RCTwith factorial design. 2 pressure-relievingmattresses used either in ICU (alternating-
pressure), or in post-ICU hospitalisation (constant low-pressure), or in combination,
and compared in each case with the standard surface. Randomised “by blocks” - method
of allocation unclear
Participants Adults over 15 y of age, admitted for major cardiovascular surgery, hospital stay likely to
be at least 5 days, with a period on ICU.
Little data provided regarding baseline comparability.
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Interventions 2 X 2 factorial design:
1: Standard mattress in ICU; standard mattress postoperatively (n = 80).
2: Nimbus (AP) in ICU; standard mattress postoperatively (n = 80).
3: Standard mattress in ICU; Tempur (CLP) postoperatively (n = 75).
4: Nimbus in ICU; Tempur postoperatively (n = 77).
Outcomes Incidence of ulcers of grade 2 or above (partial- or full-thickness skin loss and worse):
Group 1: 18% (14/80);
Group 2: 13% (10/80);
Group 3: 15% (11/75);
Group 4: 13% (10/77). NS.
Notes A priori sample size calculation. No reports of withdrawals.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Exact randomisation procedure not re-
ported: “patients were randomised among
four groups” and “patients were ran-
domised by blocks”.
Allocation concealment? Unclear See above - not reported.
Blinding?
Pressure ulcer incidence
No Blinding discussed as follows: “given the
kind of material tested, blinding was not
possible”
Incomplete outcome data addressed?
All outcomes
Yes Data available for all participants enrolled
in study (no attrition)
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes “Therewas no imbalance of characteristics,
risk factors, or surgical procedures between
the groups”
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes No other concerns.
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Methods RCT (allocation by random-number tables) in elderly nursing home population with 6-
month follow-up
Participants Nursing home residents at risk of pressure ulcers (Norton score > 15). 9/66 subjects had
pressure ulcers on entry to the study
Interventions 1. Air-filled (SofCare) overlay (33 randomised; 2 ulcer on admission; 10/31 developed
a new one).
2. Gel mattress (33 randomised; 7 ulcer on admission; 8/26 developed a new one)
Outcomes Grade 2 or greater ulcers:
1. Air overlay: 16% (5/31);
2. Gel mattress: 15% (4/26).
Notes Interventions not well described. Of the 74 who entered the study, only those who
participated for 4-6 months were included in the analysis (total of 66). 19 patients died
and were excluded from the analysis, but these might be at highest risk. It was difficult
to maintain inflation of the air overlay; it also punctured easily. During the trial, 110 air
overlays were used for 76 patients. Gel mattress was heavy
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Random-number table.
Allocation concealment? Unclear Not reported.
Blinding?
Pressure ulcer incidence
Unclear Blinding not reported: “patients in both
study groups were assessed by the same re-
searcher for the presence of pressure ul-
cer development over areas of bony promi-
nence”.
Incomplete outcome data addressed?
All outcomes
Unclear Nineteen participants died during the 6-
month study; individuals participating for
4-6 months were included in the data anal-
ysis, although exact numbers included were
not reported.
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes No important baseline differences.
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes No other concerns.
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Methods RCT with 5-month follow-up. Patients were “randomly assigned” but method of allo-
cation not described
Participants 62 residents of an extended care facility; aged≥ 60; free of pressure ulcers but at high risk
of developing an ulcer (Norton score ≤ 14); using a wheelchair for ≥3 h/day; without
progressive disease or confined to bed.
Groups well matched at baseline for sex, age, weight, Norton score, primary diagnosis,
sensory status, time spent in wheelchair, and mobility
Interventions 1. Foam slab cushion (2.5 cm medium density foam glued to 5 cm firm chipped foam)
(n = 26).
2. Contoured foam cushion (same foam as above; cut into a customised shape to relieve
pressure on ischial tuberosities) (n = 26).
Both cushions fitted with identical snug fitting covers of knitted polyester
Outcomes Included grade 1 ulcers:
1. Slab foam: 73% (19/26);
2. Contoured foam: 69% (18/26).
Mean severity score was 1.9 in the slab and 1.7 in the contoured (P value > 0.05), and
the mean healing duration was 6.2 weeks in the slab and 5.4 weeks in the contoured
group (P value > 0.05)
Notes 84% follow-up.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Exact randomisation procedure not de-
scribed: “qualifying consenting subjects
were randomly assigned to one of the two
cushions for a period of 5 months”
Allocation concealment? Unclear Not reported.
Blinding?
Pressure ulcer incidence
Unclear “The incidence, location, severity, and
healing time of DU were determined
weekly by another occupational therapist, a
research assistant, who was from outside of
the facility and was not knowledgeable of
the Norton’s score of the subjects”; assess-
ments taken a half-hour after participants
returned to bed
Incomplete outcome data addressed?
All outcomes
Yes 10 participants reported as dropouts with
reasons given; no ITT analysis conducted,
but attrition within 20% limit of total re-
cruited sample.
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Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes No important baseline differences.
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes No other concerns.
McGowan 2000
Methods RCT. Discharge from hospital, transfer to a rehabilitation ward
Participants Orthopaedic patients aged ≥ 60; assessed as being at low or moderate risk of pressure
ulcer development by Braden scale; intact skin; anticipated LOS > 48 h
Interventions 1. Standard hospital mattress, sheet and an Australian Medical Sheepskin overlay; sheep-
skin heel and elbow protectors as required (n = 155).
2. Standard hospital mattress, sheet with or without other low tech constant pressure
devices as required (n = 142). Sheepskins were changed as required (at least every 3 days)
Outcomes 1. Sheepskin:9% (4/155) (21 ulcers) 7 participants developed 1 ulcer; 7 developed 2, all
grade I.
2. Control: 30% (43/142) (67 ulcers) 25 participants developed 1 ulcer; 7 developed 2;
11 developed 3. 4 ulcers were grade II, 1 grade IV. Comfort rated significantly greater
in experimental group. Limb protectors difficult to keep in place
Notes 1 patient from each group withdrew prior to data collection. 6 patients in experimental
group withdrew because sheepskin too hot or irritable; 7 in control group withdrew plus
3 in experimental group due to protocol violations (no ITT). Patients in experimental
group rated comfort significantly higher than controls (P value < 0.0001)
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Stated, “patients were randomly allocated
(using sealed envelopes) by research nurses
to receive one of two interventions”
Allocation concealment? Unclear Not reported, although sequence genera-
tion based on sealed envelopes (see above).
Blinding?
Pressure ulcer incidence
No “Blinded outcome assessments were not
possible because the support surfaces could
not be disguised and patients could not be
moved off the bed for assessment of their
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pressure ulcers”
Incomplete outcome data addressed?
All outcomes
Yes Withdrawals from study reported with rea-
sons given; and “data collected for patients
up until the time of withdrawal has been
included in the analysis with the exception
of five controls and two patients from the
experimental group for whom study partic-
ipation time was not available”.
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes No important baseline differences.
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes No other concerns.
Mistiaen 2009
Methods RCT with 30-day follow-up.
Participants Patients recruited from aged care facility (predominantly rehabilitation department) and
rehabilitation centre. Grade 1 pressure ulcers included in the sample
Interventions 1. Australianmedical sheepskinwithin 48h of admissionon the patient’s bed. Application
in wheelchair recommended and under heels permitted. (Hi-temp, urine resistant, size
XXL mattress) (n = 271).
2. Usual care (n = 272).
Cointerventions: usual intervention for prevention of pressure ulcers in study settings
Outcomes Number and grade of pressure ulcers developed.
1. Grade 1 = 18, Grade 2 = 6, Grade 3 = 0, Grade 4 = 0.
2. Grade 1 = 32, Grade 2 = 6, Grade 3 = 2, Grade 4 = 0.
Notes ITT analyses performed. Sample size calculation performed, however, not included in
this paper (included in published protocol). 33% of intervention group believed the
sheepskin to be too warm, and thus the trial was stopped early in these patients
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Truly random methods of randomisation used.
Allocation concealment? Yes Adequate methods of allocation concealment used.
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Blinding?
Pressure ulcer incidence
No No blinding on patients, clinicians, outcome assessors.
Unclear/unstated blinding of data analysts
Incomplete outcome data addressed?
All outcomes
Unclear Not reported.
Free of selective reporting? Unclear Not reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes Groups were well matched.
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes No other concerns.
Nixon 1998
Methods RCT with 8-day follow-up. Telephone randomisation (i.e. full allocation concealment)
stratified by centre, and age
Participants Patients aged ≥ 55 y, admitted for elective major general, gynaecological or vascular
surgery in supine or lithotomy position and free of preoperative pressure damage greater
than grade 1.
Groups well matched at baseline for age, sex, Braden score, type of surgery, duration of
surgery, length of preoperative stay, proportion of time hypotensive during surgery
Interventions 1. Dry visco-elastic polymer pad on operating table (n = 222).
2. Standard operating theatre table mattress plus Gamgee heel support (n = 224)
Outcomes Incidence and severity of pressure ulcers:
Overall incidence of pressure ulcers of 16% (65/416):
1. Dry visco-elastic polymer pad on operating table: 11% (22/205);
2. Standard mattress: 20% (43/211); P value 0.01, OR = 0.46; 95% CI 0.26-0.82.
56/65 episodes of skin damage were conversions from grade 0 to grade 1 ulcers.
4/65 grade 0 to grade 2A conversions.
5/65 grade 0 to grade 2B conversions. These data were not broken down by group
Notes A priori sample size calculation. 133 paired assessments by 94 nurses for pre-study inter-
rater reliability assessments undertaken. Disagreement in only 2.2% assessments, and
only 2 disagreements related to differentiating between grade 1 and grade 2a ulcers (the
remainder were grade 0 and grade 1). Themajority were associated with heel assessments.
For the recovery and ward area assessments, there were discrepant assessments in only 8.
5% cases. Sensitivity analysis assessing the impact of this level of misclassification on the
overall result determined that the overall difference between the mattresses remained.
Main endpoint data reported for 416 patients; incomplete data for 30 patients (lost
forms 3; incomplete postoperative skin assessment 27). The patients with incomplete
data were not reported by group
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Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Stratified randomisation by centre and age:
“a telephone randomisation schedule was
developedwithin random permuted blocks
of 6, with a run-in of 8”; age as 55-69 and
70 or over.
Allocation concealment? Yes Randomisation managed by the Northern
and Yorkshire Clinical Trials and Research
Unit.
Blinding?
Pressure ulcer incidence
Yes The Data Monitoring Committee and
statistician were blind to treatment alloca-
tion; “the record pertaining to the intra-op-
erative randomised mattress allocation re-
mained separate from themain data collec-
tion pro forma to maintain the blind”
Incomplete outcome data addressed?
All outcomes
Yes ITT analyses conducted.
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
No Standard mattress group: longer length of
operation, longer pre-operative stay, more
time in hypotensive state than dry polymer
pad group
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes No other concerns.
Nixon 2006
Methods RCT with 30-day follow-up twice weekly, and a further 30-day follow-up once weekly
Participants Recruited from 11 hospitals. Patients admitted as acute or elective cases. Eligible patients
aged ≥ 55, expected to stay for at least 7 days, with either limited activity or mobility
(Braden scale activity and mobility score of 1 or 2), or an existing pressure ulcer of grade
2. Elective surgical participants without limited activity or mobility were eligible if the
mean LOS for surgery was at least 7 days and they were expected to have Braden scale
activity and mobility scores of 1 or 2 for at least 3 days postoperatively. Exclusion criteria:
grade 3 or worse pressure ulcer on admission, planned admission to ICU after surgery,
admitted to hospital more than 4 days before surgery, slept at night in a chair, weighted
> 140 kg or < 45 kg (as per mattress specifications)
Participants were well matched at baseline.
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Interventions 1. Alternating-pressure overlay (n = 990): alternating cell height minimum 8.5cm, max
12.25cm; cell cycle time 7.5-30 minutes.
2. Alternating-pressure mattress (n = 982): alternating cell height min 19.6cms, max 29.
4cms; cell cycle time 7.5-30 minutes
Intervention was allocated within 24 hrs of admission.
Outcomes Number of participants with incidence pressure ulcer grade 2 and above (unblinded
outcome assessment):
1. Overlay: 11% (106/989);
2. Mattress: 10% (101/982).
Patient acceptability: requests for mattress change:
1. Overlay: 23% (230/989);
2. Mattress: 19% (186/982).
Healing of existing pressure ulcers:
1. Overlay: 34% (20/59);
2. Mattress: 35% (19/54).
Cost of treatment (GBP):
1. Overlay: Sterling 6793.33;
2. Mattress: Sterling 6509.73.
Mean difference in time to pressure ulcer (grade 2 or higher) development (days). Par-
ticipants in mattress group took 10.64 days longer to develop pressure ulcer than overlay
group
Notes 1 participant was recruited to the trial twice (group 1) and was excluded from analysis.
Factors that had a significant effect on the proportion of people developing a newpressure
ulcer were admission for an acute condition, the presence of a wound skin trauma or
non-blanching erythema on any site at baseline, age, haemoglobin level and diabetes
The authors stated that differences in health benefits and total costs for hospital stay
between alternating-pressure mattresses and alternating-pressure overlays were not sta-
tistically significant. However, a cost effectiveness acceptability curve indicated that on
average alternating-pressure mattresses were associated with an 80% probability of cost
saving compared with alternating-pressure overlays
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Randomisation using a computer-gener-
ated algorithm.
Allocation concealment? Yes “To maintain allocation concealment,
the minimisation algorithm and subse-
quent treatment assignment was provided
through an independent, central, secure
24-hour randomisation automated tele-
phone service by the Clinical Trials Re-
search Unit (CTRU), University of Leeds”.
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Blinding?
Pressure ulcer incidence
No Stated, “owing to the nature of the mat-
tresses under investigation, it was not possi-
ble to mask the randomised intervention to
the patients participating in the trial, ward
nursing staff or the CRNs conducting the
skin assessments”.
Incomplete outcome data addressed?
All outcomes
Yes ITT analysis conducted.
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes No important baseline differences.
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes No other concerns.
Price 1999
Methods RCT with follow-up 14 days postoperatively.
Participants Patients with fractured neck of femur and Medley score of > 25 (very high risk), aged
over 60 y
Interventions 1. Repose system (low-pressure inflatable mattress and cushion in polyurethane material)
(n = 40).
2. Nimbus III dynamic flotation plus TransCell cushion (n = 40): all other care standard
best practice, including regular repositioning
Outcomes 1. Repose system: at admission 14/40 has pressure ulcers; preoperatively, 7/36;
at 7 days: 6/32;
at 14 days: 5/24.
2. Nimbus III: at admission had pressure ulcers, 13/40; preoperatively, 8/37;
at 7 days: 5/31;
at 14 days: 4/26.
Notes 80 patients randomised; 50 featured in final analysis (assessed 14 days post-operatively)
i.e. 38% attrition
Patients with pressure ulcers recruited. Difficult to ascertain how many of those with
existing pressure ulcer included in 7-day and 14-day follow up assessments (see Table 4
of paper)
Risk of bias
Item Authors’ judgement Description
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Adequate sequence generation? Yes Stated, “a concealed computer-generated
list was used to randomise eligible consec-
utive consenting patients to one of the sup-
port systems”.
Allocation concealment? Unclear Not reported.
Blinding?
Pressure ulcer incidence
No “Patients were not assessed blindly as it was
considered that displacement for examina-
tion would cause excessive discomfort”
Incomplete outcome data addressed?
All outcomes
Unclear “No patient was excluded from the analy-
ses. In many patients the data were incom-
plete, but they have been included in the
analyses for those time points where data
are present”; data from 50 (out of 80 pa-
tients) only analysed for final assessment.
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes No statistically significant differences on
prognostic indicators at baseline between
groups.
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes No other concerns.
Russell 2000
Methods RCT with 7-day follow-up. Randomisation using sealed opaque envelopes
Participants Patients aged ≥ 18 y; undergoing scheduled cardiothoracic surgery under GA; surgery
of at least 4 h duration; free of pressure ulcers.
Both groups comparable at baseline for pressure ulcer risk (modified Knoll); history of
previous ulceration; disease status; sex; age; weight; height
Interventions 1. MicroPulse system in the OR and postoperatively (n = 98).
2. Conventional care (gel pad in OR, standard mattress postoperatively) (n = 100)
Outcomes Incidence and severity of pressure ulcers:
1. MicroPulse system: 2%* (2/98);
2. Conventional management: 7% (7/100 patients developed 10 ulcers).
Grade of ulcers:
1. MicroPulse system: grade 2 = 22;
2. Conventional management: grade 1 = 2; grade 2 = 5; grade 3 = 3*
*1/2 discounted by original authors from their analysis as thought to occur for reasons
“not related to the use of the MicroPulse system”!
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Notes No equipment-related adverse events were reported.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes “Randomisation was done blindly by using
a sealed opaque envelope that contained the
randomisation information (i.e., multi-cell
pulsating dynamic mattress system vs. con-
ventional management).”
Allocation concealment? Unclear Not reported, although sequence genera-
tion based on sealed envelopes (see above).
Blinding?
Pressure ulcer incidence
No Immediate post-surgical assessment de-
scribed, therefore, patients likely to be us-
ing mattresses at time, so blinding of out-
come assessors not possible.
Incomplete outcome data addressed?
All outcomes
Yes ITT analysis conducted.
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes No statistically significant baseline differ-
ences.
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes No other concerns.
Russell 2003
Methods RCT. Median days in study presented by group by hospital (3 hospitals). For the exper-
imental group median days ranged from: 8-14; control group 9-17.
Central allocation at trials office/pharmacy, sequentially-numbered or coded vials
Participants Elderly acute, orthopaedic and rehabilitation wards; > 65 y; Waterlow score of 15-20
Interventions 1. Visco-polymer energy absorbing foam mattress (CONFOR-Med)/cushion combina-
tion (n = 562).
2. Standard mattress/cushion combination (n = 604).
Outcomes Development of non-blanching erythema or worse (including with and without blanch-
ing erythema on admission to trial)
1. CONFOR-Med: 19.9% (110/562);
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2. Standard mattress: 26.3% (161/604); P value 0.005.
Development of non-blanching erythema or worse:
1. CONFOR-Med: 8.5% (48/562);
2. Standard mattress: 10.9% (66/604). NS.
Data for ulcers of grades > 1 not presented separately.
Notes Patient comfort scores non significant. No adverse events reported
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Different randomisationprocedure for sites
1 and 2 from site 3: “equipment allocation
at 2 sites was made by converting random
numbers...on a 50:50 basis (0-0.5 and 0.5-
1.0). At site 3, trial numbers were allocated
sequentially and the patient chose from1of
2 opaque envelopes. No blocking or strati-
fication was used at any site”
Allocation concealment? Unclear Not reported.
Blinding?
Pressure ulcer incidence
No “Because the data collection team exam-
ined participants at bedside and the exper-
imental mattress surface is distinctive, data
collection could not be blinded”
Incomplete outcome data addressed?
All outcomes
Yes “Participants who died were included in
all statistical analyses”; ITT analysis con-
ducted on all randomised patients (exclud-
ing 2 where protocol violations had oc-
curred)
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes No statistically significant differences on
prognostic indicators at baseline between
groups
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes No other concerns.
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Methods RCT: duration of follow-up not reported.
Participants Recruitment from a single acute care unit. Eligile patients had a Braden score of ≤ 16,
were bed bound, free of pressure ulcers before the start of the study, and required head
elevation. Exclusion criteria not discussed. Baseline variables were generally balanced
Interventions 1. Double-layer air cell overlay (Tricell) (n = 37): two layers consisting of 24 narrow
cylinder air cells.
2. Single-layer air cell overlay (Air doctor) (n = 36): single layer consisting of 20 round
air cells.
In both overlays the pressure was alternated between cells at 5-minute intervals
3. Standard hospital mattress (Paracare) (n = 35).
All groups had change of body position every 2 h, and special skin care to guard against
friction and sheer. Nutritional intervention was given where required
Outcomes Number of participants with incidence pressure ulcer (daily assessment). All ulcers were
grade 1 or 2.
Grade 1 ulcers:
1. Double-layer: 0/26;
2. Single-layer: 3% (1/29);
3. Standard mattress: 15% (4/27).
Grade 2 ulcers:
1. Double-layer: 4% (1/26);
2. Single-layer: 14% (4/29);
3. Standard mattress: 22% (6/27).
Notes Numbers included in study analysis were 26 for the double-layer group (2 discontinued,
2 deaths, 7 head elevation ≤ 30 degrees); 29 for the single-layer group (1 mattress
malfunction, 2 deaths, 2 head elevation ≤ 30 degrees); and 27 for the standard mattress
group (1 death, 7 head elevation ≤ 30 degrees). No ITT analysis
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes “The subjects were randomly allocated to
the groups by sequentially-labelled sealed
envelopes”
Allocation concealment? Yes Following randomisation, “after baseline
assessment, the registered nurses opened
the envelopes that indicated which surface
each subject would be treated on”
Blinding?
Pressure ulcer incidence
Unclear Not reported.
Incomplete outcome data addressed?
All outcomes
No 41 patients withdrew from trial; no ITT
analysis conducted.
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Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes No statistically significant differences on
prognostic indicators at baseline between
groups
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes No other concerns.
Santy 1994
Methods RCT with 14-day follow-up. Allocation by random-number tables; degree of allocation
concealment unclear
Participants Patients aged > 55 y with hip fracture, with or without pressure ulcers. Excluded: those
with a pressure ulcer of grade 3 or 4 at entry.
Patients in each group were well matched for age and Waterlow score at baseline
Interventions Results for Group 2 (NHS contract surface - standard foam): 17/64
Results for Groups 1, 3, 4 and 5, alternating foam combined) 42/441
Outcomes Rates of removal from study due to skin deterioration:
1. Clinifloat: 9%;
2. NHS contract: 27%;
3. Transfoam: 10%;
4. Therarest: 11%;
5. Vaperm: 8%.
Notes 9% attrition. At interim analysis, Clinifloat and NHS contract mattresses were removed
from the study; Clinifloat due to superior performance, and the NHS mattress due to
high rates of pressure ulcer development. This explains why there were fewer patients
on these surfaces. Omnifoam mattress showed foam collapse after 6 weeks and were
withdrawn from use and replaced with Vapermmattresses. Problems with mattress cover
found on 2 Therarest mattresses, 3 Transfoam mattress covers, and 3 times with the
Clinifloat mattress
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Random-number tables used.
Allocation concealment? Unclear Not reported.
Blinding?
Pressure ulcer incidence
Unclear Skin assessments undertaken by research
nurse; patient unlikely to be removed from
mattress for assessment, although not ex-
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plicitly reported
Incomplete outcome data addressed?
All outcomes
Unclear Patient removal numbers reported; attri-
tion within reasonable limits (20% of total
participants recruited at baseline)
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes Mean age and Waterlow scores reported
as well-matched across different mattress
groups
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes No other concerns.
Schultz 1999
Methods RCT with 6-day follow-up.
Participants Patients admitted for surgery lasting at least 2 h in lithotomy position, aged ≥18; ad-
mitted with intact skin
Interventions 1. Experimentalmattress overlay in operating roommade of foamwith a 25% indentation
load deflection (ILD) of 30 lb and density of 1.3 cubic feet (n = 206).
2. Usual care (padding as required, including gel pads, foam mattresses, ring cushions
(donuts) etc) (n = 207)
Outcomes 1. Experimental operating room mattress overlay: 27% (55/206); 6 people had ulcers of
grade 2 or more.
2. Usual care: 16% (34/207); 3 people had ulcers of grade 2 or more
Notes Experimental product caused postoperative skin changes. Authors contacted for more
information relating to grade of ulcer by group
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Random-numbers tables used.
Allocation concealment? No Patients randomly assigned for consideration in study
from operating room schedule, then screened by nurses or
primary investigator against inclusion/exclusion criteria
before randomisation to experimental or control group.
Blinding?
Pressure ulcer incidence
Yes “Beginning on the day after surgery an continuing for 6
days, 2 research assistants, blinded to the study group of
the patient, examined the skin over the bony prominences
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of each patient for any evidence of skin changes”.
Incomplete outcome data addressed?
All outcomes
Yes No attrition.
Free of selective reporting? Yes All pre-specified outcomes reported.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes No important baseline differences.
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes No other concerns.
Sideranko 1992
Methods RCT with mean follow-up of 9.4 days. Method of randomisation not reported though
said to be “random”
Participants Adult, surgical ICU patients: Surgical ICU stay > 48 h, without existing skin breakdown
on admission. Groups broadly similar at baseline, although water mattress group ap-
peared to be heavier and had fewer days in ICU (significance of these differences unclear)
Interventions 1. Alternating air mattress: 1.5-inch thick Lapidus Airfloat System (n = 20).
2. Static air mattress: 4-inch thick Gay Mar Sof Care (n = 20).
3. Water mattress: 4-inch thick Lotus PXM 3666 (n = 17).
Outcomes Grade of ulcers not reported.
1. Alternating air mattress: 25% (5/20);
2. Static air mattress: 5% (1/20);
3. Water mattress: 12% (2/17).
Notes The trial was primarily about interface pressure and patient position, therefore, there
was relatively little detail about the incidence part of the study, and no description of co-
interventions.
No withdrawals reported.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Not explicitly reported, “...randomly as-
signed...”.
Allocation concealment? Unclear Not reported.
Blinding?
Pressure ulcer incidence
Unclear Not reported. Patients and carers would
note have been blinded
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Incomplete outcome data addressed?
All outcomes
Unclear No withdrawals reported. 57 patients were
enrolled in the study but no numbers were
provided in the results text or tables, except
to say that 8 subjects (14% of the total sam-
ple) developed pressure ulcers
Free of selective reporting? Yes Pressure measurement and development of
pressure ulcers were described as the out-
comes of interest (with interface pressure
and patient position being the main out-
comes of interest) and these were both re-
ported in the results section
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Unclear “Demographic information from patients’
charts describing patient age, sex, height,
and weight upon admission were records”
but the datawere not provided in the results
section
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Unclear Not reported.
Stapleton 1986
Methods Quasi RCT: allocation by means of alternation. Duration of follow-up unclear
Participants Female elderly patients with fractured neck of femur, without existing pressure ulcers,
Norton score 14 or less. Baseline data presented and groups well matched for age and
Norton score
Interventions 1. Large Cell Ripple (Talley) (n = 32).
2. Polyether foam pad 2 feet x 2 feet x 3-inch thickness (n = 34).
3. Spenco pad (n = 34).
Outcomes Ulcers of grade 2 or greater:
1. Large Cell Ripple: 34% (11/32);
2. Polyether foam pad: 41% (14/34);
3. Spenco pad: 35% (12/34).
Grade 3 and greater:
1. Large Cell Ripple: 0% (0/32);
2. Foam pad: 24% (8/34);
3. Spenco pad: 6% (2/34).
Notes 45 Large Cell Ripple mattresses required 50 motor repairs and 90 material repairs during
12- month study. Patients did not like the feel of the ripples. Nomention of withdrawals
Risk of bias
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Item Authors’ judgement Description
Adequate sequence generation? Unclear Randomisation for first 2 groups, but not
for subsequent groups: “patients for the
first two groups were selected by lottery,
and thereafter patients were allocated to
each group systematically, in rotation”; to-
tal numbers for the first 2 groups were not
reported
Allocation concealment? Unclear Not reported.
Blinding?
Pressure ulcer incidence
Unclear Not reported.
Incomplete outcome data addressed?
All outcomes
Yes Out of 100patients recruited, “twopatients
allocated to the Ripple pad were lost to
ward transfer”
Free of selective reporting? Unclear Outcomes not pre-specified.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes No baseline differences on mean age and
Norton scores (the presence of existing
pressure ulcers was an exclusion criterion
for the study)
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Unclear Inclusion criteria stated female patients
only.
Summer 1989
Methods RCT: duration of follow-up unclear. Randomisation by random sequences of letters
corresponding to treatment groups, however, level of concealment unclear
Participants Patients admitted to the ICU in diagnostic groups, namely: sepsis-sepsis syndrome/
pneumonia; respiratory failure; drug overdose; metabolic coma; stroke/neuromuscular
disease; adult respiratory distress syndrome. Groups comparable at baseline for APACHE
score; condition of pressure area at baseline not discussed
Interventions 1. Kinetic Treatment Table (n = 43) 7 feet x 3 feet padded, vinyl-covered platform on
central rotating pivot which turns through an arc every 1.7 seconds. Reported to be of
value in respiratory failure.
2. Routine 2-hourly turning on conventional beds (n = 43).
Outcomes 1 patient developed small facial ulcer on Kinetic Treatment Table; none on conventional
beds
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Notes 3/86 (3%) patients lost to follow-up
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes “Random sequences of 30 letters (K for
KTT and C for control) were supplied us-
ing standard tables of random numbers for
each of the six groups...”
Allocation concealment? Unclear Not reported.
Blinding?
Pressure ulcer incidence
Unclear The study nurse collecting APACHE score
data was not involved in patient man-
agement or triage decisions, but there is
no indication that outcome assessors were
blinded
Incomplete outcome data addressed?
All outcomes
Yes 83 patients were analysed as 5 separate
groups, but later in results 11/86 were di-
agnosed independently by infection con-
trol surveillance. It would appear that 3/86
were not analysed, but this was only 3.5%
so well within conventional limits. Reasons
for drop-outs not given
Free of selective reporting? Yes “...(9) development of new decubitus ul-
cers”.
Results section: “No patient developed a
classic decubitus ulcer during the entire pe-
riod.” And later “...one patient developed
a small facial ulcer related to pressure from
a padded support of the kinetic table...”
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Unclear There was no significant difference in the
initial mean APACHE-II score between all
individuals placed on KTT...and the man-
ually turned subjects... but it is not clear if
this is at baseline or throughout the study.
No other baseline data provided and noTa-
ble of characteristics shown
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Unclear Not reported.
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Methods RCT with 14-day follow-up. Randomisation influenced by mattress availability, there-
fore, not concealed
Participants Non-trauma patients admitted to ICU expected to stay > 5 days. Treatment groups
similar at baseline, however, not compared for degree of pressure ulcer risk
Interventions 1. Carital Optima (n = 21): constant low pressure mattress comprising 21 double air
bags on a base.
2. Standard hospital foam mattress (n = 19): 10 cm thick foam density 35 kg/m3.
Outcomes 1. No ulcers.
2. 37% (7/19) patients developed a total of 13 ulcers. P value < 0.005. 9 ulcers were
grade 1A (erythema), 4 were grade 1B (superficial and limited to the dermis)
Notes 40% withdrawals; ITT analysis undertaken.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Not explicitly reported, “...randomly as-
signed...”
Later the authors talk about “...each block
of four patients that completed treatment”.
This may refer to block randomisation but
it is not clear
Allocation concealment? No Randomisation influenced by mattress
availability, therefore, allocation not con-
cealed
Blinding?
Pressure ulcer incidence
Unclear This study was not blinded, since the sever-
ity of illness of the patients precluded their
transfer for evaluation of the skin condi-
tion by a blinded reviewer, and the type of
mattress in the bed could not be blinded
but further on note that ...all sore areas
were measured and photographed for inde-
pendent verification of severity... It would
appear that perhaps some outcome assess-
ment was perhaps blinded but this is still
unclear
Incomplete outcome data addressed?
All outcomes
Yes An ITT was performed but there were sig-
nificant losses - “Ten patients were ran-
domised but not treated due to either early
discharge or death...” and, “Six patients
randomised on the pressure-relieving mat-
tress were included only in the intention-
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to-treat analysis, since the start of treatment
was delayed due to mattress non-availabil-
ity...” No discussion of how the trialists
handled the missing data
Free of selective reporting? Yes Methods: ...primary outcome variable
(pressure sore formation)... All outcomes
reported related to pressure ulcer formation
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes Table 1 (from study report) indicates that
patient characteristics were well balanced,
e.g. age, clinically infected and APACHE
score
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Unclear Not reported.
Taylor 1999
Methods RCT - length of follow up - discharge from hospital or death
Participants Hospital inpatients aged 16 or over, with intact skin, requiring a pressure-relieving sup-
port
Interventions 1. Alternating-pressure mattress with pressure-redistributing cushion (Pegasus Trinova)
(n = 22).
2. Alternative alternating-pressure system (unnamed) with pressure-redistributing cush-
ion (control) (n = 22)
Outcomes 1. TriNova: 0/22;
2. Control: 9% (2/22) (both ulcers superficial).
Notes Study underpowered. Data relating to comfort were not reported for control group.
Nurse rating of acceptability:
1. TriNova: good to very good n = 15; acceptable n = 1;
2. Control: good to very good n = 9; acceptable n = 11.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Abstract states “...randomised controlled
trial”. No further details reported
Allocation concealment? Yes “Upon recruitment, the data collector
opened the next opaque envelope in se-
quence...”
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Blinding?
Pressure ulcer incidence
Unclear Not reported. Patients and nurses would
not have been blinded
Incomplete outcome data addressed?
All outcomes
Unclear No statement regarding drop-outs/with-
drawals. “Forty-four subjects were re-
cruited to the study over a 5-month period,
with equal numbers of subjects allocated to
the two mattress groups”.
“...eighteen (81.8%) of the 22 patients al-
located to the Trinova completed the com-
fort questionnaire...” but comfort datawere
not reported for the control group, so losses
in that group, and the way in which they
compared to the intervention group, re-
main unknown. This is a loss of 20% over-
all which is acceptable but there is no indi-
cation that there was an ITT analysis
Free of selective reporting? No “..the primary end point rests with measur-
ing differences in comfort and acceptance,
while the secondary objective of the study
is to measure clinical outcomes of a group
of patients vulnerable to pressure sore de-
velopment.”
Although comfort data were not reported
for the control group, but only for the in-
tervention group
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes Table 2 (from study report) indicates that
patient characteristics were well balanced,
e.g. age, weight and Waterlow score
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Unclear Not reported.
Theaker 2005
Methods RCT: follow-up for 2 weeks after discharge from ICU.
Participants Recruitment from an ICU. Eligible participants were deemed at high risk of pressure
ulcer development (from a set of 5 predetermined factors; details not provided, but ref-
erence given), and aged≥18 y. Patients with pressure ulcers on admission were excluded.
Baseline data presented by outcome, so difficult to assess
Interventions 1. KCI TheraPulse bed (n = 30).
2. Hill-Rom Duo mattress (n = 32).
No further details provided about the devices.
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Outcomes Number of participants with incidence pressure ulcer (assessed every 8 h; blinded out-
come assessment*); all grades (not given by group, reported that most were grade 2 with
one grade 3):
1. TheraPulse: 10% (3/30);
2. Duo:19% (6/32).
8/9 ulcers were heel ulcers.
Notes Participant lost not mentioned.
* Trial is described as unblinded, but themethods described blinded outcome assessment
with photographs
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Patients ”...were randomly assigned...“
”Selection of an unmarked envelope from a
pile of envelopes by staff unconnected with
the study formed the randomisation pro-
cess“.
Describes an adequate concealment of allo-
cation sequence, but not how the sequence
was generated
Allocation concealment? Yes ”Selection of an unmarked envelope from a
pile of envelopes by staff unconnected with
the study formed the randomisation pro-
cess“
Blinding?
Pressure ulcer incidence
Yes This was an unblinded, randomised
prospective trial, but it appears that out-
come assessment was blinded for the pri-
mary outcome: For the study purposes, the
digital photographs were anonymised and
analysed subsequently by two independent
Tissue Viability Nurses for confirmation of
the existence of a pressure ulcer and assess-
ment of severity
Incomplete outcome data addressed?
All outcomes
Unclear No statement made regarding withdrawals.
Free of selective reporting? Yes The only outcome mentioned in the meth-
ods section was pressure ulcer development
: ”Patients were assessed once every 8 h for
pressure sore development”.
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Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes “There were no significant differences in
age, sex, Apache score or length of stay...”
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Unclear Not reported.
Tymec 1997
Methods RCT.
Participants 52 patients admitted to selected nursing units of a large hospital with a Braden score of
<16 (risk); intact skin on heels. 23 women and 29 men aged 27-90 y, mean age 66.6 ±
16.5 y. Mean Braden score on admission 11.8; 21 patients with respiratory conditions;
6 with cancer; 5 with stroke
Interventions Factorial design evaluating effect of heel elevation device plus positioning and order of
positioning.
1. Foot Waffle (FDA approved, non-abrasive vinyl boot with built-in foot cradle and
inflated air chamber).
2. Hospital pillow under both legs from below knee to the Achilles tendon
Unclear how many patients in each group.
Outcomes Number of pressure ulcers developed:
1. Foot Waffle: 6.
2. Hospital pillow: 2.
Denominators unclear.
Notes There did not appear to be any losses.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Assignment to either pillow or Foot Waffle was undertaken ”...
using a block randomised list and the patient’s position order “.
..was determined by a coin toss”
Allocation concealment? Unclear Not reported.
Blinding?
Pressure ulcer incidence
Unclear The blinding of outcome assessment was not reported.
Incomplete outcome data addressed?
All outcomes
Unclear 52 patients (23 women and 29 men) in the study, but nowhere
was the number/group reported.
8/52 patients developed grade 1 pressure ulcers and were re-
moved from the study, so it would appear that the 52 partici-
pants were followed-up
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Tymec 1997 (Continued)
Free of selective reporting? Yes Occurrence of a pressure ulcer, mean survival time (i.e. time
until one occurred), and mean interface pressures were reported.
These are all meaningful outcomes
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Unclear No table of characteristics provided.Methods section gives char-
acteristics for the sample overall, but not by group
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Unclear Not reported.
Vanderwee 2005
Methods RCT.
Participants Recruitment from 19 surgical, internal medicine or geriatric hospital wards. Eligible
patients at risk of developing pressure ulcer (Braden score < 17); or had at least 1 grade
1 ulcer; aged ≥18 y, with expected hospital stay of > 3 days; not contraindicated for
turning. Particpants excluded if had a grade 2 or worse pressure ulcer, or weighed > 140
kg. Participants well balanced at baseline
Interventions 1. APAM (Alpha X-cell, Huntleigh Healthcare): generates alternating high and low
interface pressure between the body and support by alternating inflation and deflation.
Sitting protocol with air cushion (Airtech, Huntleigh), with no turning protocol (n =
222).
2. Visco-elastic foam mattress (Tempur, Tempur-World). Sitting protocol with air cush-
ion (Airtech, Huntleigh). Turning every 4 h (n = 225)
Outcomes Number of participants with incidence pressure ulcer (assessed daily by ward nurse; grade
1 excluded):
Grade 2 to 4 pressure ulcers (NS):
1. APAM: 15.3% (34/222); 26 grade 2; 8 grade 3 or 4.
2. Visco: 15.6% (35/225); 33 grade 2; 2 grade 3 or 4.
Notes No significant difference in incidence of pressure ulcers (grades 2-4) between the groups.
There were significantly more heel pressure ulcers in the control group (P value 0.006)
. However, authors noted that patients nursed on an APAM seemed to develop more
severe pressure ulcers
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes “...randomisation tables generated with the SPSS 10 software
package...”
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Vanderwee 2005 (Continued)
Allocation concealment? Yes “Serially numbered closed envelopes were made for each partic-
ipating ward”
Blinding?
Pressure ulcer incidence
Unclear A random sample of patients was observed at unexpected mo-
ments by both the researcher and the data nurse. In addition
a data nurse was responsible for the follow-up of the study on
each ward. So the researchers and data nurse were probably not
blinded to allocation because they were at the patients’ bedsides
Incomplete outcome data addressed?
All outcomes
Unclear Drop-outs/withdrawals not reported. Flow chart showed 447
patients enrolled in total, 297 assessed by Braden and 150 by
non-blanchable erythema (NBE). Numbers in Table 2 (from
study report) match these
Free of selective reporting? Unclear Assessment were designed to detect skin changes; used NBE and
Braden scale
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Yes Patients well balanced at baseline, e.g. Braden score and age.
Since the groups were similar in all characteristics exceptmedical
specialty, this variable was adjusted for in the analysis
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Unclear Not reported.
Vyhlidal 1997
Methods RCT with 10-21 day follow-up. Allocation to surfaces achieved by investigator drawing
assignment out of a hat, therefore, extent of concealment inadequate
Participants Patients newly admitted to a skilled nursing facility; estimated stay ≥ 10 days; free of
pressure ulcers but at risk (Braden score <18 with sub-scale score of < 3 in sensory
perception, mobility or activity levels).
Diagnoses: musculoskeletal 45%; cardiovascular 27.5%; neurological 12.4%; others
15%.
Patients in the MAXIFLOAT group were younger, though not significantly so. Braden
Scale scores (risk of pressure ulcer development) similar between groups at baseline.
Patients in theMAXIFLOAT group were significantly heavier and stayed on themattress
longer than the IRIS group
Interventions 1. IRIS 3000: 4-inch thick foam overlay with dimpled surface (n = 20).
2. MAXIFLOAT: mattress replacement in 5 sections (n = 20). The mattress has a water/
bacteria repellent top cover; is made of 1.5-inch thick antimicrobial foam with a centre
core of cut foam; has a non-removable polyester fibre heel pillow and a water/bacteria-
proof bottom cover.
Subjects in both groups received standards of care according to the protocols of the
organisation
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Vyhlidal 1997 (Continued)
Outcomes All grades of ulcer:
1. IRIS 3000: 60% (12/20);
Grade 1: 25% (4/20);
Grade 2: 40% (8/20).
2. MAXIFLOAT: 25% (5/20);
Grade 1: 10% (2/20);
Grade 2: 15% (3/20).
P value 0.025.
Time to ulcer:
1. IRIS 3000: 6.5 days;
2. MAXIFLOAT: 9.2 days (NS).
Notes No record of any withdrawals. The IRIS 3000 is an overlay which goes on an existing
mattress resulting (in the trial) in a bed height of 29 inches. 1 participant refused the
IRIS because of the height of the bed. IRIS is lighter at 6.9 lb than the MAXIFLOAT
(25 lb) and easier to manipulate, however, the latter is still lighter than standard hospital
mattress (48 lb). IRIS can be sent home with patient. IRIS costs USD 38 compared to
USD 260 for MAXIFLOAT
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes “...subjects were randomly assigned by re-
search interviewer by drawing assignment
out of a hat”.
“...randomly assigned by lot by the investi-
gator...”.
Allocation concealment? Unclear No information about what was drawn out
of the hat (as above)
Blinding?
Pressure ulcer incidence
Unclear “....skin assessments and vital signs were
performed...by a research team member”.
Probably not the research interviewer but
it was not clear
Incomplete outcome data addressed?
All outcomes
Yes No statement regarding withdrawals.
There were 20 patients per group and it
was reported that, “ ...17 subjects devel-
oped pressure ulcers, 12 of the 20 in the Iris
3000 group and 5 of the 20 in the MAXI-
FLOAT group.”
Free of selective reporting? Yes “purpose of this study was to compare the
incidence of pressure ulcers in 40 newly ad-
mitted...”.
Outcomes discussed were number of par-
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Vyhlidal 1997 (Continued)
ticipants developing pressure ulcers, and
average number of days to pressure ulcer
development, but there was no mention in
the methods of what the trialists intended
to measure, only that “...skin assessments
and vital signs were performed...”
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
No “Subjects in the MAXIFLOAT group were
significantly heavier...”
“the MAXIFLOAT group also stayed on
the mattress longer..”
Text states both differences were statisti-
cally significant.
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Unclear Not reported.
Whitney 1984
Methods RCT with 8-day follow-up. Method of allocation not reported; patients were “selected
at random” for each group
Participants Patients on medical-surgical units who were in bed for 20 h/day. Most patients had
relatively little skin breakdown. Ages ranged from 19-91 y; mean 63.2 y. Majority of
patients were confused, lethargic, stuporous. Only 39% classed as mentally alert.
Baseline data were not presented.
Interventions 1. Alternating-pressure mattress (n = 25): consisted of 134 3-inch diameter air cells. 3-
minute cycle.
2. Convoluted foam pad (Eggcrate) (n = 26).
Patients in both groups were turned every 2 h.
Outcomes Changes in skin condition did not differ significantly between patients using the alter-
nating-pressure air mattress and the foam mattress (better: 20% vs 19%; same: 60% vs
58%; worse 20% vs 23%)
Notes 4 patients died. Analysis by ITT. Alternating-pressure mattress: pump maintenance was
costly, patients objected to the movement. The alternating mattress was more easily
cleaned and retained its original properties over several weeks compared to the foam,
which compressed and flattened
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear “26 were selected at random and placed in
the foammattress group, 25 in the APmat-
tress group...”
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Whitney 1984 (Continued)
Allocation concealment? Yes “Upon recruitment, the data collector
opened the next opaque envelope in se-
quence...”
Blinding?
Pressure ulcer incidence
Unclear Not reported. Patients and nurses would
not have been blinded
Incomplete outcome data addressed?
All outcomes
Yes No statement regarding drop-outs/with-
drawals, but there were 51 patients in the
study and Table 3 (from study report) indi-
cates that data for all of these were included
(25 +26 = 51)
Free of selective reporting? Yes The study was conducted to determine “..
.which mattress is the best choice for pres-
sure sore prevention and under which cir-
cumstances”.
Free of other bias - were groups similar
at baseline regarding the most important
prognostic indicators?
Unclear Not reported. Patient characteristics de-
scribed for the group as a whole, not by
mattress group
Free of other bias - was the timing of the
outcome assessment similar in all groups?
Yes Description of outcome assessment seems
to indicate all patients were treated the
same, “Risk factors and skin assessment
scores were recorded three times each
week”. It is noted that, “In most cases pa-
tients were assessed by two investigators as
a team and occasionally by only one...”, but
that would not impact on timing of assess-
ment
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Allen 1993 No clinical outcomes, only interface pressure recorded.
Andrews 1989 Did not fulfil study design criteria.
Ballard 1997 Data recorded were comfort data; no pressure ulcer outcomes.
Barhyte 1995 Did not fulfil study design criteria. No data presented.
Bliss 1967 Did not fulfil study design criteria. Patients were recruited to the trial on the basis of their risk score
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(Continued)
Bliss 1995 Whilst 8 surfaces were evaluated in this prospective trial, not all surfaces were in the trial at the same time,
therefore, the surfaces were not truly compared with one another contemporaneously. Furthermore, it was
possible for patients to be re-randomised back into the study, which occurred frequently, with a total of
457 mattress trials reported for only 238 patients. The data were not presented by patient; only by mattress
trial.
Duplicate citation of Bliss 1994 (Conference abstract).
Braniff-Matthews 1997 Healing and prevention outcome data were not separated.
Brienza 2001 Study of pressure measurement.
Büchner 1995 Did not fulfil study design criteria. Criteria for anti-decubitus management not reported and decided by
nurses. Number of pillows provided to third arm of the study was limited and not given to all participants
Chaloner 2000 Did not fulfil study design criteria, randomisation corrupted, authors reported that randomisation was
compromised on the basis of bed availability
Colin 1996 No clinical outcomes recorded; only measurements taken were for transcutaneous oxygen tension
Conine 1991 Did not fulfil study design criteria.
deBoisblanc 1993 Outcome incidence of pneumonia, no pressure ulcer outcomes.
Defloor 1997 Compared turning.
Defloor 2000 Did not compare surfaces.
Defloor 2004 Compared turning.
Della Valle 2001 Outcome of interface pressure.
Flam 1995 Outcome skin temperature and skin moisture level, no pressure ulcer outcomes
Fleischer 1997 Did not fulfil study design criteria.
Geelkerken 1994 Did not fulfil study design criteria. No data presented.
Gil Agudo 2009 Outcome measure of interface pressure.
Gray 2008 Not an RCT, but a clinical audit.
Grindley 1996 Patients were crossed over between intervention groups at 3 days. Outcome used was the assessment of
patient comfort
Grisell 2008 Outcome measure of interface pressure.
Gunningberg 1998 Did not fulfil study design criteria. Study of risk calculation rather than prevention
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(Continued)
Haalboom 1994 Did not fulfil study design criteria.
Hampton 1998 Did not fulfil study design criteria.
Hawkins 1997 Did not fulfil study design criteria.
Heyneman 2009 Meta-analysis of 2 previously published RCTs (Vanderwee 2005; Vanderwee 2007). Vanderwee 2005
already included in this review. Vanderwee 2007 excluded as it is a turning trial.
Holzgreve 1993 Full paper unavailable. Insufficient information to assess.
Huang 2009 Evaluated dressings.
Inman 1999 Comparison of a bed rental versus a bed purchase strategy, not a comparison of surfaces
Jacksich 1997 Did not fulfil study design criteria.
Jesurum 1996 Did not fulfil study design criteria.
Koo 1995 Did not fulfil study design criteria, study of interface pressure in healthy volunteers
Marchand 1993 Did not fulfil study design criteria, was a retrospective chart audit
McMichael 2008 Outcome measure of interface pressure.
Neander 1996 Paper in German - translator stated it was not an RCT. There were no data on how the decision to include
patients in the control and intervention groups was made
Ooka 1995 Did not fulfil study design criteria, convenience sample used
Phillips 1999 N of 1 trial design, only one participant in the trial
Regan 1995 This study reported an audit of pressure ulcer incidence after implementation of a comprehensive pressure
ulcer policy; it is not a prospective RCT
Reynolds 1994 Did not fulfil study design criteria.
Rosenthal 1996 Did not fulfil study design criteria. Outcome measure of interface pressure
Scott 1995 Insufficient information available to make a decision.
Scott 1999 No clinical outcomes, healthy volunteer study of interface pressures
Scott 2000 Not an RCT of beds and mattresses.
Stoneberg 1986 Historical control group.
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(Continued)
Suarez 1995 Controlled clinical trial which recorded only pressure measurements
Takala 1994 Not an RCT, outcome measure of interface pressure.
Thomas 1994 Did not fulfil study design criteria.
Timmons 2008 Did not fulfil study design criteria. Review of a product not a trial
Torra i Bou 2002 Evaluated dressings.
Turnage-Carrier 2008 Outcome measure of interface pressure.
Vanderwee 2007 Compared turning.
Vanderwee 2008 Literature review of previously conducted studies.
Wells 1984 Only recorded interface pressure measurements.
Wild 1991 Interface pressure measurements.
Zernike 1997 Incidence of pressure ulcers not reported
Zernike 1994 Unable to assess due to information in research paper. Email address provided was no longer valid and we
were unable to find other contact details
Characteristics of studies awaiting assessment [ordered by study ID]
Allegretti 2008
Methods
Participants
Interventions
Outcomes
Notes Dissertation. Author contacted and advised us to wait for publication
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Berthe 2007
Methods
Participants
Interventions
Outcomes
Notes Further details required for appraisal. Awaiting email reply from author
Demarré 2010
Methods
Participants
Interventions
Outcomes
Notes Awaiting full text retrieval
Mastrangelo 2010
Methods
Participants
Interventions
Outcomes
Notes Awaiting full text retrieval
Mayer 2008
Methods
Participants
Interventions
Outcomes
Notes Awaiting full text retrieval
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Taccone 2009
Methods
Participants
Interventions
Outcomes
Notes Awaiting full text retrieval
van Leen 2011
Methods
Participants
Interventions
Outcomes
Notes Awaiting full text retrieval
Abbreviations
> = more than
≥ = greater than or equal to
< = less than
≤ = less than or equal to
A&E = Accident and Emergency department
AP = alternating pressure
AWS = airwave system
BMI = body mass index
CF = convoluted foam
CRN = clinical research nurse
FDA = Food and Drug Administration
GA = general anaesthetic
h = hour(s)
ICU = intensive care unit
ITT = intention-to-treat analysis
LAL = low air loss
LCR = large cell ripple
LOS = length of stay
n = number in sample/group
NBE = non-blanchable erythema
NS = not statistically significant
OR = odds ratio
PRD = pressure reducing device
SF = solid foam
vs = versus
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y = year(s)
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D A T A A N D A N A L Y S E S
Comparison 1. Constant low-pressure supports (CLP) vs standard foam mattresses (SFM)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 7 Risk Ratio (M-H, Random, 95% CI) Totals not selected
1.1 Cubed foam mattress 1 Risk Ratio (M-H, Random, 95% CI) Not estimable
1.2 Bead-filled mattress 1 Risk Ratio (M-H, Random, 95% CI) Not estimable
1.3 Softform mattress 1 Risk Ratio (M-H, Random, 95% CI) Not estimable
1.4 Water-filled mattress 1 Risk Ratio (M-H, Random, 95% CI) Not estimable
1.5 Alternative foam 2 Risk Ratio (M-H, Random, 95% CI) Not estimable
1.6 Hi-spec foam
mattress/cushion
1 Risk Ratio (M-H, Random, 95% CI) Not estimable
Comparison 2. Alternative foam mattress vs standard foam mattress
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 5 2016 Risk Ratio (M-H, Random, 95% CI) 0.40 [0.21, 0.74]
1.1 Various alternatives
(pooled)
5 2016 Risk Ratio (M-H, Random, 95% CI) 0.40 [0.21, 0.74]
2 Pressure ulcer incidence UK
studies only
4 1980 Risk Ratio (M-H, Random, 95% CI) 0.41 [0.19, 0.87]
Comparison 3. Comparisons between alternative foam supports
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 4 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Alternative foam vs
standard foam
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.2 Maxifloat foam mattress
vs Iris foam overlay
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.3 Solid foam vs convoluted
foam
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.4 Transfoam mattress vs
Transfoamwave mattress
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
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Comparison 4. Comparisons between CLP supports
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 9 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Optima vs SFM 1 40 Risk Ratio (M-H, Random, 95% CI) 0.06 [0.00, 0.99]
1.2 Sofflex vs ROHO 1 84 Risk Ratio (M-H, Random, 95% CI) 0.63 [0.16, 2.47]
1.3 Gel mattress vs air-filled
overlay
1 66 Risk Ratio (M-H, Random, 95% CI) 0.8 [0.24, 2.72]
1.4 Static air mattress vs water
mattress
1 37 Risk Ratio (M-H, Random, 95% CI) 0.43 [0.04, 4.29]
1.5 Foam overlay vs Silicore
overlay
1 68 Risk Ratio (M-H, Random, 95% CI) 1.17 [0.64, 2.14]
1.6 Sheepskin vs no sheepskin
(Including all pressure ulcers
regardless of Grade)
3 1281 Risk Ratio (M-H, Random, 95% CI) 0.48 [0.31, 0.74]
1.7 Foam support surface vs
no support
1 70 Risk Ratio (M-H, Random, 95% CI) 0.16 [0.05, 0.49]
2 Pressure ulcer incidence 3 1281 Risk Ratio (M-H, Fixed, 95% CI) 0.56 [0.32, 0.97]
2.1 Sheepskin vs no sheepskin
(grade 2 + pressure ulcers only)
3 1281 Risk Ratio (M-H, Fixed, 95% CI) 0.56 [0.32, 0.97]
Comparison 5. Alternating-pressure vs standard foam mattress
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 2 409 Risk Ratio (M-H, Fixed, 95% CI) 0.31 [0.17, 0.58]
Comparison 6. Alternating-pressure (AP) vs constant low-pressure
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 10 1606 Risk Ratio (M-H, Random, 95% CI) 0.85 [0.64, 1.13]
1.1 AP (various) vs CLP
(various)
1 230 Risk Ratio (M-H, Random, 95% CI) 0.38 [0.22, 0.66]
1.2 AP vs Silicore or foam
overlay
4 331 Risk Ratio (M-H, Random, 95% CI) 0.91 [0.72, 1.16]
1.3 AP vs water or static air
mattress
3 458 Risk Ratio (M-H, Random, 95% CI) 1.31 [0.51, 3.35]
1.4 AP vs continuous low
pressure mattress
1 140 Risk Ratio (M-H, Random, 95% CI) 2.06 [0.19, 22.18]
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1.5 AP vs visco-elastic foam
mattress
1 447 Risk Ratio (M-H, Random, 95% CI) 0.98 [0.64, 1.52]
Comparison 7. AP and CLP in ICU/post ICU (factorial design)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Standard ICU/SFM
post-ICU vs Nimbus AP
ICU/SFM post-ICU
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.2 Standard ICU/SFM
post-ICU vs standard
ICU/Tempur CLP post-ICU
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.3 Nimbus AP ICU/SFM
post-ICU vs standard
ICU/Tempur CLP post-ICU
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.4 Standard ICU/SFM
post-ICU vs Nimbus AP
ICU/Tempur CLP post-ICU
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.5 Nimbus AP ICU/SFM
post-ICU vs Nimbus
ICU/Tempur post-ICU
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.6 Standard ICU/Tempur
post-ICU vs Nimbus
ICU/Tempur post-ICU
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
Comparison 8. Comparisons between alternating-pressure devices
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 5 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Airwave vs Large Cell
Ripple
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.2 Airwave vs Pegasus
Carewave
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.3 Trinova vs control 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.4 AP overlay vs AP mattress 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.5 TheraPulse vs Duo 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
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Comparison 9. Low Air Loss vs standard bed
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 3 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Pressure incidence pooled 2 221 Risk Ratio (M-H, Random, 95% CI) 0.33 [0.16, 0.67]
3 Incidence of patients developing
multiple ulcers
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 10. Air-Fluidised therapy vs dry flotation
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Rate of wound breakdown 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 11. Kinetic treatment table vs standard care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 2 151 Risk Ratio (M-H, Fixed, 95% CI) 1.23 [0.57, 2.65]
Comparison 12. Operating table overlay vs no overlay
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Viscoelastic polymer pad
vs no overlay
1 416 Risk Ratio (M-H, Random, 95% CI) 0.53 [0.33, 0.85]
1.2 Viscoelastic foam overlay
vs no overlay
1 175 Risk Ratio (M-H, Random, 95% CI) 1.53 [0.69, 3.39]
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Comparison 13. Micropulse System for surgical patients
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 2 368 Risk Ratio (M-H, Fixed, 95% CI) 0.21 [0.06, 0.70]
Comparison 14. Seat cushions
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 4 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Slab foam v Bespoke
contoured foam
2 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.2 Jay Gel Cushion v Foam 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.3 Pressure reducing cushion
v Standard foam cushion
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
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Analysis 1.1. Comparison 1 Constant low-pressure supports (CLP) vs standard foam mattresses (SFM),
Outcome 1 Pressure ulcer incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 1 Constant low-pressure supports (CLP) vs standard foam mattresses (SFM)
Outcome: 1 Pressure ulcer incidence
Study or subgroup Favours CLP SFM Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Cubed foam mattress
Hofman 1994 4/17 13/19 0.34 [ 0.14, 0.85 ]
2 Bead-filled mattress
Goldstone 1982 5/32 21/43 0.32 [ 0.14, 0.76 ]
3 Softform mattress
Gray 1994 6/90 27/80 0.20 [ 0.09, 0.45 ]
4 Water-filled mattress
Andersen 1982 7/155 21/161 0.35 [ 0.15, 0.79 ]
5 Alternative foam
Collier 1996 0/130 0/9 Not estimable
Santy 1994 42/441 17/64 0.36 [ 0.22, 0.59 ]
6 Hi-spec foam mattress/cushion
Russell 2003 48/562 66/604 0.78 [ 0.55, 1.11 ]
0.001 0.01 0.1 1 10 100 1000
Favours CLP Favours SFM
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Analysis 2.1. Comparison 2 Alternative foam mattress vs standard foam mattress, Outcome 1 Pressure
ulcer incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 2 Alternative foam mattress vs standard foam mattress
Outcome: 1 Pressure ulcer incidence
Study or subgroup Alternative Foam Std Foam Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Various alternatives (pooled)
Collier 1996 0/130 0/9 Not estimable
Gray 1994 6/90 27/80 21.3 % 0.20 [ 0.09, 0.45 ]
Hofman 1994 4/17 13/19 19.8 % 0.34 [ 0.14, 0.85 ]
Russell 2003 48/562 66/604 30.8 % 0.78 [ 0.55, 1.11 ]
Santy 1994 42/441 17/64 28.1 % 0.36 [ 0.22, 0.59 ]
Total (95% CI) 1240 776 100.0 % 0.40 [ 0.21, 0.74 ]
Total events: 100 (Alternative Foam), 123 (Std Foam)
Heterogeneity: Tau2 = 0.30; Chi2 = 13.24, df = 3 (P = 0.004); I2 =77%
Test for overall effect: Z = 2.89 (P = 0.0039)
0.001 0.01 0.1 1 10 100 1000
Favours Alternative Favours SFM
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Analysis 2.2. Comparison 2 Alternative foam mattress vs standard foam mattress, Outcome 2 Pressure
ulcer incidence UK studies only.
Review: Support surfaces for pressure ulcer prevention
Comparison: 2 Alternative foam mattress vs standard foam mattress
Outcome: 2 Pressure ulcer incidence UK studies only
Study or subgroup Alternative foam Std Foam Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Collier 1996 0/130 0/9 Not estimable
Gray 1994 6/90 27/80 27.5 % 0.20 [ 0.09, 0.45 ]
Russell 2003 48/562 66/604 37.6 % 0.78 [ 0.55, 1.11 ]
Santy 1994 42/441 17/64 34.8 % 0.36 [ 0.22, 0.59 ]
Total (95% CI) 1223 757 100.0 % 0.41 [ 0.19, 0.87 ]
Total events: 96 (Alternative foam), 110 (Std Foam)
Heterogeneity: Tau2 = 0.37; Chi2 = 12.41, df = 2 (P = 0.002); I2 =84%
Test for overall effect: Z = 2.31 (P = 0.021)
0.001 0.01 0.1 1 10 100 1000
Favours Alternative Favours SFM
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Analysis 3.1. Comparison 3 Comparisons between alternative foam supports, Outcome 1 Pressure ulcer
incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 3 Comparisons between alternative foam supports
Outcome: 1 Pressure ulcer incidence
Study or subgroup Foam 1 Foam 2 Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Alternative foam vs standard foam
Santy 1994 42/441 17/64 0.36 [ 0.22, 0.59 ]
2 Maxifloat foam mattress vs Iris foam overlay
Vyhlidal 1997 5/20 12/20 0.42 [ 0.18, 0.96 ]
3 Solid foam vs convoluted foam
Kemp 1993 12/39 21/45 0.66 [ 0.37, 1.16 ]
4 Transfoam mattress vs Transfoamwave mattress
Gray 1998 1/50 1/50 1.00 [ 0.06, 15.55 ]
0.002 0.1 1 10 500
Favours Foam 1 Favours Foam 2
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Analysis 4.1. Comparison 4 Comparisons between CLP supports, Outcome 1 Pressure ulcer incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 4 Comparisons between CLP supports
Outcome: 1 Pressure ulcer incidence
Study or subgroup CLP1 CLP2 Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Optima vs SFM
Takala 1996 0/21 7/19 100.0 % 0.06 [ 0.00, 0.99 ]
Subtotal (95% CI) 21 19 100.0 % 0.06 [ 0.00, 0.99 ]
Total events: 0 (CLP1), 7 (CLP2)
Heterogeneity: not applicable
Test for overall effect: Z = 1.96 (P = 0.050)
2 Sofflex vs ROHO
Cooper 1998 3/41 5/43 100.0 % 0.63 [ 0.16, 2.47 ]
Subtotal (95% CI) 41 43 100.0 % 0.63 [ 0.16, 2.47 ]
Total events: 3 (CLP1), 5 (CLP2)
Heterogeneity: not applicable
Test for overall effect: Z = 0.66 (P = 0.51)
3 Gel mattress vs air-filled overlay
Lazzara 1991 4/33 5/33 100.0 % 0.80 [ 0.24, 2.72 ]
Subtotal (95% CI) 33 33 100.0 % 0.80 [ 0.24, 2.72 ]
Total events: 4 (CLP1), 5 (CLP2)
Heterogeneity: not applicable
Test for overall effect: Z = 0.36 (P = 0.72)
4 Static air mattress vs water mattress
Sideranko 1992 1/20 2/17 100.0 % 0.43 [ 0.04, 4.29 ]
Subtotal (95% CI) 20 17 100.0 % 0.43 [ 0.04, 4.29 ]
Total events: 1 (CLP1), 2 (CLP2)
Heterogeneity: not applicable
Test for overall effect: Z = 0.73 (P = 0.47)
5 Foam overlay vs Silicore overlay
Stapleton 1986 14/34 12/34 100.0 % 1.17 [ 0.64, 2.14 ]
Subtotal (95% CI) 34 34 100.0 % 1.17 [ 0.64, 2.14 ]
Total events: 14 (CLP1), 12 (CLP2)
Heterogeneity: not applicable
Test for overall effect: Z = 0.50 (P = 0.62)
6 Sheepskin vs no sheepskin (Including all pressure ulcers regardless of Grade)
Jolley 2004 (1) 21/218 37/223 33.9 % 0.58 [ 0.35, 0.96 ]
McGowan 2000 (2) 14/155 43/142 30.5 % 0.30 [ 0.17, 0.52 ]
0.001 0.01 0.1 1 10 100 1000
Favours CLP1 Favours CLP2
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(. . . Continued)
Study or subgroup CLP1 CLP2 Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Mistiaen 2009 (3) 24/271 40/272 35.5 % 0.60 [ 0.37, 0.97 ]
Subtotal (95% CI) 644 637 100.0 % 0.48 [ 0.31, 0.74 ]
Total events: 59 (CLP1), 120 (CLP2)
Heterogeneity: Tau2 = 0.07; Chi2 = 4.20, df = 2 (P = 0.12); I2 =52%
Test for overall effect: Z = 3.36 (P = 0.00077)
7 Foam support surface vs no support
Cadue 2008 3/35 19/35 100.0 % 0.16 [ 0.05, 0.49 ]
Subtotal (95% CI) 35 35 100.0 % 0.16 [ 0.05, 0.49 ]
Total events: 3 (CLP1), 19 (CLP2)
Heterogeneity: not applicable
Test for overall effect: Z = 3.22 (P = 0.0013)
0.001 0.01 0.1 1 10 100 1000
Favours CLP1 Favours CLP2
(1) This study evaluates all patients with pressure ulcers regardless of grade
(2) This study evaluates all patients with pressure ulcers regardless of grade
(3) This study evaluates all patients with pressure ulcers regardless of grade
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Analysis 4.2. Comparison 4 Comparisons between CLP supports, Outcome 2 Pressure ulcer incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 4 Comparisons between CLP supports
Outcome: 2 Pressure ulcer incidence
Study or subgroup Sheepskin No sheepskin Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Sheepskin vs no sheepskin (grade 2 + pressure ulcers only)
Jolley 2004 12/218 20/223 59.0 % 0.61 [ 0.31, 1.22 ]
McGowan 2000 0/155 5/142 17.1 % 0.08 [ 0.00, 1.49 ]
Mistiaen 2009 6/271 8/272 23.8 % 0.75 [ 0.26, 2.14 ]
Total (95% CI) 644 637 100.0 % 0.56 [ 0.32, 0.97 ]
Total events: 18 (Sheepskin), 33 (No sheepskin)
Heterogeneity: Chi2 = 2.06, df = 2 (P = 0.36); I2 =3%
Test for overall effect: Z = 2.09 (P = 0.037)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours sheepskin Favours no sheepskin
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Analysis 5.1. Comparison 5 Alternating-pressure vs standard foam mattress, Outcome 1 Pressure ulcer
incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 5 Alternating-pressure vs standard foam mattress
Outcome: 1 Pressure ulcer incidence
Study or subgroup Alternating Pressure SFM Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Andersen 1982 7/166 21/161 61.4 % 0.32 [ 0.14, 0.74 ]
Sanada 2003 6/55 10/27 38.6 % 0.29 [ 0.12, 0.73 ]
Total (95% CI) 221 188 100.0 % 0.31 [ 0.17, 0.58 ]
Total events: 13 (Alternating Pressure), 31 (SFM)
Heterogeneity: Chi2 = 0.02, df = 1 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 3.69 (P = 0.00022)
Test for subgroup differences: Not applicable
0.02 0.1 1 10 50
Favours AP Favours SFM
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Analysis 6.1. Comparison 6 Alternating-pressure (AP) vs constant low-pressure, Outcome 1 Pressure ulcer
incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 6 Alternating-pressure (AP) vs constant low-pressure
Outcome: 1 Pressure ulcer incidence
Study or subgroup AP CLP Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 AP (various) vs CLP (various)
Gebhardt 1996 15/115 39/115 15.7 % 0.38 [ 0.22, 0.66 ]
Subtotal (95% CI) 115 115 15.7 % 0.38 [ 0.22, 0.66 ]
Total events: 15 (AP), 39 (CLP)
Heterogeneity: not applicable
Test for overall effect: Z = 3.49 (P = 0.00048)
2 AP vs Silicore or foam overlay
Conine 1990 39/72 45/76 26.1 % 0.91 [ 0.69, 1.21 ]
Daechsel 1985 4/16 4/16 4.9 % 1.00 [ 0.30, 3.32 ]
Stapleton 1986 11/32 26/68 14.7 % 0.90 [ 0.51, 1.58 ]
Whitney 1984 5/25 6/26 6.1 % 0.87 [ 0.30, 2.48 ]
Subtotal (95% CI) 145 186 51.8 % 0.91 [ 0.72, 1.16 ]
Total events: 59 (AP), 81 (CLP)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.03, df = 3 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.74 (P = 0.46)
3 AP vs water or static air mattress
Andersen 1982 7/166 7/155 6.3 % 0.93 [ 0.34, 2.60 ]
Price 1999 1/40 2/40 1.4 % 0.50 [ 0.05, 5.30 ]
Sideranko 1992 5/20 3/37 4.1 % 3.08 [ 0.82, 11.59 ]
Subtotal (95% CI) 226 232 11.8 % 1.31 [ 0.51, 3.35 ]
Total events: 13 (AP), 12 (CLP)
Heterogeneity: Tau2 = 0.18; Chi2 = 2.67, df = 2 (P = 0.26); I2 =25%
Test for overall effect: Z = 0.57 (P = 0.57)
4 AP vs continuous low pressure mattress
Cavicchioli 2007 2/69 1/71 1.4 % 2.06 [ 0.19, 22.18 ]
Subtotal (95% CI) 69 71 1.4 % 2.06 [ 0.19, 22.18 ]
Total events: 2 (AP), 1 (CLP)
Heterogeneity: not applicable
Test for overall effect: Z = 0.59 (P = 0.55)
5 AP vs visco-elastic foam mattress
Vanderwee 2005 34/222 35/225 19.4 % 0.98 [ 0.64, 1.52 ]
0.002 0.1 1 10 500
Favours AP Favours CLP
(Continued . . . )
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(. . . Continued)
Study or subgroup AP CLP Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Subtotal (95% CI) 222 225 19.4 % 0.98 [ 0.64, 1.52 ]
Total events: 34 (AP), 35 (CLP)
Heterogeneity: not applicable
Test for overall effect: Z = 0.07 (P = 0.94)
Total (95% CI) 777 829 100.0 % 0.85 [ 0.64, 1.13 ]
Total events: 123 (AP), 168 (CLP)
Heterogeneity: Tau2 = 0.06; Chi2 = 13.69, df = 9 (P = 0.13); I2 =34%
Test for overall effect: Z = 1.09 (P = 0.28)
0.002 0.1 1 10 500
Favours AP Favours CLP
Analysis 7.1. Comparison 7 AP and CLP in ICU/post ICU (factorial design), Outcome 1 Pressure ulcer
incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 7 AP and CLP in ICU/post ICU (factorial design)
Outcome: 1 Pressure ulcer incidence
Study or subgroup Comparison 1 Comparison 2 Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Standard ICU/SFM post-ICU vs Nimbus AP ICU/SFM post-ICU
Laurent 1998 4/80 10/80 0.40 [ 0.13, 1.22 ]
2 Standard ICU/SFM post-ICU vs standard ICU/Tempur CLP post-ICU
Laurent 1998 14/80 11/75 1.19 [ 0.58, 2.46 ]
3 Nimbus AP ICU/SFM post-ICU vs standard ICU/Tempur CLP post-ICU
Laurent 1998 10/80 11/75 0.85 [ 0.38, 1.89 ]
4 Standard ICU/SFM post-ICU vs Nimbus AP ICU/Tempur CLP post-ICU
Laurent 1998 14/80 10/77 1.35 [ 0.64, 2.85 ]
5 Nimbus AP ICU/SFM post-ICU vs Nimbus ICU/Tempur post-ICU
Laurent 1998 10/80 10/77 0.96 [ 0.42, 2.18 ]
6 Standard ICU/Tempur post-ICU vs Nimbus ICU/Tempur post-ICU
Laurent 1998 11/75 10/77 1.13 [ 0.51, 2.50 ]
0.1 0.2 0.5 1 2 5 10
Favours Comparison 1 Favours Comparison 2
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Analysis 8.1. Comparison 8 Comparisons between alternating-pressure devices, Outcome 1 Pressure ulcer
incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 8 Comparisons between alternating-pressure devices
Outcome: 1 Pressure ulcer incidence
Study or subgroup AP device Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Airwave vs Large Cell Ripple
Exton-Smith 1982 5/31 12/31 0.42 [ 0.17, 1.04 ]
2 Airwave vs Pegasus Carewave
Hampton 1997 0/36 0/39 Not estimable
3 Trinova vs control
Taylor 1999 0/22 2/22 0.20 [ 0.01, 3.94 ]
4 AP overlay vs AP mattress
Nixon 2006 106/989 101/982 1.04 [ 0.81, 1.35 ]
5 TheraPulse vs Duo
Theaker 2005 3/30 6/32 0.53 [ 0.15, 1.94 ]
0.1 0.2 0.5 1 2 5 10
Favours AP Favours Control
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Analysis 9.1. Comparison 9 Low Air Loss vs standard bed, Outcome 1 Pressure ulcer incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 9 Low Air Loss vs standard bed
Outcome: 1 Pressure ulcer incidence
Study or subgroup Low Air Loss Standard ICU bed Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Bennett 1998 8/42 4/56 2.67 [ 0.86, 8.27 ]
Cobb 1997 6/62 12/61 0.49 [ 0.20, 1.23 ]
Inman 1993 6/49 25/49 0.24 [ 0.11, 0.53 ]
0.001 0.01 0.1 1 10 100 1000
Favours Low Air Loss Favours Std ICU bed
Analysis 9.2. Comparison 9 Low Air Loss vs standard bed, Outcome 2 Pressure incidence pooled.
Review: Support surfaces for pressure ulcer prevention
Comparison: 9 Low Air Loss vs standard bed
Outcome: 2 Pressure incidence pooled
Study or subgroup Low Air Loss Standard ICU bed Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Cobb 1997 6/62 12/61 45.0 % 0.49 [ 0.20, 1.23 ]
Inman 1993 6/49 25/49 55.0 % 0.24 [ 0.11, 0.53 ]
Total (95% CI) 111 110 100.0 % 0.33 [ 0.16, 0.67 ]
Total events: 12 (Low Air Loss), 37 (Standard ICU bed)
Heterogeneity: Tau2 = 0.07; Chi2 = 1.35, df = 1 (P = 0.25); I2 =26%
Test for overall effect: Z = 3.09 (P = 0.0020)
Test for subgroup differences: Not applicable
0.005 0.1 1 10 200
Favours Low Air Loss Favours Std ICU bed
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Analysis 9.3. Comparison 9 Low Air Loss vs standard bed, Outcome 3 Incidence of patients developing
multiple ulcers.
Review: Support surfaces for pressure ulcer prevention
Comparison: 9 Low Air Loss vs standard bed
Outcome: 3 Incidence of patients developing multiple ulcers
Study or subgroup Low Air Loss Standard ICU Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Inman 1993 1/49 12/49 0.08 [ 0.01, 0.62 ]
0.01 0.1 1 10 100
Favours Low Air Loss Favours Std ICU bed
Analysis 10.1. Comparison 10 Air-Fluidised therapy vs dry flotation, Outcome 1 Rate of wound breakdown.
Review: Support surfaces for pressure ulcer prevention
Comparison: 10 Air-Fluidised therapy vs dry flotation
Outcome: 1 Rate of wound breakdown
Study or subgroup Air fluidised bed
Dry
flotation
mattress Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Economides 1995 2/6 2/6 1.00 [ 0.20, 4.95 ]
0.01 0.1 1 10 100
Favours Air fluidised Favours Dry flotation
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Analysis 11.1. Comparison 11 Kinetic treatment table vs standard care, Outcome 1 Pressure ulcer
incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 11 Kinetic treatment table vs standard care
Outcome: 1 Pressure ulcer incidence
Study or subgroup KTT Standard Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gentilello 1988 8/27 10/38 94.3 % 1.13 [ 0.51, 2.48 ]
Summer 1989 1/43 0/43 5.7 % 3.00 [ 0.13, 71.65 ]
Total (95% CI) 70 81 100.0 % 1.23 [ 0.57, 2.65 ]
Total events: 9 (KTT), 10 (Standard)
Heterogeneity: Chi2 = 0.35, df = 1 (P = 0.55); I2 =0.0%
Test for overall effect: Z = 0.54 (P = 0.59)
0.01 0.1 1 10 100
Favours KTT Favours Std
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Analysis 12.1. Comparison 12 Operating table overlay vs no overlay, Outcome 1 Pressure ulcer incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 12 Operating table overlay vs no overlay
Outcome: 1 Pressure ulcer incidence
Study or subgroup Overlay No Overlay Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Viscoelastic polymer pad vs no overlay
Nixon 1998 22/205 43/211 100.0 % 0.53 [ 0.33, 0.85 ]
Subtotal (95% CI) 205 211 100.0 % 0.53 [ 0.33, 0.85 ]
Total events: 22 (Overlay), 43 (No Overlay)
Heterogeneity: not applicable
Test for overall effect: Z = 2.64 (P = 0.0083)
2 Viscoelastic foam overlay vs no overlay
Feuchtinger 2006 13/85 9/90 100.0 % 1.53 [ 0.69, 3.39 ]
Subtotal (95% CI) 85 90 100.0 % 1.53 [ 0.69, 3.39 ]
Total events: 13 (Overlay), 9 (No Overlay)
Heterogeneity: not applicable
Test for overall effect: Z = 1.05 (P = 0.30)
0.005 0.1 1 10 200
Favours Overlay Favours No Overlay
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Analysis 13.1. Comparison 13 Micropulse System for surgical patients, Outcome 1 Pressure ulcer incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 13 Micropulse System for surgical patients
Outcome: 1 Pressure ulcer incidence
Study or subgroup Micropulse System Std Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Aronovitch 1999 1/90 7/80 51.7 % 0.13 [ 0.02, 1.01 ]
Russell 2000 2/98 7/100 48.3 % 0.29 [ 0.06, 1.37 ]
Total (95% CI) 188 180 100.0 % 0.21 [ 0.06, 0.70 ]
Total events: 3 (Micropulse System), 14 (Std Care)
Heterogeneity: Chi2 = 0.40, df = 1 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 2.53 (P = 0.011)
0.01 0.1 1 10 100
Favours Micropulse Favours Standard
Analysis 14.1. Comparison 14 Seat cushions, Outcome 1 Pressure ulcer incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 14 Seat cushions
Outcome: 1 Pressure ulcer incidence
Study or subgroup Treatment Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Slab foam v Bespoke contoured foam
Conine 1993 85/125 84/123 1.00 [ 0.84, 1.18 ]
Lim 1988 19/26 18/26 1.06 [ 0.75, 1.49 ]
2 Jay Gel Cushion v Foam
Conine 1994 17/68 30/73 0.61 [ 0.37, 1.00 ]
3 Pressure reducing cushion v Standard foam cushion
Geyer 2001 6/15 10/17 0.68 [ 0.33, 1.42 ]
0.2 0.5 1 2 5
Favours Treatment Favours Control
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A D D I T I O N A L T A B L E S
Table 1. Additional information on included studies
Trial Clear inclusion
& exclusion crite-
ria
Sample size
(arms)
A priori
calculation
Grade 1 ulcer
excluded
Intervention well
documented
Andersen 1982 Yes 482 (3) Yes Yes No
Aronovitch 1999 Yes 217 (2) No Yes Yes
Bennett 1998 Yes 98 (2) No Yes No
Cadue 2008 Yes 70/69 (2) No No Yes
Cavicchioli 2007 Yes 170 (2) No No Yes
Cobb 1997 Yes 123 (2) No No Yes
Collier 1996 No 99 (9) No Not applicable Yes
Conine 1990 Yes 187 (2) No Yes No
Conine 1993 Yes 288 (2) No Unclear/No Yes
Conine 1994 Yes 163 (2) No Yes Yes
Cooper 1998 Yes 100 (2) No Yes Yes
Daechsel 1985 Yes 32 (2) No No Yes
Economides 1995 Yes 12 (2) No Yes Yes
Ewing 1964 No 30 (2) No No Yes
Exton-Smith 1982 Yes 66 (2) No Yes Yes
Feuchtinger 2006 Yes 175 (2) Yes No Yes
Gebhardt 1996 Yes 43 (2) No Unclear/No Yes
Gentilello 1988 Yes 65 (2) No No Yes
Geyer 2001 Yes 32 (2) No Unclear/No Yes
Gilcreast 2005 Yes 338 (2) Yes No Yes
Goldstone 1982 Yes 75 (2) No No Yes
Gray 1998 Yes 100 (2) No Yes No
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Table 1. Additional information on included studies (Continued)
Gray 1994 Yes 170 (2) No Yes Yes
Gunningberg 2000 Yes 101 (2) Yes Yes Yes
Hampton 1997 Yes 75 (2) No No Yes
Hofman 1994 Yes 44 (2) Yes Yes Yes
Inman 1993 Yes 100 (2) Yes Yes No
Jolley 2004 Yes 539 (2) Unclear/No No Yes
Kemp 1993 Yes 84 (2) No No No
Keogh 2001 Yes 100 (2) Yes Unclear/No Yes
Laurent 1998 Yes 312 (4) Yes Yes Yes
Lazzara 1991 Yes 74 (2) No Yes No
Lim 1988 Yes 62 (2) No Yes Yes
McGowan 2000 Yes 297 (2) Yes No Yes
Mistiaen 2009 Yes 5434 (2) Yes No Yes
Nixon 1998 Yes 446 (2) Yes Yes Yes
Nixon 2006 Yes 1972 (2) Yes Yes Yes
Price 1999 Yes 80 (2) Yes Yes No
Russell 2000 Yes 198 (2) No No Yes
Russell 2003 Yes 1166 (2) Yes No Yes
Sanada 2003 Yes 103 (3) Unclear/No No Yes
Santy 1994 Yes 505 (5) Yes No Yes
Schultz 1999 Yes 413 (2) Yes No No
Sideranko 1992 Yes 57 (3) No No No
Stapleton 1986 Yes 100 (3) No Yes No
Summer 1989 Yes 83 (2) No No Yes
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Table 1. Additional information on included studies (Continued)
Takala 1996 Yes 40 (2) Yes Yes Yes
Taylor 1999 Yes 44 (2) Yes No Yes
Theaker 2005 Yes 62 (2) Yes Unclear/No Yes
Tymec 1997 Yes 52 (2) Yes Yes Yes
Vanderwee 2005 Yes 447 (2) Yes Yes Yes
Vyhlidal 1997 Yes 40 (2) No Yes Yes
Whitney 1984 No 51 (2) No No No
A P P E N D I C E S
Appendix 1. Search strategy for the second update of this review - 2008
Electronic searches
For the second update of this review we searched:
• Cochrane Wounds Group Specialised Register (Searched 28 February 2008);
• The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2008, Issue 1);
• Ovid MEDLINE (1950 to February Week 3 2008);
• Ovid EMBASE (1980 to 2008 Week 08);
• Ovid CINAHL (1982 to February Week 3 2008).
The following search strategy was used for CENTRAL, and modified, where appropriate, for other databases:
#1 MeSH descriptor Beds explode all trees
#2 mattress*
#3 cushion*
#4 “foam” or transfoam
#5 overlay*
#6 “pad” or “pads”
#7 “gel”
#8 pressure NEXT relie*
#9 pressure NEXT reduc*
#10 pressure NEXT alleviat*
#11 “low pressure” NEAR/2 device*
#12 “low pressure” NEAR/2 support
#13 constant NEAR/2 pressure
#14 “static air”
#15 alternat* NEXT pressure
#16 air NEXT suspension*
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#17 air NEXT bag*
#18 water NEXT suspension*
#19 elevation NEAR/2 device*
#20 clinifloat or maxifloat or vaperm or therarest or sheepskin or hammock or “foot waffle” or silicore or pegasus or cairwave
#21 (turn* or tilt*) NEXT (bed* or frame*)
#22 kinetic NEXT (therapy or table*)
#23 net NEXT bed*
#24 “positioning” or “repositioning”
#25 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16
OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24)
#26 MeSH descriptor Pressure Ulcer explode all trees
#27 pressure NEXT (ulcer* or sore*)
#28 decubitus NEXT (ulcer* or sore*)
#29 (bed NEXT sore*) or bedsore*
#30 (#26 OR #27 OR #28 OR #29)
#31 (#25 AND #30)
The MEDLINE search was combined with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MED-
LINE: sensitivity- and precision-maximizing version (2008 revision); Ovid format (Lefebvre 2008). The EMBASE and CINAHL
searches were combined with the trial filters developed by the Scottish Intercollegiate Guidelines Network (SIGN 2008). There was
no restriction on the basis of the language in which the study reports were written, nor publication status.
Appendix 2. Ovid MEDLINE Search Strategy
1 exp Beds/
2 mattress$.mp.
3 cushion$.mp.
4 (foam or transfoam).mp.
5 overlay$.mp.
6 (pad or pads).ti,ab.
7 gel.ti,ab.
8 pressure relie$.mp.
9 pressure reduc$.mp.
10 pressure alleviat$.mp.
11 (low pressure adj2 device$).mp.
12 (low pressure adj2 support).mp.
13 (constant adj2 pressure).mp.
14 static air.mp.
15 (alternat$ adj pressure).mp.
16 air suspension$.mp.
17 air bag$.mp.
18 water suspension$.mp.
19 (elevation adj2 device$).mp.
20 (clinifloat or maxifloat or vaperm or therarest or sheepskin or hammock or foot waffle or silicore or pegasus or cairwave).mp.
21 ((turn$ or tilt$) adj (bed$ or frame$)).mp.
22 (kinetic adj (therapy or table$)).mp.
23 net bed$.mp.
24 (positioning or repositioning).mp.
25 or/1-24
26 exp Pressure Ulcer/
27 (pressure adj (ulcer$ or sore$)).mp.
28 (decubitus adj (ulcer$ or sore$)).mp.
29 (bed adj (ulcer$ or sore$)).mp.
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30 or/26-29
31 25 and 30
Appendix 3. Ovid EMBASE Search Strategy
1 exp Bed/
2 mattress$.mp.
3 cushion$.mp.
4 (foam or transfoam).mp.
5 overlay$.mp.
6 (pad or pads).ti,ab.
7 gel.ti,ab.
8 pressure relie$.mp.
9 pressure reduc$.mp.
10 pressure alleviat$.mp.
11 (low pressure adj2 device$).mp.
12 (low pressure adj2 support).mp.
13 (constant adj2 pressure).mp.
14 static air.mp.
15 (alternat$ adj pressure).mp.
16 air suspension$.mp.
17 air bag$.mp.
18 water suspension$.mp.
19 (elevation adj2 device$).mp.
20 (clinifloat or maxifloat or vaperm or therarest or sheepskin or hammock or foot waffle or silicore or pegasus or cairwave).mp.
21 ((turn$ or tilt$) adj (bed$ or frame$)).mp.
22 (kinetic adj (therapy or table$)).mp.
23 net bed$.mp.
24 (positioning or repositioning).mp.
25 or/1-24
26 exp Decubitus/
27 (pressure adj (ulcer$ or sore$)).mp.
28 (decubitus adj (ulcer$ or sore$)).mp.
29 (bed adj (ulcer$ or sore$)).mp.
30 or/26-29
31 25 and 30
Appendix 4. EBSCO CINAHL Search Strategy
S29 S23 and S28
S28 S24 or S25 or S26 or S27
S27 TI decubitus or AB decubitus
S26 TI ( bed sore* or bedsore* ) or AB ( bed sore* or bedsore* )
S25 TI ( pressure ulcer* or pressure sore* ) or AB ( pressure ulcer* or pressure sore* )
S24 (MH “Pressure Ulcer”)
S23 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or S12 or S13 or S14 or S15 or S16 or S17 or S18 or S19 or S20
or S21 or S22
S22 TI ( positioning or repositioning ) or AB ( positioning or repositioning )
S21 TI net bed* or AB net bed*
S20 TI ( kinetic therapy or kinetic table* ) or AB ( kinetic therapy or kinetic table* )
S19 TI ( turn* bed* or tilt* bed* ) or AB ( turn* frame* or tilt* frame* )
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S18 TI ( clinifloat or maxifloat or vaperm or therarest or sheepskin or hammock or foot waffle or silicore or pegasus or cairwave ) or
AB ( clinifloat or maxifloat or vaperm or therarest or sheepskin or hammock or foot waffle or silicore or pegasus or cairwave )
S17 TI elevation N2 device* or AB elevation N2 device*
S16 TI water suspension or AB water suspension
S15 TI air bag* or AB air bag*
S14 TI air suspension or AB air suspension
S13 TI alternat* pressure or AB alternat* pressure
S12 TI static air or AB static air
S11 TI constant N2 pressure or AB constant N2 pressure
S10 TI low pressure N2 support or AB low pressure N2 support
S9 TI low pressure N2 device* or AB low pressure N2 device*
S8 TI pressure alleviat* or AB pressure alleviat*
S7 TI pressure reduc* or AB pressure reduc*
S6 TI pressure relie* or AB pressure relie*
S5 TI ( overlay* or pad or pads or gel ) or AB ( overlay* or pad or pads or gel )
S4 TI ( foam or transfoam ) or AB ( foam or transfoam )
S3 TI ( mattress* or cushion* ) or AB ( mattress* or cushion* )
S2 (MH “Pillows and Cushions”)
S1 (MH “Beds and Mattresses+”)
Appendix 5. Criteria for judgments for the sources of bias
1. Was the allocation sequence randomly generated?
Yes, low risk of bias
The investigators describe a random component in the sequence generation process such as: referring to a random number table; using
a computer random number generator; coin tossing; shuffling cards or envelopes; throwing dice; drawing of lots.
No, high risk of bias
The investigators describe a non-random component in the sequence generation process. Usually, the description would involve some
systematic, non-random approach, for example: sequence generated by odd or even date of birth; sequence generated by some rule
based on date (or day) of admission; sequence generated by some rule based on hospital or clinic record number.
Unclear
Insufficient information about the sequence generation process to permit judgement of either Yes or No (as above) to be made.
2. Was the treatment allocation adequately concealed?
Yes, low risk of bias
Participants and investigators enrolling participants could not foresee assignment either because one of the following, or an equivalent
method, was used to conceal allocation: central allocation (including telephone, web-based and pharmacy-controlled randomisation);
sequentially-numbered drug containers of identical appearance; sequentially-numbered, opaque, sealed envelopes.
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No, high risk of bias
Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, i.e. when
allocation used: an open random allocation schedule (e.g. a list of random numbers); assignment envelopes without appropriate
safeguards (e.g. if envelopes were unsealed or nonopaque or not sequentially numbered); alternation or rotation; date of birth; case
record number; any other explicitly unconcealed procedure.
Unclear
Insufficient information to permit judgement of either Yes or No to be made. This is usually the case if the method of concealment is
not described, or is not described in sufficient detail to allow a definite judgement, for example if the use of assignment envelopes is
described, but it remains unclear whether envelopes were sequentially numbered, opaque and sealed.
3. Blinding was knowledge of the allocated interventions adequately prevented during the study?
Yes, low risk of bias
Any one of the following:
• No blinding, but the review authors judge that the outcome and the outcome measurement are not likely to be influenced by
lack of blinding.
• Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, but outcome assessment was blinded and the non-blinding of
others unlikely to introduce bias.
No, high risk of bias
Any one of the following:
• No blinding or incomplete blinding, and the outcome or outcome measurement is likely to be influenced by lack of blinding.
• Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, and the non-blinding of others likely to introduce bias.
Unclear
Any one of the following:
• Insufficient information to permit judgement of Yes or No to be made.
• The study did not address this outcome.
4. Were incomplete outcome data adequately addressed?
Yes, low risk of bias
Any one of the following:
• No missing outcome data.
• Reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing
bias).
• Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a
clinically relevant impact on the intervention effect estimate.
• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing
outcomes not enough to have a clinically relevant impact on observed effect size.
• Missing data have been imputed using appropriate methods.
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No, high risk of bias
Any one of the following:
• Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing
data across intervention groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce
clinically relevant bias in intervention effect estimate.
• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing
outcomes enough to induce clinically relevant bias in observed effect size.
• As-treated analysis done with substantial departure of the intervention received from that assigned at randomisation.
• Potentially inappropriate application of simple imputation.
Unclear
Any one of the following:
• Insufficient reporting of attrition/exclusions to permit judgement of Yes or No (e.g. number randomised not stated, no reasons
for missing data provided).
• The study did not address this outcome.
5. Are reports of the study free of suggestion of selective outcome reporting?
Yes, low risk of bias
Any of the following:
• The study protocol is available and all of the pre-specified (primary and secondary) outcomes that are of interest in the review
have been reported in the pre-specified way.
• The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that
were pre-specified (convincing text of this nature may be uncommon).
No, high risk of bias
Any one of the following:
• Not all of the study’s pre-specified primary outcomes reported.
• One or more primary outcomes is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that
were not pre-specified.
• One or more reported primary outcomes were not pre-specified (unless clear justification for their reporting is provided, such as
an unexpected adverse effect).
• One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-analysis.
• The study report fails to include results for a key outcome that would be expected to have been reported for such a study.
Unclear
Insufficient information to permit judgement of Yes or No to be made. It is likely that the majority of studies will fall into this category.
6. Other sources of potential bias:
Yes, low risk of bias
The study appears to be free of other sources of bias.
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No, high risk of bias
There is at least one important risk of bias. For example, the study:
• Had a potential source of bias related to the specific study design used; or
• Stopped early due to some data-dependent process (including a formal-stopping rule); or
• Had extreme baseline imbalance; or
• Has been claimed to have been fraudulent; or
• Had some other problem.
Unclear
There may be a risk of bias, but there is either:
• Insufficient information to assess whether an important risk of bias exists; or
• Insufficient rationale or evidence that an identified problem will introduce bias
WH A T ’ S N E W
Last assessed as up-to-date: 7 December 2010.
Date Event Description
20 December 2010 New search has been performed Third update of review, new searches undertaken. One
new trial included; excluded list, pending assessment
list and reference list updated. Risk of bias assessment
completed
20 December 2010 New citation required but conclusions have not
changed
New author added to the review team.
H I S T O R Y
Protocol first published: Issue 3, 1998
Review first published: Issue 2, 2000
Date Event Description
18 July 2008 New search has been performed Second update of review.
18 July 2008 New citation required and conclusions have changed Second update with the inclusion of 11 additional trials.
23 April 2008 Amended Converted to new review format.
20 May 2004 New citation required and conclusions have changed First update (substantive amendment) published Issue 3,
2004. This review includes only trials which consider inter-
ventions which aim to prevent pressure ulcers. The title of
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(Continued)
the review has been changed to more accurately reflect the
scope of the review
The original review: Beds, mattresses and cushions for pre-
venting and treating pressure ulcers. Cullum N, Deeks J,
Sheldon TA, Song F, Fletcher AW, has been substantially
updated and now forms the basis of a prevention review and
a separate treatment review
C O N T R I B U T I O N S O F A U T H O R S
NC conceived the original idea, wrote the protocol, extracted and analysed the data and drafted the original review, contributed to
both updates and is responsible for the final edit.
EMcI made inclusion decisions, extracted data, assessed study quality, undertook analyses and contributed to the text for all updates.
SBS undertook searching, inclusion decisions, analysis, contributed text for all updates, addressed the copy editor feedback and co-
ordinated the editorial process for the updates.
JD made inclusion decisions, extracted data, assessed study quality, undertook analyses and contributed to the text for the second and
third updates.
AJ-B made inclusion decisions, extracted data, updated the pending assessment of studies list, updated the background section,
undertook analyses and contributed to the text for the third update.
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Nicky Cullum was the Principal Investigator in the PRESSURE Trial, one of the trials included in this review (Nixon 2006), however,
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External sources
• NIHR/Depatment of Health (England), (Cochrane Wounds Group) (all versions), UK.
• NHS Health Technology Assessment Programme (original review), UK.
• National Institute of Clinical Excellence Guidelines Programme (first update), UK.
• Nursing Research Institute SV&MHS and Australian Catholic University, Sydney (third update), Australia.
N O T E S
The original review: Beds, mattresses and cushions for preventing and treating pressure ulcers. Cullum N, Deeks J, Sheldon TA, Song
F, Fletcher AW, has been substantially updated and now forms the basis of a prevention review and a separate treatment review. The
review: Support surfaces for treating pressure ulcers is currently being updated.
This review along with the updates: Support surfaces for pressure ulcer prevention has been prepared by McInnes E, Jammali-Blasi A,
Bell-Syer SEM, Dumville JC, and Cullum NA and includes only trials which consider interventions which aim to prevent pressure
ulcers. The title of the review has been changed to reflect the scope of the review more accurately.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Beds [standards]; Pressure Ulcer [∗prevention & control; therapy]; Randomized Controlled Trials as Topic
MeSH check words
Humans
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